Additional Information
Book Details
Abstract
From Abilify to Zyrtec and nearly every drug in between, Mosby's Drug Reference for Health Professions, 4th Edition is the must-have portable drug handbook for every current or aspiring health professional in the field today. This updated edition features concise, reliable information that is easy to navigate, with alphabetically listed monographs for over 900 generic drugs (including 4,500 trade-name drugs, for both US and Canada).
- Precautions and Considerations sections address key storage and administration details appropriate for a wide variety of health professions.
- Abbreviated drug monographs organized alphabetically by generic name save you time finding need-to-know details for day-to-day practice.
- Special drug information icons call your attention to important information necessary in emergency situations when a quick answer is critical.
- Two-color design format highlights key elements and information for quick and easy access.
- Lifespan content equips you with the answers you need when working with the elderly, pediatric and adult populations health professionals encounter.
- Drug storage information arms health professionals with information about the extra care necessary to maintain drug potency.
- NEW! A thoroughly reviewed and clinically accurate drug list that health professionals, practitioners and students can rely on.
- NEW! E-book version has pill images from the website integrated into corresponding monographs.
- NEW! English to Spanish drug phrases translator available on companion website.
- NEW! 45 new monographs! Over 900 drug monographs in total supply you with the most current and inclusive drug information.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
IFC\r | IFC | ||
Mosby’s Drug Reference for Health Professions | i | ||
Copyright | ii | ||
Drug Information Reviewer Panel | iii | ||
Reviewers\r | iii | ||
Past Reviewers | iv | ||
Contents | viii | ||
A | 1 | ||
MECHANISM OF ACTION | 1 | ||
PHARMACOKINETICS | 1 | ||
AVAILABILITY | 1 | ||
INDICATIONS AND DOSAGES | 1 | ||
CONTRAINDICATIONS | 1 | ||
SERIOUS REACTIONS | 1 | ||
MECHANISM OF ACTION | 2 | ||
PHARMACOKINETICS | 2 | ||
AVAILABILITY | 2 | ||
INDICATIONS AND DOSAGES | 3 | ||
CONTRAINDICATIONS | 3 | ||
DIAGNOSTIC TEST EFFECTS | 3 | ||
IV INCOMPATIBILITIES | 3 | ||
SIDE EFFECTS | 3 | ||
SERIOUS REACTIONS | 3 | ||
MECHANISM OF ACTION | 5 | ||
PHARMACOKINETICS | 5 | ||
AVAILABILITY | 5 | ||
INDICATIONS AND DOSAGES | 5 | ||
CONTRAINDICATIONS | 5 | ||
DIAGNOSTIC TEST EFFECTS | 5 | ||
IV INCOMPATIBILITIES | 5 | ||
SERIOUS REACTIONS | 6 | ||
MECHANISM OF ACTION | 7 | ||
PHARMACOKINETICS | 7 | ||
AVAILABILITY | 7 | ||
INDICATIONS AND DOSAGES | 7 | ||
CONTRAINDICATIONS | 7 | ||
DIAGNOSTIC TEST EFFECTS | 8 | ||
SERIOUS REACTIONS | 8 | ||
PHARMACOKINETICS | 9 | ||
AVAILABILITY | 9 | ||
INDICATIONS AND DOSAGES | 9 | ||
CONTRAINDICATIONS | 9 | ||
DIAGNOSTIC TEST EFFECTS | 9 | ||
SERIOUS REACTIONS | 9 | ||
MECHANISM OF ACTION | 10 | ||
AVAILABILITY | 10 | ||
INDICATIONS AND DOSAGES | 10 | ||
CONTRAINDICATIONS | 10 | ||
DIAGNOSTIC TEST EFFECTS | 11 | ||
SIDE EFFECTS | 11 | ||
SERIOUS REACTIONS | 11 | ||
MECHANISM OF ACTION | 11 | ||
PHARMACOKINETICS | 12 | ||
AVAILABILITY | 12 | ||
INDICATIONS AND DOSAGES | 12 | ||
OFF-LABEL USES | 12 | ||
CONTRAINDICATIONS | 12 | ||
DIAGNOSTIC TEST EFFECTS | 12 | ||
SERIOUS REACTIONS | 12 | ||
MECHANISM OF ACTION | 13 | ||
PHARMACOKINETICS | 14 | ||
AVAILABILITY | 14 | ||
INDICATIONS AND DOSAGES | 14 | ||
CONTRAINDICATIONS | 14 | ||
DIAGNOSTIC TEST EFFECTS | 15 | ||
IV INCOMPATIBILITIES | 15 | ||
MECHANISM OF ACTION | 16 | ||
PHARMACOKINETICS | 16 | ||
AVAILABILITY | 16 | ||
INDICATIONS AND DOSAGES | 16 | ||
CONTRAINDICATIONS | 17 | ||
DIAGNOSTIC TEST EFFECTS | 17 | ||
IV INCOMPATIBILITIES | 17 | ||
IV COMPATIBILITIES | 17 | ||
SERIOUS REACTIONS | 18 | ||
MECHANISM OF ACTION | 18 | ||
PHARMACOKINETICS | 19 | ||
AVAILABILITY | 19 | ||
INDICATIONS AND DOSAGES | 19 | ||
CONTRAINDICATIONS | 19 | ||
DIAGNOSTIC TEST EFFECTS | 19 | ||
SERIOUS REACTIONS | 19 | ||
MECHANISM OF ACTION | 20 | ||
PHARMACOKINETICS | 20 | ||
AVAILABILITY | 20 | ||
INDICATIONS AND DOSAGES | 20 | ||
OFF-LABEL USES | 20 | ||
CONTRAINDICATIONS | 20 | ||
DIAGNOSTIC TEST EFFECTS | 20 | ||
SERIOUS REACTIONS | 21 | ||
MECHANISM OF ACTION | 21 | ||
PHARMACOKINETICS | 22 | ||
AVAILABILITY | 22 | ||
INDICATIONS AND DOSAGES | 22 | ||
OFF-LABEL USES | 22 | ||
CONTRAINDICATIONS | 22 | ||
DIAGNOSTIC TEST EFFECTS | 22 | ||
SERIOUS REACTIONS | 23 | ||
MECHANISM OF ACTION | 23 | ||
PHARMACOKINETICS | 23 | ||
AVAILABILITY | 24 | ||
INDICATIONS AND DOSAGES | 24 | ||
OFF-LABEL USES | 25 | ||
CONTRAINDICATIONS | 25 | ||
DIAGNOSTIC TEST EFFECTS | 25 | ||
IV INCOMPATIBILITIES | 25 | ||
IV COMPATIBILITIES | 25 | ||
SERIOUS REACTIONS | 25 | ||
MECHANISM OF ACTION | 27 | ||
PHARMACOKINETICS | 27 | ||
AVAILABILITY | 27 | ||
INDICATIONS AND DOSAGES | 27 | ||
CONTRAINDICATIONS | 27 | ||
DIAGNOSTIC TEST EFFECTS | 27 | ||
SERIOUS REACTIONS | 28 | ||
MECHANISM OF ACTION | 28 | ||
PHARMACOKINETICS | 29 | ||
AVAILABILITY | 29 | ||
INDICATIONS AND DOSAGES | 29 | ||
CONTRAINDICATIONS | 29 | ||
DIAGNOSTIC TEST EFFECTS | 29 | ||
SERIOUS REACTIONS | 29 | ||
MECHANISM OF ACTION | 30 | ||
PHARMACOKINETICS | 30 | ||
AVAILABILITY | 30 | ||
INDICATIONS AND DOSAGES | 30 | ||
CONTRAINDICATIONS | 30 | ||
DIAGNOSTIC TEST EFFECTS | 30 | ||
SERIOUS REACTIONS | 30 | ||
MECHANISM OF ACTION | 31 | ||
PHARMACOKINETICS | 31 | ||
AVAILABILITY | 31 | ||
INDICATIONS AND DOSAGES | 31 | ||
CONTRAINDICATIONS | 31 | ||
DIAGNOSTIC TEST EFFECTS | 32 | ||
IV INCOMPATIBILITIES | 32 | ||
IV COMPATIBILITIES | 32 | ||
SERIOUS REACTIONS | 32 | ||
PHARMACOKINETICS | 33 | ||
AVAILABILITY | 33 | ||
INDICATIONS AND DOSAGES | 33 | ||
OFF-LABEL USES | 33 | ||
CONTRAINDICATIONS | 33 | ||
DIAGNOSTIC TEST EFFECTS | 33 | ||
SERIOUS REACTIONS | 33 | ||
MECHANISM OF ACTION | 34 | ||
PHARMACOKINETICS | 34 | ||
AVAILABILITY | 34 | ||
INDICATIONS AND DOSAGES | 34 | ||
CONTRAINDICATIONS | 35 | ||
DIAGNOSTIC TEST EFFECTS | 35 | ||
IV INCOMPATIBILITIES | 35 | ||
IV COMPATIBILITIES | 35 | ||
SERIOUS REACTIONS | 35 | ||
MECHANISM OF ACTION | 36 | ||
PHARMACOKINETICS | 36 | ||
AVAILABILITY | 36 | ||
INDICATIONS AND DOSAGES | 36 | ||
OFF-LABEL USES | 36 | ||
CONTRAINDICATIONS | 36 | ||
DIAGNOSTIC TEST EFFECTS | 37 | ||
SERIOUS REACTIONS | 37 | ||
MECHANISM OF ACTION | 38 | ||
PHARMACOKINETICS | 38 | ||
AVAILABILITY | 38 | ||
INDICATIONS AND DOSAGES | 38 | ||
OFF-LABEL USES | 38 | ||
CONTRAINDICATIONS | 38 | ||
DIAGNOSTIC TEST EFFECTS | 39 | ||
SERIOUS REACTIONS | 39 | ||
MECHANISM OF ACTION | 40 | ||
PHARMACOKINETICS | 40 | ||
AVAILABILITY | 40 | ||
INDICATIONS AND DOSAGES | 40 | ||
CONTRAINDICATIONS | 40 | ||
INTERACTIONS | 40 | ||
SERIOUS REACTIONS | 40 | ||
MECHANISM OF ACTION | 41 | ||
PHARMACOKINETICS | 41 | ||
AVAILABILITY | 41 | ||
INDICATIONS AND DOSAGES | 41 | ||
CONTRAINDICATIONS | 41 | ||
DIAGNOSTIC TEST EFFECTS | 41 | ||
PHARMACOKINETICS | 42 | ||
AVAILABILITY | 42 | ||
INDICATIONS AND DOSAGES | 42 | ||
CONTRAINDICATIONS | 42 | ||
DIAGNOSTIC TEST EFFECTS | 42 | ||
IV INCOMPATIBILITIES | 43 | ||
SERIOUS REACTIONS | 43 | ||
PHARMACOKINETICS | 43 | ||
AVAILABILITY | 44 | ||
INDICATIONS AND DOSAGES | 44 | ||
CONTRAINDICATIONS | 44 | ||
DIAGNOSTIC TEST EFFECTS | 44 | ||
SERIOUS REACTIONS | 44 | ||
MECHANISM OF ACTION | 45 | ||
PHARMACOKINETICS | 45 | ||
AVAILABILITY | 45 | ||
INDICATIONS AND DOSAGES | 45 | ||
CONTRAINDICATIONS | 45 | ||
DIAGNOSTIC TEST EFFECTS | 46 | ||
SERIOUS REACTIONS | 46 | ||
MECHANISM OF ACTION | 46 | ||
PHARMACOKINETICS | 46 | ||
AVAILABILITY | 46 | ||
INDICATIONS AND DOSAGES | 47 | ||
CONTRAINDICATIONS | 47 | ||
DIAGNOSTIC TEST EFFECTS | 47 | ||
SERIOUS REACTIONS | 47 | ||
MECHANISM OF ACTION | 48 | ||
PHARMACOKINETICS | 48 | ||
AVAILABILITY | 48 | ||
INDICATIONS AND DOSAGES | 48 | ||
OFF-LABEL USES | 48 | ||
CONTRAINDICATIONS | 48 | ||
DIAGNOSTIC TEST EFFECTS | 48 | ||
SERIOUS REACTIONS | 48 | ||
MECHANISM OF ACTION | 49 | ||
PHARMACOKINETICS | 49 | ||
AVAILABILITY | 49 | ||
INDICATIONS AND DOSAGES | 49 | ||
CONTRAINDICATIONS | 49 | ||
DIAGNOSTIC TEST EFFECTS | 50 | ||
IV INCOMPATIBILITIES | 50 | ||
IV COMPATIBILITIES | 50 | ||
SERIOUS REACTIONS | 50 | ||
MECHANISM OF ACTION | 51 | ||
PHARMACOKINETICS | 51 | ||
AVAILABILITY | 51 | ||
INDICATIONS AND DOSAGES | 51 | ||
CONTRAINDICATIONS | 51 | ||
DIAGNOSTIC TEST EFFECTS | 52 | ||
SERIOUS REACTIONS | 52 | ||
MECHANISM OF ACTION | 52 | ||
PHARMACOKINETICS | 52 | ||
AVAILABILITY | 53 | ||
INDICATIONS AND DOSAGES | 53 | ||
CONTRAINDICATIONS | 53 | ||
DIAGNOSTIC TEST EFFECTS | 53 | ||
SERIOUS REACTIONS | 53 | ||
MECHANISM OF ACTION | 54 | ||
PHARMACOKINETICS | 54 | ||
AVAILABILITY | 54 | ||
INDICATIONS AND DOSAGES | 54 | ||
CONTRAINDICATIONS | 55 | ||
DIAGNOSTIC TEST EFFECTS | 55 | ||
SERIOUS REACTIONS | 55 | ||
MECHANISM OF ACTION | 56 | ||
PHARMACOKINETICS | 56 | ||
AVAILABILITY | 56 | ||
INDICATIONS AND DOSAGES | 56 | ||
OFF-LABEL USES | 57 | ||
CONTRAINDICATIONS | 57 | ||
DIAGNOSTIC TEST EFFECTS | 57 | ||
IV INCOMPATIBILITIES | 57 | ||
IV COMPATIBILITIES | 57 | ||
SERIOUS REACTIONS | 57 | ||
MECHANISM OF ACTION | 58 | ||
PHARMACOKINETICS | 59 | ||
AVAILABILITY | 59 | ||
INDICATIONS AND DOSAGES | 59 | ||
CONTRAINDICATIONS | 59 | ||
DIAGNOSTIC TEST EFFECTS | 59 | ||
SERIOUS REACTIONS | 59 | ||
MECHANISM OF ACTION | 59 | ||
AVAILABILITY | 60 | ||
INDICATIONS AND DOSAGES | 60 | ||
CONTRAINDICATIONS | 60 | ||
DIAGNOSTIC TEST EFFECTS | 60 | ||
SERIOUS REACTIONS | 60 | ||
MECHANISM OF ACTION | 61 | ||
PHARMACOKINETICS | 61 | ||
AVAILABILITY | 61 | ||
INDICATIONS AND DOSAGES | 61 | ||
CONTRAINDICATIONS | 61 | ||
DIAGNOSTIC TEST EFFECTS | 61 | ||
SERIOUS REACTIONS | 62 | ||
MECHANISM OF ACTION | 62 | ||
PHARMACOKINETICS | 62 | ||
AVAILABILITY | 63 | ||
INDICATIONS AND DOSAGES | 63 | ||
CONTRAINDICATIONS | 63 | ||
DIAGNOSTIC TEST EFFECTS | 63 | ||
SERIOUS REACTIONS | 63 | ||
PHARMACOKINETICS | 64 | ||
AVAILABILITY | 65 | ||
INDICATIONS AND DOSAGES | 65 | ||
CONTRAINDICATIONS | 65 | ||
DIAGNOSTIC TEST EFFECTS | 65 | ||
SERIOUS REACTIONS | 65 | ||
MECHANISM OF ACTION | 66 | ||
PHARMACOKINETICS | 66 | ||
AVAILABILITY | 66 | ||
INDICATIONS AND DOSAGES | 66 | ||
CONTRAINDICATIONS | 66 | ||
DIAGNOSTIC TEST EFFECTS | 66 | ||
SERIOUS REACTIONS | 66 | ||
MECHANISM OF ACTION | 67 | ||
PHARMACOKINETICS | 67 | ||
AVAILABILITY | 67 | ||
INDICATIONS AND DOSAGES | 67 | ||
CONTRAINDICATIONS | 68 | ||
DIAGNOSTIC TEST EFFECTS | 68 | ||
IV INCOMPATIBILITIES | 68 | ||
IV COMPATIBILITIES | 68 | ||
SERIOUS REACTIONS | 68 | ||
MECHANISM OF ACTION | 69 | ||
PHARMACOKINETICS | 69 | ||
AVAILABILITY | 70 | ||
INDICATIONS AND DOSAGES | 70 | ||
OFF-LABEL USES | 70 | ||
CONTRAINDICATIONS | 70 | ||
DIAGNOSTIC TEST EFFECTS | 70 | ||
SERIOUS REACTIONS | 70 | ||
MECHANISM OF ACTION | 71 | ||
PHARMACOKINETICS | 71 | ||
AVAILABILITY | 71 | ||
INDICATIONS AND DOSAGES | 71 | ||
OFF-LABEL USES | 71 | ||
CONTRAINDICATIONS | 71 | ||
DIAGNOSTIC TEST EFFECTS | 71 | ||
IV INCOMPATIBILITIES | 72 | ||
SERIOUS REACTIONS | 72 | ||
MECHANISM OF ACTION | 72 | ||
PHARMACOKINETICS | 73 | ||
AVAILABILITY | 73 | ||
INDICATIONS AND DOSAGES | 73 | ||
CONTRAINDICATIONS | 74 | ||
DIAGNOSTIC TEST EFFECTS | 74 | ||
IV INCOMPATIBILITIES | 74 | ||
IV COMPATIBILITIES | 74 | ||
SERIOUS REACTIONS | 74 | ||
MECHANISM OF ACTION | 75 | ||
PHARMACOKINETICS | 75 | ||
AVAILABILITY | 75 | ||
INDICATIONS AND DOSAGES | 75 | ||
OFF-LABEL USES | 75 | ||
CONTRAINDICATIONS | 75 | ||
DIAGNOSTIC TEST EFFECTS | 75 | ||
SERIOUS REACTIONS | 76 | ||
MECHANISM OF ACTION | 76 | ||
PHARMACOKINETICS | 76 | ||
AVAILABILITY | 77 | ||
INDICATIONS AND DOSAGES | 77 | ||
OFF-LABEL USES | 77 | ||
CONTRAINDICATIONS | 77 | ||
DIAGNOSTIC TEST EFFECTS | 77 | ||
IV INCOMPATIBILITIES | 78 | ||
IV COMPATIBILITIES | 78 | ||
SERIOUS REACTIONS | 78 | ||
MECHANISM OF ACTION | 79 | ||
PHARMACOKINETICS | 79 | ||
AVAILABILITY | 79 | ||
INDICATIONS AND DOSAGES | 80 | ||
OFF-LABEL USES | 80 | ||
CONTRAINDICATIONS | 80 | ||
DIAGNOSTIC TEST EFFECTS | 80 | ||
SERIOUS REACTIONS | 80 | ||
MECHANISM OF ACTION | 81 | ||
PHARMACOKINETICS | 81 | ||
AVAILABILITY | 82 | ||
INDICATIONS AND DOSAGES | 82 | ||
CONTRAINDICATIONS | 82 | ||
DIAGNOSTIC TEST EFFECTS | 82 | ||
SERIOUS REACTIONS | 82 | ||
B | 154 | ||
MECHANISM OF ACTION | 154 | ||
PHARMACOKINETICS | 154 | ||
AVAILABILITY | 154 | ||
INDICATIONS AND DOSAGES | 154 | ||
CONTRAINDICATIONS | 154 | ||
DIAGNOSTIC TEST EFFECTS | 154 | ||
SERIOUS REACTIONS | 155 | ||
MECHANISM OF ACTION | 155 | ||
PHARMACOKINETICS | 155 | ||
AVAILABILITY | 155 | ||
INDICATIONS AND DOSAGES | 156 | ||
OFF-LABEL USES | 156 | ||
CONTRAINDICATIONS | 156 | ||
INTERACTIONS | 156 | ||
DIAGNOSTIC TEST EFFECTS | 156 | ||
SERIOUS REACTIONS | 156 | ||
MECHANISM OF ACTION | 157 | ||
PHARMACOKINETICS | 157 | ||
AVAILABILITY | 157 | ||
INDICATIONS AND DOSAGES | 157 | ||
CONTRAINDICATIONS | 158 | ||
INTERACTIONS | 158 | ||
SERIOUS REACTIONS | 158 | ||
PHARMACOKINETICS | 158 | ||
AVAILABILITY | 158 | ||
INDICATIONS AND DOSAGES | 158 | ||
CONTRAINDICATIONS | 159 | ||
DIAGNOSTIC TEST EFFECTS | 159 | ||
SERIOUS REACTIONS | 159 | ||
MECHANISM OF ACTION | 159 | ||
PHARMACOKINETICS | 160 | ||
AVAILABILITY | 160 | ||
INDICATIONS AND DOSAGES | 160 | ||
CONTRAINDICATIONS | 160 | ||
DIAGNOSTIC TEST EFFECTS | 160 | ||
SERIOUS REACTIONS | 160 | ||
MECHANISM OF ACTION | 161 | ||
PHARMACOKINETICS | 161 | ||
AVAILABILITY | 161 | ||
INDICATIONS AND DOSAGES | 161 | ||
CONTRAINDICATIONS | 162 | ||
DIAGNOSTIC TEST EFFECTS | 162 | ||
IV INCOMPATIBILITIES | 162 | ||
SERIOUS REACTIONS | 162 | ||
MECHANISM OF ACTION | 164 | ||
PHARMACOKINETICS | 164 | ||
AVAILABILITY | 164 | ||
INDICATIONS AND DOSAGES | 164 | ||
CONTRAINDICATIONS | 164 | ||
DIAGNOSTIC TEST EFFECTS | 165 | ||
SERIOUS REACTIONS | 165 | ||
MECHANISM OF ACTION | 166 | ||
PHARMACOKINETICS | 166 | ||
AVAILABILITY | 166 | ||
INDICATIONS AND DOSAGES | 166 | ||
CONTRAINDICATIONS | 166 | ||
DIAGNOSTIC TEST EFFECTS | 166 | ||
SERIOUS REACTIONS | 167 | ||
MECHANISM OF ACTION | 167 | ||
PHARMACOKINETICS | 167 | ||
AVAILABILITY | 167 | ||
INDICATIONS AND DOSAGES | 167 | ||
OFF-LABEL USES | 168 | ||
CONTRAINDICATIONS | 168 | ||
DIAGNOSTIC TEST EFFECTS | 168 | ||
SERIOUS REACTIONS | 168 | ||
PHARMACOKINETICS | 169 | ||
AVAILABILITY | 169 | ||
INDICATIONS AND DOSAGES | 170 | ||
CONTRAINDICATIONS | 170 | ||
DIAGNOSTIC TEST EFFECTS | 170 | ||
SERIOUS REACTIONS | 170 | ||
MECHANISM OF ACTION | 170 | ||
PHARMACOKINETICS | 170 | ||
AVAILABILITY | 171 | ||
INDICATIONS AND DOSAGES | 171 | ||
CONTRAINDICATIONS | 171 | ||
DIAGNOSTIC TEST EFFECTS | 171 | ||
SERIOUS REACTIONS | 172 | ||
MECHANISM OF ACTION | 172 | ||
PHARMACOKINETICS | 172 | ||
AVAILABILITY | 172 | ||
INDICATIONS AND DOSAGES | 172 | ||
OFF-LABEL USES | 172 | ||
CONTRAINDICATIONS | 172 | ||
DIAGNOSTIC TEST EFFECTS | 173 | ||
SERIOUS REACTIONS | 173 | ||
MECHANISM OF ACTION | 173 | ||
PHARMACOKINETICS | 173 | ||
AVAILABILITY | 173 | ||
INDICATIONS AND DOSAGES | 174 | ||
OFF-LABEL USES | 174 | ||
CONTRAINDICATIONS | 174 | ||
DIAGNOSTIC TEST EFFECTS | 174 | ||
SERIOUS REACTIONS | 174 | ||
MECHANISM OF ACTION | 175 | ||
PHARMACOKINETICS | 175 | ||
AVAILABILITY | 175 | ||
INDICATIONS AND DOSAGES | 175 | ||
IV INCOMPATIBILITIES | 175 | ||
CONTRAINDICATIONS | 175 | ||
DIAGNOSTIC TEST EFFECTS | 175 | ||
SERIOUS REACTIONS | 175 | ||
MECHANISM OF ACTION | 176 | ||
PHARMACOKINETICS | 176 | ||
AVAILABILITY | 176 | ||
INDICATIONS AND DOSAGES | 176 | ||
CONTRAINDICATIONS | 176 | ||
DIAGNOSTIC TEST EFFECTS | 176 | ||
SERIOUS REACTIONS | 177 | ||
MECHANISM OF ACTION | 177 | ||
PHARMACOKINETICS | 178 | ||
AVAILABILITY | 178 | ||
INDICATIONS AND DOSAGES | 178 | ||
CONTRAINDICATIONS | 178 | ||
SERIOUS REACTIONS | 178 | ||
PHARMACOKINETICS | 179 | ||
AVAILABILITY | 179 | ||
INDICATIONS AND DOSAGES | 179 | ||
CONTRAINDICATIONS | 179 | ||
SERIOUS REACTIONS | 179 | ||
MECHANISM OF ACTION | 180 | ||
PHARMACOKINETICS | 180 | ||
AVAILABILITY | 180 | ||
INDICATIONS AND DOSAGES | 180 | ||
OFF-LABEL USES | 180 | ||
CONTRAINDICATIONS | 180 | ||
DIAGNOSTIC TEST EFFECTS | 181 | ||
SERIOUS REACTIONS | 181 | ||
MECHANISM OF ACTION | 182 | ||
PHARMACOKINETICS | 182 | ||
AVAILABILITY | 182 | ||
INDICATIONS AND DOSAGES | 182 | ||
OFF-LABEL USES | 182 | ||
CONTRAINDICATIONS | 182 | ||
DIAGNOSTIC TEST EFFECTS | 182 | ||
SIDE EFFECTS | 182 | ||
SERIOUS REACTIONS | 183 | ||
MECHANISM OF ACTION | 184 | ||
PHARMACOKINETICS | 184 | ||
AVAILABILITY | 184 | ||
INDICATIONS AND DOSAGES | 184 | ||
OFF-LABEL USES | 184 | ||
CONTRAINDICATIONS | 184 | ||
DIAGNOSTIC TEST EFFECTS | 184 | ||
SERIOUS REACTIONS | 184 | ||
PHARMACOKINETICS | 185 | ||
AVAILABILITY | 185 | ||
INDICATIONS AND DOSAGES | 185 | ||
OFF-LABEL USES | 185 | ||
CONTRAINDICATIONS | 185 | ||
DIAGNOSTIC TEST EFFECTS | 185 | ||
SERIOUS REACTIONS | 186 | ||
MECHANISM OF ACTION | 186 | ||
PHARMACOKINETICS | 186 | ||
AVAILABILITY | 186 | ||
INDICATIONS AND DOSAGES | 186 | ||
CONTRAINDICATIONS | 187 | ||
DIAGNOSTIC TEST EFFECTS | 187 | ||
SERIOUS REACTIONS | 187 | ||
MECHANISM OF ACTION | 187 | ||
PHARMACOKINETICS | 187 | ||
AVAILABILITY | 188 | ||
INDICATIONS AND DOSAGES | 188 | ||
CONTRAINDICATIONS | 188 | ||
DIAGNOSTIC TEST EFFECTS | 188 | ||
SERIOUS REACTIONS | 188 | ||
MECHANISM OF ACTION | 189 | ||
PHARMACOKINETICS | 189 | ||
AVAILABILITY | 189 | ||
INDICATIONS AND DOSAGES | 189 | ||
CONTRAINDICATIONS | 189 | ||
DIAGNOSTIC TEST EFFECTS | 189 | ||
SERIOUS REACTIONS | 190 | ||
MECHANISM OF ACTION | 190 | ||
AVAILABILITY | 190 | ||
INDICATIONS AND DOSAGES | 191 | ||
OFF-LABEL USES | 191 | ||
CONTRAINDICATIONS | 191 | ||
DIAGNOSTIC TEST EFFECTS | 191 | ||
SERIOUS REACTIONS | 191 | ||
MECHANISM OF ACTION | 192 | ||
PHARMACOKINETICS | 192 | ||
AVAILABILITY | 192 | ||
INDICATIONS AND DOSAGES | 192 | ||
OFF-LABEL USES | 192 | ||
CONTRAINDICATIONS | 192 | ||
DIAGNOSTIC TEST EFFECTS | 193 | ||
SERIOUS REACTIONS | 193 | ||
MECHANISM OF ACTION | 194 | ||
PHARMACOKINETICS | 194 | ||
AVAILABILITY | 194 | ||
INDICATIONS AND DOSAGES | 194 | ||
GFR | 194 | ||
OFF-LABEL USE | 194 | ||
CONTRAINDICATIONS | 194 | ||
DIAGNOSTIC TEST EFFECTS | 195 | ||
IV INCOMPATIBILITIES | 195 | ||
SERIOUS REACTIONS | 195 | ||
PHARMACOKINETICS | 196 | ||
AVAILABILITY | 196 | ||
INDICATIONS AND DOSAGES | 196 | ||
CONTRAINDICATIONS | 196 | ||
DIAGNOSTIC TEST EFFECTS | 197 | ||
SIDE EFFECTS | 197 | ||
SERIOUS REACTIONS | 197 | ||
PHARMACOKINETICS | 199 | ||
AVAILABILITY | 199 | ||
INDICATIONS AND DOSAGES | 199 | ||
MODERATE TO SEVERE HEPATIC IMPAIRMENT | 199 | ||
CONTRAINDICATIONS | 199 | ||
DIAGNOSTIC TEST EFFECTS | 199 | ||
SERIOUS REACTIONS | 200 | ||
MECHANISM OF ACTION | 200 | ||
PHARMACOKINETICS | 201 | ||
AVAILABILITY | 201 | ||
INDICATIONS AND DOSAGES | 201 | ||
CONTRAINDICATIONS | 201 | ||
DIAGNOSTIC TEST EFFECTS | 201 | ||
SERIOUS REACTIONS | 201 | ||
MECHANISM OF ACTION | 203 | ||
PHARMACOKINETICS | 203 | ||
AVAILABILITY | 203 | ||
INDICATIONS AND DOSAGES | 203 | ||
CONTRAINDICATIONS | 203 | ||
SERIOUS REACTIONS | 203 | ||
MECHANISM OF ACTION | 204 | ||
PHARMACOKINETICS | 204 | ||
AVAILABILITY | 204 | ||
INDICATIONS AND DOSAGES | 204 | ||
CONTRAINDICATIONS | 204 | ||
DIAGNOSTIC TEST EFFECTS | 204 | ||
SERIOUS REACTIONS | 204 | ||
MECHANISM OF ACTION | 205 | ||
PHARMACOKINETICS | 205 | ||
AVAILABILITY | 205 | ||
INDICATIONS AND DOSAGES | 205 | ||
CONTRAINDICATIONS | 205 | ||
DIAGNOSTIC TEST EFFECTS | 205 | ||
SERIOUS REACTIONS | 206 | ||
MECHANISM OF ACTION | 206 | ||
PHARMACOKINETICS | 207 | ||
AVAILABILITY | 207 | ||
INDICATIONS AND DOSAGES | 207 | ||
OFF-LABEL USES | 207 | ||
CONTRAINDICATIONS | 207 | ||
DIAGNOSTIC TEST EFFECTS | 208 | ||
SERIOUS REACTIONS | 208 | ||
MECHANISM OF ACTION | 208 | ||
PHARMACOKINETICS | 209 | ||
AVAILABILITY | 209 | ||
INDICATIONS AND DOSAGES | 209 | ||
CONTRAINDICATIONS | 209 | ||
DIAGNOSTIC TEST EFFECTS | 209 | ||
SERIOUS REACTIONS | 210 | ||
MECHANISM OF ACTION | 210 | ||
PHARMACOKINETICS | 210 | ||
AVAILABILITY | 210 | ||
INDICATIONS AND DOSAGES | 211 | ||
CONTRAINDICATIONS | 211 | ||
DIAGNOSTIC TEST EFFECTS | 211 | ||
SERIOUS REACTIONS | 211 | ||
MECHANISM OF ACTION | 212 | ||
PHARMACOKINETICS | 213 | ||
AVAILABILITY | 213 | ||
INDICATIONS AND DOSAGES | 213 | ||
CONTRAINDICATIONS | 213 | ||
DIAGNOSTIC TEST EFFECTS | 213 | ||
SERIOUS REACTIONS | 213 | ||
MECHANISM OF ACTION | 215 | ||
PHARMACOKINETICS | 215 | ||
AVAILABILITY | 215 | ||
INDICATIONS AND DOSAGES | 215 | ||
OFF-LABEL USES | 215 | ||
CONTRAINDICATIONS | 215 | ||
DIAGNOSTIC TEST EFFECTS | 215 | ||
IV INCOMPATIBILITIES | 215 | ||
IV COMPATIBILITIES | 215 | ||
SERIOUS REACTIONS | 216 | ||
MECHANISM OF ACTION | 217 | ||
PHARMACOKINETICS | 217 | ||
AVAILABILITY | 217 | ||
INDICATIONS AND DOSAGES | 217 | ||
CONTRAINDICATIONS | 218 | ||
DIAGNOSTIC TEST EFFECTS | 219 | ||
SERIOUS REACTIONS | 219 | ||
MECHANISM OF ACTION | 220 | ||
PHARMACOKINETICS | 220 | ||
AVAILABILITY | 220 | ||
INDICATIONS AND DOSAGES | 220 | ||
CHRONIC ANALGESIA | 221 | ||
CONTRAINDICATIONS | 221 | ||
DIAGNOSTIC TEST EFFECTS | 221 | ||
SERIOUS REACTIONS | 221 | ||
MECHANISM OF ACTION | 222 | ||
PHARMACOKINETICS | 222 | ||
AVAILABILITY | 222 | ||
INDICATIONS AND DOSAGES | 222 | ||
CONTRAINDICATIONS | 223 | ||
INTERACTIONS | 223 | ||
DIAGNOSTIC TEST EFFECTS | 223 | ||
SERIOUS REACTIONS | 223 | ||
MECHANISM OF ACTION | 224 | ||
PHARMACOKINETICS | 224 | ||
AVAILABILITY | 224 | ||
INDICATIONS AND DOSAGES | 224 | ||
OFF-LABEL USES | 224 | ||
CONTRAINDICATIONS | 224 | ||
DIAGNOSTIC TEST EFFECTS | 224 | ||
SERIOUS REACTIONS | 225 | ||
MECHANISM OF ACTION | 225 | ||
PHARMACOKINETICS | 225 | ||
AVAILABILITY | 225 | ||
INDICATIONS AND DOSAGES | 225 | ||
C | 230 | ||
MECHANISM OF ACTION | 230 | ||
PHARMACOKINETICS | 230 | ||
AVAILABILITY | 230 | ||
OFF-LABEL USES | 230 | ||
CONTRAINDICATIONS | 230 | ||
DIAGNOSTIC TEST EFFECTS | 230 | ||
SERIOUS REACTIONS | 231 | ||
MECHANISM OF ACTION | 231 | ||
PHARMACOKINETICS | 231 | ||
AVAILABILITY | 231 | ||
CONTRAINDICATIONS | 231 | ||
DIAGNOSTIC TEST EFFECTS | 232 | ||
IV INCOMPATIBILITIES | 232 | ||
IV COMPATIBILITIES | 232 | ||
SERIOUS REACTIONS | 232 | ||
MECHANISM OF ACTION | 233 | ||
PHARMACOKINETICS | 233 | ||
AVAILABILITY | 233 | ||
CONTRAINDICATIONS | 233 | ||
DIAGNOSTIC TEST EFFECTS | 233 | ||
SERIOUS REACTIONS | 233 | ||
MECHANISM OF ACTION | 234 | ||
PHARMACOKINETICS | 234 | ||
AVAILABILITY | 234 | ||
OFF-LABEL USES | 234 | ||
CONTRAINDICATIONS | 234 | ||
DIAGNOSTIC TEST EFFECTS | 235 | ||
SERIOUS REACTIONS | 235 | ||
MECHANISM OF ACTION | 236 | ||
PHARMACOKINETICS | 236 | ||
AVAILABILITY | 236 | ||
CONTRAINDICATIONS | 236 | ||
DIAGNOSTIC TEST EFFECTS | 237 | ||
SERIOUS REACTIONS | 237 | ||
MECHANISM OF ACTION | 238 | ||
PHARMACOKINETICS | 238 | ||
AVAILABILITY | 238 | ||
INDICATIONS AND DOSAGES | 238 | ||
CONTRAINDICATIONS | 238 | ||
DIAGNOSTIC TEST EFFECTS | 238 | ||
SERIOUS REACTIONS | 238 | ||
MECHANISM OF ACTION | 239 | ||
PHARMACOKINETICS | 239 | ||
AVAILABILITY | 239 | ||
CONTRAINDICATIONS | 240 | ||
DIAGNOSTIC TEST EFFECTS | 241 | ||
IV INCOMPATIBILITIES | 241 | ||
IV COMPATIBILITIES | 241 | ||
SERIOUS REACTIONS | 241 | ||
PHARMACOKINETICS | 242 | ||
AVAILABILITY | 242 | ||
CONTRAINDICATIONS | 243 | ||
DIAGNOSTIC TEST EFFECTS | 243 | ||
SERIOUS REACTIONS | 243 | ||
MECHANISM OF ACTION | 244 | ||
PHARMACOKINETICS | 244 | ||
AVAILABILITY | 244 | ||
CONTRAINDICATIONS | 244 | ||
DIAGNOSTIC TEST EFFECTS | 244 | ||
SERIOUS REACTIONS | 245 | ||
MECHANISM OF ACTION | 245 | ||
PHARMACOKINETICS | 245 | ||
AVAILABILITY | 245 | ||
OFF-LABEL USES | 246 | ||
CONTRAINDICATIONS | 246 | ||
DIAGNOSTIC TEST EFFECTS | 246 | ||
SERIOUS REACTIONS | 246 | ||
MECHANISM OF ACTION | 247 | ||
PHARMACOKINETICS | 247 | ||
AVAILABILITY | 247 | ||
CONTRAINDICATIONS | 247 | ||
DIAGNOSTIC TEST EFFECTS | 247 | ||
SERIOUS REACTIONS | 247 | ||
MECHANISM OF ACTION | 248 | ||
PHARMACOKINETICS | 248 | ||
AVAILABILITY | 248 | ||
OFF-LABEL USES | 249 | ||
CONTRAINDICATIONS | 249 | ||
DIAGNOSTIC TEST EFFECTS | 249 | ||
SERIOUS REACTIONS | 249 | ||
MECHANISM OF ACTION | 250 | ||
PHARMACOKINETICS | 250 | ||
AVAILABILITY | 250 | ||
CONTRAINDICATIONS | 251 | ||
DIAGNOSTIC TEST EFFECTS | 251 | ||
SERIOUS REACTIONS | 251 | ||
MECHANISM OF ACTION | 251 | ||
PHARMACOKINETICS | 251 | ||
AVAILABILITY | 252 | ||
INDICATIONS AND DOSAGES | 252 | ||
OFF-LABEL USES | 252 | ||
CONTRAINDICATIONS | 252 | ||
DIAGNOSTIC TEST EFFECTS | 253 | ||
SERIOUS REACTIONS | 253 | ||
MECHANISM OF ACTION | 254 | ||
PHARMACOKINETICS | 254 | ||
AVAILABILITY | 254 | ||
CONTRAINDICATIONS | 255 | ||
DIAGNOSTIC TEST EFFECTS | 255 | ||
SERIOUS REACTIONS | 255 | ||
MECHANISM OF ACTION | 255 | ||
PHARMACOKINETICS | 255 | ||
AVAILABILITY | 256 | ||
CONTRAINDICATIONS | 256 | ||
DIAGNOSTIC TEST EFFECTS | 256 | ||
SERIOUS REACTIONS | 257 | ||
PHARMACOKINETICS | 257 | ||
AVAILABILITY | 258 | ||
OFF-LABEL USES | 258 | ||
CONTRAINDICATIONS | 258 | ||
DIAGNOSTIC TEST EFFECTS | 258 | ||
SERIOUS REACTIONS | 258 | ||
MECHANISM OF ACTION | 259 | ||
PHARMACOKINETICS | 259 | ||
AVAILABILITY | 259 | ||
CONTRAINDICATIONS | 259 | ||
DIAGNOSTIC TEST EFFECTS | 259 | ||
SERIOUS REACTIONS | 259 | ||
PHARMACOKINETICS | 260 | ||
AVAILABILITY | 260 | ||
OFF-LABEL USES | 260 | ||
CONTRAINDICATIONS | 260 | ||
INTERACTIONS | 260 | ||
DIAGNOSTIC TEST EFFECTS | 260 | ||
SERIOUS REACTIONS | 260 | ||
MECHANISM OF ACTION | 261 | ||
PHARMACOKINETICS | 261 | ||
AVAILABILITY | 261 | ||
OFF-LABEL USES | 262 | ||
CONTRAINDICATIONS | 262 | ||
DIAGNOSTIC TEST EFFECTS | 262 | ||
SIDE EFFECTS | 262 | ||
SERIOUS REACTIONS | 262 | ||
MECHANISM OF ACTION | 263 | ||
PHARMACOKINETICS | 264 | ||
AVAILABILITY | 264 | ||
CONTRAINDICATIONS | 264 | ||
DIAGNOSTIC TEST EFFECTS | 264 | ||
IV INCOMPATIBILITIES | 264 | ||
SERIOUS REACTIONS | 264 | ||
MECHANISM OF ACTION | 265 | ||
PHARMACOKINETICS | 265 | ||
AVAILABILITY | 265 | ||
CONTRAINDICATIONS | 265 | ||
DIAGNOSTIC TEST EFFECTS | 266 | ||
SERIOUS REACTIONS | 266 | ||
MECHANISM OF ACTION | 266 | ||
PHARMACOKINETICS | 266 | ||
AVAILABILITY | 266 | ||
CONTRAINDICATIONS | 267 | ||
DIAGNOSTIC TEST EFFECTS | 267 | ||
SERIOUS REACTIONS | 267 | ||
MECHANISM OF ACTION | 268 | ||
PHARMACOKINETICS | 268 | ||
AVAILABILITY | 268 | ||
CONTRAINDICATIONS | 268 | ||
DIAGNOSTIC TEST EFFECTS | 268 | ||
SERIOUS REACTIONS | 269 | ||
MECHANISM OF ACTION | 269 | ||
PHARMACOKINETICS | 269 | ||
AVAILABILITY | 270 | ||
CONTRAINDICATIONS | 270 | ||
DIAGNOSTIC TEST EFFECTS | 270 | ||
IV INCOMPATIBILITIES | 270 | ||
IV COMPATIBILITIES | 270 | ||
SERIOUS REACTIONS | 271 | ||
MECHANISM OF ACTION | 272 | ||
PHARMACOKINETICS | 272 | ||
AVAILABILITY | 272 | ||
CONTRAINDICATIONS | 272 | ||
DIAGNOSTIC TEST EFFECTS | 273 | ||
SERIOUS REACTIONS | 273 | ||
MECHANISM OF ACTION | 273 | ||
PHARMACOKINETICS | 274 | ||
AVAILABILITY | 274 | ||
CONTRAINDICATIONS | 274 | ||
DIAGNOSTIC TEST EFFECTS | 274 | ||
SERIOUS REACTIONS | 274 | ||
MECHANISM OF ACTION | 275 | ||
PHARMACOKINETICS | 275 | ||
AVAILABILITY | 275 | ||
CONTRAINDICATIONS | 276 | ||
DIAGNOSTIC TEST EFFECTS | 276 | ||
IV INCOMPATIBILITIES | 276 | ||
IV COMPATIBILITIES | 276 | ||
SERIOUS REACTIONS | 276 | ||
MECHANISM OF ACTION | 277 | ||
PHARMACOKINETICS | 277 | ||
AVAILABILITY | 277 | ||
DIAGNOSTIC TEST EFFECTS | 278 | ||
SERIOUS REACTIONS | 278 | ||
MECHANISM OF ACTION | 279 | ||
PHARMACOKINETICS | 279 | ||
AVAILABILITY | 279 | ||
OFF-LABEL USES | 279 | ||
CONTRAINDICATIONS | 279 | ||
DIAGNOSTIC TEST EFFECTS | 279 | ||
IV INCOMPATIBILITIES | 279 | ||
IV COMPATIBILITIES | 279 | ||
SERIOUS REACTIONS | 280 | ||
MECHANISM OF ACTION | 281 | ||
PHARMACOKINETICS | 281 | ||
AVAILABILITY | 281 | ||
CONTRAINDICATIONS | 281 | ||
DIAGNOSTIC TEST EFFECTS | 281 | ||
IV INCOMPATIBILITIES | 282 | ||
IV COMPATIBILITIES | 282 | ||
SERIOUS REACTIONS | 282 | ||
MECHANISM OF ACTION | 283 | ||
AVAILABILITY | 283 | ||
CONTRAINDICATIONS | 283 | ||
DIAGNOSTIC TEST EFFECTS | 283 | ||
IV INCOMPATIBILITIES | 284 | ||
IV COMPATIBILITIES | 284 | ||
SERIOUS REACTIONS | 284 | ||
MECHANISM OF ACTION | 285 | ||
PHARMACOKINETICS | 285 | ||
AVAILABILITY | 285 | ||
CONTRAINDICATIONS | 285 | ||
DIAGNOSTIC TEST EFFECTS | 286 | ||
SERIOUS REACTIONS | 286 | ||
MECHANISM OF ACTION | 286 | ||
PHARMACOKINETICS | 286 | ||
AVAILABILITY | 287 | ||
CONTRAINDICATIONS | 287 | ||
DIAGNOSTIC TEST EFFECTS | 287 | ||
SERIOUS REACTIONS | 287 | ||
MECHANISM OF ACTION | 288 | ||
PHARMACOKINETICS | 288 | ||
AVAILABILITY | 288 | ||
INDICATIONS AND DOSAGES | 288 | ||
CONTRAINDICATIONS | 288 | ||
INTERACTIONS | 288 | ||
DIAGNOSTIC TEST EFFECTS | 289 | ||
IV INCOMPATIBILITIES | 289 | ||
SIDE EFFECTS | 289 | ||
SERIOUS REACTIONS | 289 | ||
MECHANISM OF ACTION | 290 | ||
PHARMACOKINETICS | 290 | ||
AVAILABILITY | 290 | ||
DIAGNOSTIC TEST EFFECTS | 291 | ||
IV INCOMPATIBILITIES | 291 | ||
IV COMPATIBILITIES | 291 | ||
SERIOUS REACTIONS | 291 | ||
MECHANISM OF ACTION | 292 | ||
PHARMACOKINETICS | 292 | ||
AVAILABILITY | 292 | ||
DIAGNOSTIC TEST EFFECTS | 293 | ||
SERIOUS REACTIONS | 293 | ||
MECHANISM OF ACTION | 293 | ||
PHARMACOKINETICS | 293 | ||
AVAILABILITY | 294 | ||
CONTRAINDICATIONS | 294 | ||
DIAGNOSTIC TEST EFFECTS | 294 | ||
IV INCOMPATIBILITIES | 294 | ||
IV COMPATIBILITIES | 294 | ||
SERIOUS REACTIONS | 295 | ||
MECHANISM OF ACTION | 295 | ||
PHARMACOKINETICS | 295 | ||
AVAILABILITY | 295 | ||
CONTRAINDICATIONS | 296 | ||
DIAGNOSTIC TEST EFFECTS | 296 | ||
IV INCOMPATIBILITIES | 296 | ||
IV COMPATIBILITIES | 296 | ||
SERIOUS REACTIONS | 297 | ||
MECHANISM OF ACTION | 298 | ||
PHARMACOKINETICS | 298 | ||
AVAILABILITY | 298 | ||
DIAGNOSTIC TEST EFFECTS | 299 | ||
IV INCOMPATIBILITIES | 299 | ||
IV COMPATIBILITIES | 299 | ||
SERIOUS REACTIONS | 299 | ||
MECHANISM OF ACTION | 300 | ||
PHARMACOKINETICS | 300 | ||
AVAILABILITY | 300 | ||
CONTRAINDICATIONS | 301 | ||
DIAGNOSTIC TEST EFFECTS | 301 | ||
SERIOUS REACTIONS | 301 | ||
MECHANISM OF ACTION | 302 | ||
PHARMACOKINETICS | 302 | ||
AVAILABILITY | 302 | ||
DIAGNOSTIC TEST EFFECTS | 303 | ||
SERIOUS REACTIONS | 303 | ||
MECHANISM OF ACTION | 304 | ||
PHARMACOKINETICS | 304 | ||
AVAILABILITY | 304 | ||
INDICATIONS AND DOSAGES | 304 | ||
CONTRAINDICATIONS | 304 | ||
DIAGNOSTIC TEST EFFECTS | 304 | ||
SERIOUS REACTIONS | 305 | ||
MECHANISM OF ACTION | 306 | ||
PHARMACOKINETICS | 306 | ||
AVAILABILITY | 306 | ||
CONTRAINDICATIONS | 306 | ||
DIAGNOSTIC TEST EFFECTS | 307 | ||
SERIOUS REACTIONS | 307 | ||
PHARMACOKINETICS | 307 | ||
AVAILABILITY | 308 | ||
CONTRAINDICATIONS | 308 | ||
DIAGNOSTIC TEST EFFECTS | 308 | ||
SERIOUS REACTIONS | 308 | ||
MECHANISM OF ACTION | 308 | ||
PHARMACOKINETICS | 309 | ||
AVAILABILITY | 309 | ||
OFF-LABEL USES | 309 | ||
CONTRAINDICATIONS | 309 | ||
DIAGNOSTIC TEST EFFECTS | 309 | ||
SERIOUS REACTIONS | 309 | ||
MECHANISM OF ACTION | 310 | ||
PHARMACOKINETICS | 310 | ||
AVAILABILITY | 310 | ||
INDICATIONS AND DOSAGES | 310 | ||
CONTRAINDICATIONS | 310 | ||
INTERACTIONS | 311 | ||
DIAGNOSTIC TEST EFFECTS | 311 | ||
SIDE EFFECTS | 311 | ||
SERIOUS REACTIONS | 311 | ||
MECHANISM OF ACTION | 312 | ||
PHARMACOKINETICS | 312 | ||
AVAILABILITY | 312 | ||
CONTRAINDICATIONS | 312 | ||
DIAGNOSTIC TEST EFFECTS | 312 | ||
SERIOUS REACTIONS | 312 | ||
MECHANISM OF ACTION | 313 | ||
PHARMACOKINETICS | 313 | ||
AVAILABILITY | 313 | ||
CONTRAINDICATIONS | 314 | ||
DIAGNOSTIC TEST EFFECTS | 314 | ||
IV INCOMPATIBILITIES | 314 | ||
SERIOUS REACTIONS | 314 | ||
MECHANISM OF ACTION | 315 | ||
PHARMACOKINETICS | 315 | ||
AVAILABILITY | 315 | ||
CONTRAINDICATIONS | 315 | ||
DIAGNOSTIC TEST EFFECTS | 315 | ||
SERIOUS REACTIONS | 316 | ||
MECHANISM OF ACTION | 316 | ||
PHARMACOKINETICS | 316 | ||
AVAILABILITY | 317 | ||
OFF-LABEL USES | 317 | ||
CONTRAINDICATIONS | 317 | ||
DIAGNOSTIC TEST EFFECTS | 317 | ||
SERIOUS REACTIONS | 317 | ||
MECHANISM OF ACTION | 318 | ||
PHARMACOKINETICS | 318 | ||
AVAILABILITY | 318 | ||
OFF-LABEL USES | 318 | ||
CONTRAINDICATIONS | 318 | ||
DIAGNOSTIC TEST EFFECTS | 319 | ||
SERIOUS REACTIONS | 319 | ||
MECHANISM OF ACTION | 319 | ||
PHARMACOKINETICS | 320 | ||
AVAILABILITY | 320 | ||
OFF-LABEL USES | 320 | ||
CONTRAINDICATIONS | 320 | ||
DIAGNOSTIC TEST EFFECTS | 320 | ||
SIDE EFFECTS | 320 | ||
SERIOUS REACTIONS | 321 | ||
MECHANISM OF ACTION | 322 | ||
PHARMACOKINETICS | 322 | ||
AVAILABILITY | 322 | ||
CONTRAINDICATIONS | 322 | ||
DIAGNOSTIC TEST EFFECTS | 322 | ||
SERIOUS REACTIONS | 323 | ||
MECHANISM OF ACTION | 323 | ||
PHARMACOKINETICS | 323 | ||
AVAILABILITY | 324 | ||
OFF-LABEL USES | 324 | ||
CONTRAINDICATIONS | 324 | ||
DIAGNOSTIC TEST EFFECTS | 325 | ||
SERIOUS REACTIONS | 325 | ||
MECHANISM OF ACTION | 326 | ||
PHARMACOKINETICS | 326 | ||
AVAILABILITY | 326 | ||
OFF-LABEL USES | 326 | ||
CONTRAINDICATIONS | 326 | ||
DIAGNOSTIC TEST EFFECTS | 327 | ||
SERIOUS REACTIONS | 327 | ||
MECHANISM OF ACTION | 328 | ||
PHARMACOKINETICS | 328 | ||
AVAILABILITY | 328 | ||
CONTRAINDICATIONS | 328 | ||
DIAGNOSTIC TEST EFFECTS | 328 | ||
SERIOUS REACTIONS | 328 | ||
MECHANISM OF ACTION | 329 | ||
PHARMACOKINETICS | 329 | ||
AVAILABILITY | 329 | ||
CONTRAINDICATIONS | 329 | ||
DIAGNOSTIC TEST EFFECTS | 330 | ||
SERIOUS REACTIONS | 330 | ||
MECHANISM OF ACTION | 330 | ||
PHARMACOKINETICS | 330 | ||
AVAILABILITY | 330 | ||
OFF-LABEL USES | 331 | ||
CONTRAINDICATIONS | 331 | ||
DIAGNOSTIC TEST EFFECTS | 331 | ||
SERIOUS REACTIONS | 331 | ||
MECHANISM OF ACTION | 332 | ||
PHARMACOKINETICS | 332 | ||
AVAILABILITY | 332 | ||
CONTRAINDICATIONS | 332 | ||
DIAGNOSTIC TEST EFFECTS | 333 | ||
SERIOUS REACTIONS | 333 | ||
MECHANISM OF ACTION | 333 | ||
PHARMACOKINETICS | 334 | ||
AVAILABILITY | 334 | ||
CONTRAINDICATIONS | 334 | ||
DIAGNOSTIC TEST EFFECTS | 334 | ||
SERIOUS REACTIONS | 334 | ||
MECHANISM OF ACTION | 335 | ||
PHARMACOKINETICS | 336 | ||
AVAILABILITY | 336 | ||
CONTRAINDICATIONS | 336 | ||
DIAGNOSTIC TEST EFFECTS | 336 | ||
SERIOUS REACTIONS | 336 | ||
PHARMACOKINETICS | 337 | ||
AVAILABILITY | 337 | ||
OFF-LABEL USES | 337 | ||
CONTRAINDICATIONS | 337 | ||
DIAGNOSTIC TEST EFFECTS | 338 | ||
SERIOUS REACTIONS | 338 | ||
MECHANISM OF ACTION | 338 | ||
PHARMACOKINETICS | 339 | ||
AVAILABILITY | 339 | ||
OFF-LABEL USES | 339 | ||
CONTRAINDICATIONS | 339 | ||
DIAGNOSTIC TEST EFFECTS | 340 | ||
IV INCOMPATIBILITIES | 340 | ||
IV COMPATIBILITIES | 340 | ||
SERIOUS REACTIONS | 340 | ||
MECHANISM OF ACTION | 341 | ||
PHARMACOKINETICS | 341 | ||
AVAILABILITY | 341 | ||
CONTRAINDICATIONS | 341 | ||
DIAGNOSTIC TEST EFFECTS | 342 | ||
SERIOUS REACTIONS | 342 | ||
MECHANISM OF ACTION | 342 | ||
PHARMACOKINETICS | 342 | ||
AVAILABILITY | 342 | ||
OFF-LABEL USES | 343 | ||
CONTRAINDICATIONS | 343 | ||
DIAGNOSTIC TEST EFFECTS | 344 | ||
IV INCOMPATIBILITIES | 344 | ||
IV COMPATIBILITIES | 344 | ||
SERIOUS REACTIONS | 344 | ||
PHARMACOKINETICS | 345 | ||
AVAILABILITY | 345 | ||
OFF-LABEL USES | 346 | ||
CONTRAINDICATIONS | 346 | ||
DIAGNOSTIC TEST EFFECTS | 346 | ||
SERIOUS REACTIONS | 346 | ||
MECHANISM OF ACTION | 347 | ||
PHARMACOKINETICS | 347 | ||
AVAILABILITY | 347 | ||
CONTRAINDICATIONS | 348 | ||
DIAGNOSTIC TEST EFFECTS | 348 | ||
SERIOUS REACTIONS | 349 | ||
MECHANISM OF ACTION | 349 | ||
PHARMACOKINETICS | 349 | ||
AVAILABILITY | 349 | ||
CONTRAINDICATIONS | 350 | ||
DIAGNOSTIC TEST EFFECTS | 350 | ||
SERIOUS REACTIONS | 350 | ||
MECHANISM OF ACTION | 351 | ||
PHARMACOKINETICS | 351 | ||
AVAILABILITY | 351 | ||
INDICATIONS AND DOSAGES | 351 | ||
CONTRAINDICATIONS | 351 | ||
DIAGNOSTIC TEST EFFECTS | 351 | ||
IV INCOMPATIBILITIES | 351 | ||
IV COMPATIBILITIES | 351 | ||
SERIOUS REACTIONS | 352 | ||
MECHANISM OF ACTION | 352 | ||
PHARMACOKINETICS | 353 | ||
AVAILABILITY | 353 | ||
OFF-LABEL USES | 353 | ||
CONTRAINDICATIONS | 353 | ||
DIAGNOSTIC TEST EFFECTS | 353 | ||
IV INCOMPATIBILITIES | 353 | ||
IV COMPATIBILITIES | 354 | ||
SERIOUS REACTIONS | 354 | ||
MECHANISM OF ACTION | 355 | ||
PHARMACOKINETICS | 355 | ||
AVAILABILITY | 355 | ||
CONTRAINDICATIONS | 355 | ||
DIAGNOSTIC TEST EFFECTS | 355 | ||
SERIOUS REACTIONS | 355 | ||
MECHANISM OF ACTION | 356 | ||
PHARMACOKINETICS | 356 | ||
AVAILABILITY | 356 | ||
INDICATIONS AND DOSAGES | 356 | ||
CONTRAINDICATIONS | 357 | ||
INTERACTIONS | 357 | ||
DIAGNOSTIC TEST EFFECTS | 357 | ||
SIDE EFFECTS | 357 | ||
SERIOUS REACTIONS | 357 | ||
MECHANISM OF ACTION | 358 | ||
PHARMACOKINETICS | 358 | ||
AVAILABILITY | 358 | ||
CONTRAINDICATIONS | 358 | ||
DIAGNOSTIC TEST EFFECTS | 359 | ||
SERIOUS REACTIONS | 359 | ||
MECHANISM OF ACTION | 359 | ||
PHARMACOKINETICS | 359 | ||
AVAILABILITY | 359 | ||
D | 401 | ||
MECHANISM OF ACTION | 401 | ||
PHARMACOKINETICS | 401 | ||
AVAILABILITY | 401 | ||
INDICATIONS AND DOSAGES | 401 | ||
OFF-LABEL USES | 401 | ||
CONTRAINDICATIONS | 401 | ||
INTERACTIONS | 401 | ||
DIAGNOSTIC TEST EFFECTS | 402 | ||
SIDE EFFECTS | 402 | ||
SERIOUS REACTIONS | 402 | ||
PHARMACOKINETICS | 403 | ||
AVAILABILITY | 403 | ||
INDICATIONS AND DOSAGES | 403 | ||
CONTRAINDICATIONS | 403 | ||
DIAGNOSTIC TEST EFFECTS | 404 | ||
SERIOUS REACTIONS | 404 | ||
MECHANISM OF ACTION | 404 | ||
PHARMACOKINETICS | 404 | ||
AVAILABILITY | 404 | ||
CONTRAINDICATIONS | 405 | ||
DIAGNOSTIC TEST EFFECTS | 406 | ||
SERIOUS REACTIONS | 406 | ||
MECHANISM OF ACTION | 407 | ||
PHARMACOKINETICS | 407 | ||
AVAILABILITY | 407 | ||
OFF-LABEL USES | 407 | ||
CONTRAINDICATIONS | 407 | ||
DIAGNOSTIC TEST EFFECTS | 408 | ||
SERIOUS REACTIONS | 408 | ||
MECHANISM OF ACTION | 409 | ||
PHARMACOKINETICS | 409 | ||
AVAILABILITY | 409 | ||
OFF-LABEL USES | 409 | ||
CONTRAINDICATIONS | 409 | ||
DIAGNOSTIC TEST EFFECTS | 410 | ||
IV INCOMPATIBILITIES | 410 | ||
SERIOUS REACTIONS | 410 | ||
MECHANISM OF ACTION | 411 | ||
AVAILABILITY | 411 | ||
OFF-LABEL USES | 411 | ||
CONTRAINDICATIONS | 411 | ||
DIAGNOSTIC TEST EFFECTS | 411 | ||
SERIOUS REACTIONS | 412 | ||
MECHANISM OF ACTION | 412 | ||
PHARMACOKINETICS | 412 | ||
AVAILABILITY | 412 | ||
OFF-LABEL USES | 413 | ||
CONTRAINDICATIONS | 413 | ||
DIAGNOSTIC TEST EFFECTS | 413 | ||
IV INCOMPATIBILITIES | 413 | ||
IV COMPATIBILITIES | 413 | ||
SERIOUS REACTIONS | 413 | ||
MECHANISM OF ACTION | 414 | ||
PHARMACOKINETICS | 414 | ||
AVAILABILITY | 415 | ||
CONTRAINDICATIONS | 415 | ||
DIAGNOSTIC TEST EFFECTS | 415 | ||
IV INCOMPATIBILITIES | 415 | ||
SERIOUS REACTIONS | 415 | ||
MECHANISM OF ACTION | 417 | ||
AVAILABILITY | 417 | ||
CONTRAINDICATIONS | 417 | ||
DIAGNOSTIC TEST EFFECTS | 418 | ||
SERIOUS REACTIONS | 418 | ||
MECHANISM OF ACTION | 418 | ||
PHARMACOKINETICS | 418 | ||
AVAILABILITY | 418 | ||
INDICATIONS AND DOSAGES | 419 | ||
CONTRAINDICATIONS | 419 | ||
DIAGNOSTIC TEST EFFECTS | 420 | ||
SERIOUS REACTIONS | 420 | ||
MECHANISM OF ACTION | 421 | ||
PHARMACOKINETICS | 421 | ||
AVAILABILITY | 421 | ||
CONTRAINDICATIONS | 421 | ||
DIAGNOSTIC TEST EFFECTS | 421 | ||
SERIOUS REACTIONS | 422 | ||
PHARMACOKINETICS | 422 | ||
AVAILABILITY | 423 | ||
INDICATIONS | 423 | ||
CONTRAINDICATIONS | 423 | ||
DIAGNOSTIC TEST EFFECTS | 423 | ||
SERIOUS REACTIONS | 424 | ||
MECHANISM OF ACTION | 425 | ||
PHARMACOKINETICS | 425 | ||
AVAILABILITY | 425 | ||
OFF-LABEL USES | 425 | ||
CONTRAINDICATIONS | 425 | ||
DIAGNOSTIC TEST EFFECTS | 425 | ||
IV INCOMPATIBILITIES | 425 | ||
SERIOUS REACTIONS | 425 | ||
MECHANISM OF ACTION | 426 | ||
PHARMACOKINETICS | 426 | ||
AVAILABILITY | 426 | ||
CONTRAINDICATIONS | 426 | ||
DIAGNOSTIC TEST EFFECTS | 427 | ||
SERIOUS REACTIONS | 427 | ||
MECHANISM OF ACTION | 428 | ||
AVAILABILITY | 428 | ||
CONTRAINDICATIONS | 428 | ||
DIAGNOSTIC TEST EFFECTS | 429 | ||
SERIOUS REACTIONS | 429 | ||
MECHANISM OF ACTION | 430 | ||
PHARMACOKINETICS | 430 | ||
AVAILABILITY | 430 | ||
INDICATIONS AND DOSAGES | 430 | ||
CONTRAINDICATIONS | 430 | ||
INTERACTIONS | 430 | ||
SIDE EFFECTS | 430 | ||
SERIOUS REACTIONS | 430 | ||
MECHANISM OF ACTION | 431 | ||
PHARMACOKINETICS | 432 | ||
AVAILABILITY | 432 | ||
OFF-LABEL USES | 432 | ||
CONTRAINDICATIONS | 432 | ||
DIAGNOSTIC TEST EFFECTS | 432 | ||
SERIOUS REACTIONS | 433 | ||
MECHANISM OF ACTION | 433 | ||
PHARMACOKINETICS | 433 | ||
AVAILABILITY | 434 | ||
CONTRAINDICATIONS | 434 | ||
DIAGNOSTIC TEST EFFECTS | 434 | ||
SERIOUS REACTIONS | 434 | ||
MECHANISM OF ACTION | 435 | ||
PHARMACOKINETICS | 435 | ||
AVAILABILITY | 435 | ||
CONTRAINDICATIONS | 436 | ||
DIAGNOSTIC TEST EFFECTS | 436 | ||
SERIOUS REACTIONS | 436 | ||
MECHANISM OF ACTION | 437 | ||
PHARMACOKINETICS | 437 | ||
AVAILABILITY | 437 | ||
CONTRAINDICATIONS | 437 | ||
DIAGNOSTIC TEST EFFECTS | 437 | ||
SERIOUS REACTIONS | 438 | ||
MECHANISM OF ACTION | 438 | ||
PHARMACOKINETICS | 438 | ||
AVAILABILITY | 438 | ||
CONTRAINDICATIONS | 439 | ||
DIAGNOSTIC TEST EFFECTS | 439 | ||
SERIOUS REACTIONS | 439 | ||
MECHANISM OF ACTION | 439 | ||
PHARMACOKINETICS | 440 | ||
AVAILABILITY | 440 | ||
INDICATIONS AND DOSAGES | 440 | ||
CONTRAINDICATIONS | 440 | ||
DIAGNOSTIC TEST EFFECTS | 440 | ||
SERIOUS REACTIONS | 440 | ||
MECHANISM OF ACTION | 441 | ||
PHARMACOKINETICS | 441 | ||
AVAILABILITY | 442 | ||
CONTRAINDICATIONS | 442 | ||
DIAGNOSTIC TEST EFFECTS | 443 | ||
IV INCOMPATIBILITIES | 443 | ||
SERIOUS REACTIONS | 443 | ||
MECHANISM OF ACTION | 445 | ||
PHARMACOKINETICS | 445 | ||
AVAILABILITY | 445 | ||
CONTRAINDICATIONS | 445 | ||
DIAGNOSTIC TEST EFFECTS | 445 | ||
SERIOUS REACTIONS | 445 | ||
MECHANISM OF ACTION | 446 | ||
PHARMACOKINETICS | 446 | ||
AVAILABILITY | 446 | ||
INDICATIONS AND DOSAGES | 446 | ||
CONTRAINDICATIONS | 447 | ||
DIAGNOSTIC TEST EFFECTS | 447 | ||
SERIOUS REACTIONS | 447 | ||
PHARMACOKINETICS | 448 | ||
AVAILABILITY | 448 | ||
CONTRAINDICATIONS | 448 | ||
DIAGNOSTIC TEST EFFECTS | 449 | ||
SERIOUS REACTIONS | 449 | ||
MECHANISM OF ACTION | 450 | ||
AVAILABILITY | 450 | ||
CONTRAINDICATIONS | 450 | ||
DIAGNOSTIC TEST EFFECTS | 450 | ||
IV INCOMPATIBILITIES | 450 | ||
SERIOUS REACTIONS | 450 | ||
MECHANISM OF ACTION | 451 | ||
AVAILABILITY | 451 | ||
CONTRAINDICATIONS | 452 | ||
DIAGNOSTIC TEST EFFECTS | 452 | ||
SERIOUS REACTIONS | 453 | ||
MECHANISM OF ACTION | 453 | ||
PHARMACOKINETICS | 453 | ||
AVAILABILITY | 453 | ||
CONTRAINDICATIONS | 454 | ||
DIAGNOSTIC TEST EFFECTS | 454 | ||
SERIOUS REACTIONS | 454 | ||
MECHANISM OF ACTION | 455 | ||
PHARMACOKINETICS | 455 | ||
AVAILABILITY | 455 | ||
OFF-LABEL USES | 455 | ||
CONTRAINDICATIONS | 456 | ||
DIAGNOSTIC TEST EFFECTS | 456 | ||
IV INCOMPATIBILITIES | 456 | ||
IV COMPATIBILITIES | 457 | ||
SERIOUS REACTIONS | 457 | ||
PHARMACOKINETICS | 459 | ||
AVAILABILITY | 459 | ||
OFF-LABEL USES | 460 | ||
CONTRAINDICATIONS | 460 | ||
DIAGNOSTIC TEST EFFECTS | 460 | ||
SERIOUS REACTIONS | 461 | ||
MECHANISM OF ACTION | 462 | ||
PHARMACOKINETICS | 462 | ||
AVAILABILITY | 462 | ||
CONTRAINDICATIONS | 462 | ||
DIAGNOSTIC TEST EFFECTS | 462 | ||
SERIOUS REACTIONS | 462 | ||
MECHANISM OF ACTION | 463 | ||
PHARMACOKINETICS | 463 | ||
AVAILABILITY | 463 | ||
CONTRAINDICATIONS | 463 | ||
DIAGNOSTIC TEST EFFECTS | 464 | ||
SERIOUS REACTIONS | 464 | ||
MECHANISM OF ACTION | 465 | ||
PHARMACOKINETICS | 465 | ||
AVAILABILITY | 465 | ||
DIAGNOSTIC TEST EFFECTS | 466 | ||
SERIOUS REACTIONS | 466 | ||
MECHANISM OF ACTION | 467 | ||
PHARMACOKINETICS | 467 | ||
AVAILABILITY | 467 | ||
CONTRAINDICATIONS | 468 | ||
DIAGNOSTIC TEST EFFECTS | 468 | ||
SERIOUS REACTIONS | 468 | ||
MECHANISM OF ACTION | 469 | ||
PHARMACOKINETICS | 469 | ||
AVAILABILITY | 469 | ||
CONTRAINDICATIONS | 469 | ||
DIAGNOSTIC TEST EFFECTS | 469 | ||
SERIOUS REACTIONS | 469 | ||
MECHANISM OF ACTION | 470 | ||
PHARMACOKINETICS | 470 | ||
AVAILABILITY | 470 | ||
OFF-LABEL USES | 470 | ||
CONTRAINDICATIONS | 470 | ||
DIAGNOSTIC TEST EFFECTS | 471 | ||
SIDE EFFECTS | 471 | ||
SERIOUS REACTIONS | 471 | ||
MECHANISM OF ACTION | 472 | ||
PHARMACOKINETICS | 472 | ||
AVAILABILITY | 472 | ||
DIAGNOSTIC TEST EFFECTS | 474 | ||
IV INCOMPATIBILITIES | 474 | ||
SIDE EFFECTS | 474 | ||
SERIOUS REACTIONS | 474 | ||
MECHANISM OF ACTION | 475 | ||
PHARMACOKINETICS | 475 | ||
AVAILABILITY | 475 | ||
CONTRAINDICATIONS | 476 | ||
DIAGNOSTIC TEST EFFECTS | 476 | ||
IV INCOMPATIBILITIES | 476 | ||
SIDE EFFECTS | 476 | ||
SERIOUS REACTIONS | 476 | ||
MECHANISM OF ACTION | 477 | ||
PHARMACOKINETICS | 477 | ||
AVAILABILITY | 477 | ||
OFF-LABEL USES | 478 | ||
CONTRAINDICATIONS | 478 | ||
DIAGNOSTIC TEST EFFECTS | 478 | ||
SERIOUS REACTIONS | 478 | ||
MECHANISM OF ACTION | 479 | ||
PHARMACOKINETICS | 479 | ||
AVAILABILITY | 480 | ||
OFF-LABEL USES | 480 | ||
CONTRAINDICATIONS | 481 | ||
DIAGNOSTIC TEST EFFECTS | 481 | ||
IV INCOMPATIBILITIES | 481 | ||
IV COMPATIBILITIES | 481 | ||
SERIOUS REACTIONS | 482 | ||
MECHANISM OF ACTION | 483 | ||
AVAILABILITY | 483 | ||
CONTRAINDICATIONS | 484 | ||
DIAGNOSTIC TEST EFFECTS | 484 | ||
SERIOUS REACTIONS | 484 | ||
MECHANISM OF ACTION | 484 | ||
PHARMACOKINETICS | 485 | ||
AVAILABILITY | 485 | ||
OFF-LABEL USES | 485 | ||
CONTRAINDICATIONS | 485 | ||
DIAGNOSTIC TEST EFFECTS | 486 | ||
IV INCOMPATIBILITIES | 486 | ||
SERIOUS REACTIONS | 486 | ||
PHARMACOKINETICS | 487 | ||
AVAILABILITY | 487 | ||
CONTRAINDICATIONS | 487 | ||
DIAGNOSTIC TEST EFFECTS | 488 | ||
IV INCOMPATIBILITIES | 488 | ||
SERIOUS REACTIONS | 488 | ||
MECHANISM OF ACTION | 489 | ||
PHARMACOKINETICS | 489 | ||
AVAILABILITY | 489 | ||
CONTRAINDICATIONS | 490 | ||
DIAGNOSTIC TEST EFFECTS | 490 | ||
SERIOUS REACTIONS | 490 | ||
MECHANISM OF ACTION | 491 | ||
PHARMACOKINETICS | 491 | ||
AVAILABILITY | 491 | ||
OFF-LABEL USES | 491 | ||
CONTRAINDICATIONS | 491 | ||
DIAGNOSTIC TEST EFFECTS | 491 | ||
IV INCOMPATIBILITIES | 491 | ||
SERIOUS REACTIONS | 492 | ||
MECHANISM OF ACTION | 492 | ||
AVAILABILITY | 492 | ||
OFF-LABEL USES | 493 | ||
CONTRAINDICATIONS | 493 | ||
DIAGNOSTIC TEST EFFECTS | 493 | ||
SERIOUS REACTIONS | 494 | ||
MECHANISM OF ACTION | 494 | ||
PHARMACOKINETICS | 494 | ||
AVAILABILITY | 494 | ||
CONTRAINDICATIONS | 495 | ||
DRUG INTERACTIONS | 495 | ||
DIAGNOSTIC TEST EFFECTS | 495 | ||
SERIOUS REACTIONS | 495 | ||
MECHANISM OF ACTION | 496 | ||
PHARMACOKINETICS | 496 | ||
AVAILABILITY | 496 | ||
CONTRAINDICATIONS | 496 | ||
DIAGNOSTIC TEST EFFECTS | 496 | ||
IV INCOMPATIBILITIES | 496 | ||
IV COMPATIBILITIES | 496 | ||
SERIOUS REACTIONS | 497 | ||
MECHANISM OF ACTION | 498 | ||
PHARMACOKINETICS | 498 | ||
AVAILABILITY | 498 | ||
CONTRAINDICATIONS | 498 | ||
SIDE EFFECTS | 498 | ||
MECHANISM OF ACTION | 499 | ||
PHARMACOKINETICS | 499 | ||
AVAILABILITY | 499 | ||
CONTRAINDICATIONS | 499 | ||
DIAGNOSTIC TEST EFFECTS | 499 | ||
SERIOUS REACTIONS | 499 | ||
MECHANISM OF ACTION | 500 | ||
AVAILABILITY | 500 | ||
CONTRAINDICATIONS | 500 | ||
DIAGNOSTIC TEST EFFECTS | 501 | ||
SERIOUS REACTIONS | 501 | ||
MECHANISM OF ACTION | 501 | ||
PHARMACOKINETICS | 501 | ||
AVAILABILITY | 501 | ||
CONTRAINDICATIONS | 502 | ||
DIAGNOSTIC TEST EFFECTS | 502 | ||
IV INCOMPATIBILITIES | 502 | ||
IV COMPATIBILITIES | 502 | ||
SERIOUS REACTIONS | 502 | ||
MECHANISM OF ACTION | 503 | ||
PHARMACOKINETICS | 503 | ||
AVAILABILITY | 503 | ||
CONTRAINDICATIONS | 503 | ||
DIAGNOSTIC TEST EFFECTS | 504 | ||
SERIOUS REACTIONS | 504 | ||
MECHANISM OF ACTION | 505 | ||
PHARMACOKINETICS | 505 | ||
AVAILABILITY | 505 | ||
CONTRAINDICATIONS | 505 | ||
DIAGNOSTIC TEST EFFECTS | 505 | ||
IV INCOMPATIBILITIES | 505 | ||
IV COMPATIBILITIES | 506 | ||
SERIOUS REACTIONS | 507 | ||
MECHANISM OF ACTION | 508 | ||
PHARMACOKINETICS | 508 | ||
AVAILABILITY | 508 | ||
INDICATIONS AND DOSAGE | 508 | ||
CONTRAINDICATIONS | 508 | ||
DIAGNOSTIC TEST EFFECTS | 508 | ||
IV INCOMPATIBILITIES | 508 | ||
SERIOUS REACTIONS | 509 | ||
MECHANISM OF ACTION | 510 | ||
AVAILABILITY | 510 | ||
CONTRAINDICATIONS | 510 | ||
DIAGNOSTIC TEST EFFECTS | 510 | ||
SERIOUS REACTIONS | 510 | ||
PHARMACOKINETICS | 511 | ||
AVAILABILITY | 511 | ||
OFF-LABEL USES | 511 | ||
CONTRAINDICATIONS | 511 | ||
DIAGNOSTIC TEST EFFECTS | 512 | ||
SERIOUS REACTIONS | 512 | ||
MECHANISM OF ACTION | 513 | ||
PHARMACOKINETICS | 513 | ||
AVAILABILITY | 513 | ||
CONTRAINDICATIONS | 514 | ||
DIAGNOSTIC TEST EFFECTS | 514 | ||
SERIOUS REACTIONS | 514 | ||
PHARMACOKINETICS | 515 | ||
AVAILABILITY | 515 | ||
E | 531 | ||
MECHANISM OF ACTION | 531 | ||
PHARMACOKINETICS | 531 | ||
AVAILABILITY | 531 | ||
INDICATIONS AND DOSAGES | 531 | ||
CONTRAINDICATIONS | 531 | ||
DIAGNOSTIC TEST EFFECTS | 531 | ||
SERIOUS REACTIONS | 531 | ||
MECHANISM OF ACTION | 532 | ||
PHARMACOKINETICS | 532 | ||
AVAILABILITY | 532 | ||
CONTRAINDICATIONS | 532 | ||
DIAGNOSTIC TEST EFFECTS | 532 | ||
SERIOUS REACTIONS | 532 | ||
PHARMACOKINETICS | 533 | ||
AVAILABILITY | 533 | ||
CONTRAINDICATIONS | 533 | ||
DIAGNOSTIC TEST EFFECTS | 534 | ||
SERIOUS REACTIONS | 534 | ||
MECHANISM OF ACTION | 535 | ||
PHARMACOKINETICS | 535 | ||
AVAILABILITY | 535 | ||
OFF-LABEL USES | 535 | ||
CONTRAINDICATIONS | 535 | ||
DIAGNOSTIC TEST EFFECTS | 536 | ||
SERIOUS REACTIONS | 536 | ||
MECHANISM OF ACTION | 536 | ||
PHARMACOKINETICS | 536 | ||
AVAILABILITY | 536 | ||
CONTRAINDICATIONS | 536 | ||
DIAGNOSTIC TEST EFFECTS | 537 | ||
SERIOUS REACTIONS | 537 | ||
MECHANISM OF ACTION | 538 | ||
PHARMACOKINETICS | 538 | ||
AVAILABILITY | 538 | ||
CONTRAINDICATIONS | 539 | ||
DIAGNOSTIC TEST EFFECTS | 539 | ||
SIDE EFFECTS | 539 | ||
SERIOUS REACTIONS | 539 | ||
MECHANISM OF ACTION | 540 | ||
PHARMACOKINETICS | 540 | ||
AVAILABILITY | 540 | ||
CONTRAINDICATIONS | 540 | ||
SERIOUS REACTIONS | 541 | ||
MECHANISM OF ACTION | 541 | ||
PHARMACOKINETICS | 541 | ||
AVAILABILITY | 541 | ||
OFF-LABEL USES | 542 | ||
CONTRAINDICATIONS | 542 | ||
DIAGNOSTIC TEST EFFECTS | 542 | ||
SERIOUS REACTIONS | 542 | ||
MECHANISM OF ACTION | 543 | ||
PHARMACOKINETICS | 543 | ||
AVAILABILITY | 543 | ||
OFF-LABEL USES | 543 | ||
CONTRAINDICATIONS | 544 | ||
DIAGNOSTIC TEST EFFECTS | 544 | ||
IV INCOMPATIBILITIES | 544 | ||
SERIOUS REACTIONS | 544 | ||
MECHANISM OF ACTION | 545 | ||
PHARMACOKINETICS | 545 | ||
AVAILABILITY | 545 | ||
CONTRAINDICATIONS | 545 | ||
INTERACTIONS | 545 | ||
DIAGNOSTIC TEST EFFECTS | 545 | ||
SERIOUS REACTIONS | 546 | ||
MECHANISM OF ACTION | 547 | ||
PHARMACOKINETICS | 547 | ||
AVAILABILITY | 547 | ||
IV INCOMPATIBILITIES | 548 | ||
OFF-LABEL USES | 548 | ||
CONTRAINDICATIONS | 548 | ||
DIAGNOSTIC TEST EFFECTS | 548 | ||
SERIOUS REACTIONS | 548 | ||
MECHANISM OF ACTION | 549 | ||
PHARMACOKINETICS | 549 | ||
AVAILABILITY | 550 | ||
CONTRAINDICATIONS | 550 | ||
DIAGNOSTIC TEST EFFECTS | 550 | ||
SERIOUS REACTIONS | 550 | ||
MECHANISM OF ACTION | 551 | ||
PHARMACOKINETICS | 551 | ||
AVAILABILITY | 551 | ||
INDICATIONS AND DOSAGES | 551 | ||
CONTRAINDICATIONS | 552 | ||
DIAGNOSTIC TEST EFFECTS | 552 | ||
SERIOUS REACTIONS | 552 | ||
MECHANISM OF ACTION | 553 | ||
PHARMACOKINETICS | 553 | ||
AVAILABILITY | 553 | ||
CONTRAINDICATIONS | 553 | ||
DIAGNOSTIC TEST EFFECTS | 554 | ||
IV INCOMPATIBILITIES | 554 | ||
IV COMPATIBILITIES | 554 | ||
SERIOUS REACTIONS | 554 | ||
MECHANISM OF ACTION | 555 | ||
PHARMACOKINETICS | 555 | ||
AVAILABILITY | 555 | ||
CONTRAINDICATIONS | 555 | ||
DIAGNOSTIC TEST EFFECTS | 555 | ||
SERIOUS REACTIONS | 555 | ||
MECHANISM OF ACTION | 556 | ||
PHARMACOKINETICS | 556 | ||
AVAILABILITY | 556 | ||
OFF-LABEL USES | 557 | ||
CONTRAINDICATIONS | 557 | ||
DIAGNOSTIC TEST EFFECTS | 557 | ||
IV INCOMPATIBILITIES | 557 | ||
IV COMPATIBILITIES | 557 | ||
SERIOUS REACTIONS | 558 | ||
MECHANISM OF ACTION | 559 | ||
PHARMACOKINETICS | 559 | ||
AVAILABILITY | 559 | ||
CONTRAINDICATIONS | 560 | ||
DIAGNOSTIC TEST EFFECTS | 560 | ||
SERIOUS REACTIONS | 560 | ||
MECHANISM OF ACTION | 561 | ||
PHARMACOKINETICS | 561 | ||
AVAILABILITY | 561 | ||
OFF-LABEL USES | 562 | ||
CONTRAINDICATIONS | 562 | ||
DIAGNOSTIC TEST EFFECTS | 562 | ||
IV INCOMPATIBILITIES | 562 | ||
IV COMPATIBILITIES | 562 | ||
SERIOUS REACTIONS | 563 | ||
MECHANISM OF ACTION | 565 | ||
AVAILABILITY | 565 | ||
OFF-LABEL USES | 565 | ||
CONTRAINDICATIONS | 565 | ||
DIAGNOSTIC TEST EFFECTS | 565 | ||
IV INCOMPATIBILITIES | 565 | ||
IV COMPATIBILITIES | 565 | ||
SERIOUS REACTIONS | 566 | ||
MECHANISM OF ACTION | 566 | ||
PHARMACOKINETICS | 566 | ||
AVAILABILITY | 567 | ||
CONTRAINDICATIONS | 567 | ||
DIAGNOSTIC TEST EFFECTS | 567 | ||
SERIOUS REACTIONS | 567 | ||
MECHANISM OF ACTION | 568 | ||
AVAILABILITY | 568 | ||
CONTRAINDICATIONS | 568 | ||
DIAGNOSTIC TEST EFFECTS | 568 | ||
IV INCOMPATIBILITIES | 568 | ||
IV COMPATIBILITIES | 568 | ||
SERIOUS REACTIONS | 569 | ||
MECHANISM OF ACTION | 569 | ||
PHARMACOKINETICS | 569 | ||
AVAILABILITY | 569 | ||
CONTRAINDICATIONS | 570 | ||
SERIOUS REACTIONS | 570 | ||
MECHANISM OF ACTION | 570 | ||
PHARMACOKINETICS | 570 | ||
AVAILABILITY | 570 | ||
CONTRAINDICATIONS | 571 | ||
DIAGNOSTIC TEST EFFECTS | 571 | ||
SERIOUS REACTIONS | 571 | ||
MECHANISM OF ACTION | 572 | ||
AVAILABILITY | 572 | ||
OFF-LABEL USES | 573 | ||
CONTRAINDICATIONS | 573 | ||
DIAGNOSTIC TEST EFFECTS | 573 | ||
SERIOUS REACTIONS | 573 | ||
MECHANISM OF ACTION | 574 | ||
PHARMACOKINETICS | 574 | ||
AVAILABILITY | 574 | ||
CONTRAINDICATIONS | 574 | ||
DIAGNOSTIC TEST EFFECTS | 575 | ||
IV INCOMPATIBILITIES | 575 | ||
IV COMPATIBILITIES | 575 | ||
SERIOUS REACTIONS | 576 | ||
MECHANISM OF ACTION | 577 | ||
PHARMACOKINETICS | 577 | ||
AVAILABILITY | 577 | ||
OFF-LABEL USES | 578 | ||
CONTRAINDICATIONS | 578 | ||
DIAGNOSTIC TEST EFFECTS | 578 | ||
IV INCOMPATIBILITIES | 578 | ||
IV COMPATIBILITIES | 578 | ||
SERIOUS REACTIONS | 579 | ||
MECHANISM OF ACTION | 580 | ||
PHARMACOKINETICS | 580 | ||
AVAILABILITY | 581 | ||
OFF-LABEL USES | 581 | ||
CONTRAINDICATIONS | 581 | ||
DIAGNOSTIC TEST EFFECTS | 581 | ||
SERIOUS REACTIONS | 581 | ||
MECHANISM OF ACTION | 582 | ||
AVAILABILITY | 582 | ||
OFF-LABEL USES | 583 | ||
CONTRAINDICATIONS | 583 | ||
DIAGNOSTIC TEST EFFECTS | 583 | ||
IV INCOMPATIBILITIES | 583 | ||
IV COMPATIBILITIES | 583 | ||
SIDE EFFECTS | 584 | ||
SERIOUS REACTIONS | 584 | ||
MECHANISM OF ACTION | 585 | ||
PHARMACOKINETICS | 585 | ||
AVAILABILITY | 585 | ||
CONTRAINDICATIONS | 586 | ||
DIAGNOSTIC TEST EFFECTS | 586 | ||
IV INCOMPATIBILITIES | 586 | ||
IV COMPATIBILITIES | 586 | ||
SERIOUS REACTIONS | 587 | ||
MECHANISM OF ACTION | 587 | ||
PHARMACOKINETICS | 588 | ||
AVAILABILITY | 588 | ||
CONTRAINDICATIONS | 588 | ||
SERIOUS REACTIONS | 588 | ||
MECHANISM OF ACTION | 589 | ||
PHARMACOKINETICS | 589 | ||
AVAILABILITY | 589 | ||
OFF-LABEL USES | 590 | ||
CONTRAINDICATIONS | 590 | ||
DIAGNOSTIC TEST EFFECTS | 591 | ||
SERIOUS REACTIONS | 591 | ||
MECHANISM OF ACTION | 593 | ||
PHARMACOKINETICS | 593 | ||
AVAILABILITY | 593 | ||
OFF-LABEL USES | 593 | ||
CONTRAINDICATIONS | 593 | ||
DIAGNOSTIC TEST EFFECTS | 594 | ||
IV INCOMPATIBILITIES | 594 | ||
IV COMPATIBILITIES | 594 | ||
SERIOUS REACTIONS | 594 | ||
MECHANISM OF ACTION | 595 | ||
PHARMACOKINETICS | 595 | ||
AVAILABILITY | 596 | ||
CONTRAINDICATIONS | 596 | ||
DIAGNOSTIC TEST EFFECTS | 596 | ||
SERIOUS REACTIONS | 596 | ||
MECHANISM OF ACTION | 597 | ||
AVAILABILITY | 598 | ||
CONTRAINDICATIONS | 598 | ||
DIAGNOSTIC TEST EFFECTS | 598 | ||
SERIOUS REACTIONS | 599 | ||
MECHANISM OF ACTION | 600 | ||
AVAILABILITY | 600 | ||
CONTRAINDICATIONS | 600 | ||
DIAGNOSTIC TEST EFFECTS | 600 | ||
SERIOUS REACTIONS | 600 | ||
MECHANISM OF ACTION | 601 | ||
PHARMACOKINETICS | 601 | ||
AVAILABILITY | 601 | ||
CONTRAINDICATIONS | 601 | ||
DIAGNOSTIC TEST EFFECTS | 602 | ||
SERIOUS REACTIONS | 602 | ||
MECHANISM OF ACTION | 603 | ||
PHARMACOKINETICS | 603 | ||
AVAILABILITY | 603 | ||
OFF-LABEL USES | 603 | ||
CONTRAINDICATIONS | 603 | ||
DIAGNOSTIC TEST EFFECTS | 604 | ||
SERIOUS REACTIONS | 604 | ||
MECHANISM OF ACTION | 604 | ||
PHARMACOKINETICS | 604 | ||
AVAILABILITY | 605 | ||
OFF-LABEL USES | 605 | ||
CONTRAINDICATIONS | 605 | ||
DIAGNOSTIC TEST EFFECTS | 605 | ||
SERIOUS REACTIONS | 605 | ||
MECHANISM OF ACTION | 606 | ||
PHARMACOKINETICS | 606 | ||
AVAILABILITY | 606 | ||
CONTRAINDICATIONS | 606 | ||
DIAGNOSTIC TEST EFFECTS | 606 | ||
SERIOUS REACTIONS | 607 | ||
MECHANISM OF ACTION | 607 | ||
AVAILABILITY | 607 | ||
OFF-LABEL USES | 608 | ||
CONTRAINDICATIONS | 608 | ||
DIAGNOSTIC TEST EFFECTS | 608 | ||
SERIOUS REACTIONS | 608 | ||
MECHANISM OF ACTION | 608 | ||
PHARMACOKINETICS | 609 | ||
AVAILABILITY | 609 | ||
OFF-LABEL USES | 609 | ||
CONTRAINDICATIONS | 609 | ||
DIAGNOSTIC TEST EFFECTS | 610 | ||
SERIOUS REACTIONS | 610 | ||
F | 624 | ||
MECHANISM OF ACTION | 624 | ||
PHARMACOKINETICS | 624 | ||
AVAILABILITY | 624 | ||
OFF-LABEL USES | 624 | ||
CONTRAINDICATIONS | 624 | ||
DIAGNOSTIC TEST EFFECTS | 624 | ||
IV INCOMPATIBILITIES | 624 | ||
SERIOUS REACTIONS | 625 | ||
MECHANISM OF ACTION | 625 | ||
PHARMACOKINETICS | 625 | ||
AVAILABILITY | 626 | ||
OFF-LABEL USES | 626 | ||
CONTRAINDICATIONS | 626 | ||
DIAGNOSTIC TEST EFFECTS | 626 | ||
SERIOUS REACTIONS | 627 | ||
MECHANISM OF ACTION | 627 | ||
PHARMACOKINETICS | 627 | ||
AVAILABILITY | 627 | ||
CONTRAINDICATIONS | 628 | ||
DIAGNOSTIC TEST EFFECTS | 628 | ||
IV INCOMPATIBILITIES | 629 | ||
IV COMPATIBILITIES | 629 | ||
SERIOUS REACTIONS | 630 | ||
MECHANISM OF ACTION | 630 | ||
PHARMACOKINETICS | 630 | ||
AVAILABILITY | 631 | ||
INDICATIONS AND DOSAGES | 631 | ||
CONTRAINDICATIONS | 631 | ||
DIAGNOSTIC TEST EFFECTS | 631 | ||
SERIOUS REACTIONS | 631 | ||
MECHANISM OF ACTION | 632 | ||
PHARMACOKINETICS | 632 | ||
AVAILABILITY | 632 | ||
INDICATIONS AND DOSAGES | 632 | ||
OFF-LABEL USES | 633 | ||
CONTRAINDICATIONS | 633 | ||
DIAGNOSTIC TEST EFFECTS | 633 | ||
SERIOUS REACTIONS | 633 | ||
MECHANISM OF ACTION | 634 | ||
PHARMACOKINETICS | 634 | ||
AVAILABILITY | 634 | ||
OFF-LABEL USES | 634 | ||
CONTRAINDICATIONS | 634 | ||
SERIOUS REACTIONS | 635 | ||
MECHANISM OF ACTION | 635 | ||
PHARMACOKINETICS | 635 | ||
AVAILABILITY | 636 | ||
OFF-LABEL USES | 636 | ||
CONTRAINDICATIONS | 636 | ||
DIAGNOSTIC TEST EFFECTS | 636 | ||
SERIOUS REACTIONS | 637 | ||
MECHANISM OF ACTION | 637 | ||
PHARMACOKINETICS | 637 | ||
AVAILABILITY | 637 | ||
INDICATIONS AND DOSAGES | 638 | ||
CONTRAINDICATIONS | 638 | ||
INTERACTIONS | 638 | ||
DIAGNOSTIC TEST EFFECTS | 638 | ||
SERIOUS REACTIONS | 638 | ||
MECHANISM OF ACTION | 639 | ||
AVAILABILITY | 639 | ||
OFF-LABEL USES | 639 | ||
CONTRAINDICATIONS | 639 | ||
DIAGNOSTIC TEST EFFECTS | 640 | ||
SERIOUS REACTIONS | 640 | ||
MECHANISM OF ACTION | 641 | ||
PHARMACOKINETICS | 641 | ||
AVAILABILITY | 641 | ||
CONTRAINDICATIONS | 643 | ||
DIAGNOSTIC TEST EFFECTS | 644 | ||
IV INCOMPATIBILITIES | 644 | ||
IV COMPATIBILITIES | 644 | ||
SERIOUS REACTIONS | 645 | ||
MECHANISM OF ACTION | 648 | ||
PHARMACOKINETICS | 648 | ||
CONTRAINDICATIONS | 649 | ||
DIAGNOSTIC TEST EFFECTS | 649 | ||
SERIOUS REACTIONS | 649 | ||
MECHANISM OF ACTION | 650 | ||
PHARMACOKINETICS | 650 | ||
AVAILABILITY | 650 | ||
INDICATIONS AND DOSAGES | 650 | ||
CONTRAINDICATIONS | 650 | ||
DIAGNOSTIC TEST EFFECTS | 651 | ||
SERIOUS REACTIONS | 651 | ||
MECHANISM OF ACTION | 651 | ||
PHARMACOKINETICS | 651 | ||
AVAILABILITY | 652 | ||
CONTRAINDICATIONS | 652 | ||
DIAGNOSTIC TEST EFFECTS | 652 | ||
SERIOUS REACTIONS | 652 | ||
MECHANISM OF ACTION | 653 | ||
PHARMACOKINETICS | 653 | ||
AVAILABILITY | 653 | ||
INDICATIONS AND DOSAGES | 653 | ||
CONTRAINDICATIONS | 653 | ||
INTERACTIONS | 653 | ||
DIAGNOSTIC TEST EFFECTS | 653 | ||
SIDE EFFECTS | 653 | ||
SERIOUS REACTIONS | 653 | ||
MECHANISM OF ACTION | 654 | ||
PHARMACOKINETICS | 654 | ||
AVAILABILITY | 654 | ||
OFF-LABEL USES | 654 | ||
CONTRAINDICATIONS | 654 | ||
DIAGNOSTIC TEST EFFECTS | 655 | ||
IV INCOMPATIBILITIES | 655 | ||
SERIOUS REACTIONS | 655 | ||
MECHANISM OF ACTION | 656 | ||
PHARMACOKINETICS | 656 | ||
AVAILABILITY | 656 | ||
OFF-LABEL USES | 656 | ||
CONTRAINDICATIONS | 656 | ||
DIAGNOSTIC TEST EFFECTS | 657 | ||
SERIOUS REACTIONS | 657 | ||
MECHANISM OF ACTION | 657 | ||
PHARMACOKINETICS | 658 | ||
AVAILABILITY | 658 | ||
INDICATIONS AND DOSAGES | 658 | ||
CONTRAINDICATIONS | 658 | ||
INTERACTIONS | 658 | ||
DIAGNOSTIC TEST EFFECTS | 658 | ||
SIDE EFFECTS | 658 | ||
SERIOUS REACTIONS | 658 | ||
MECHANISM OF ACTION | 659 | ||
PHARMACOKINETICS | 659 | ||
AVAILABILITY | 659 | ||
CONTRAINDICATIONS | 659 | ||
DIAGNOSTIC TEST EFFECTS | 659 | ||
SERIOUS REACTIONS | 659 | ||
MECHANISM OF ACTION | 660 | ||
AVAILABILITY | 660 | ||
CONTRAINDICATIONS | 660 | ||
DIAGNOSTIC TEST EFFECTS | 660 | ||
SERIOUS REACTIONS | 661 | ||
MECHANISM OF ACTION | 661 | ||
AVAILABILITY | 661 | ||
CONTRAINDICATIONS | 661 | ||
DIAGNOSTIC TEST EFFECTS | 662 | ||
SERIOUS REACTIONS | 662 | ||
MECHANISM OF ACTION | 663 | ||
PHARMACOKINETICS | 663 | ||
AVAILABILITY | 663 | ||
OFF-LABEL USES | 663 | ||
CONTRAINDICATIONS | 663 | ||
DIAGNOSTIC TEST EFFECTS | 664 | ||
IV INCOMPATIBILITIES | 664 | ||
IV COMPATIBILITIES | 664 | ||
SERIOUS REACTIONS | 665 | ||
MECHANISM OF ACTION | 666 | ||
PHARMACOKINETICS | 666 | ||
AVAILABILITY | 666 | ||
CONTRAINDICATIONS | 666 | ||
DIAGNOSTIC TEST EFFECTS | 666 | ||
SERIOUS REACTIONS | 667 | ||
MECHANISM OF ACTION | 667 | ||
PHARMACOKINETICS | 667 | ||
AVAILABILITY | 668 | ||
OFF-LABEL USES | 668 | ||
CONTRAINDICATIONS | 668 | ||
DIAGNOSTIC TEST EFFECTS | 668 | ||
SERIOUS REACTIONS | 668 | ||
MECHANISM OF ACTION | 669 | ||
PHARMACOKINETICS | 669 | ||
AVAILABILITY | 669 | ||
CONTRAINDICATIONS | 670 | ||
DIAGNOSTIC TEST EFFECTS | 670 | ||
IV INCOMPATIBILITIES | 670 | ||
IV COMPATIBILITIES | 670 | ||
SERIOUS REACTIONS | 670 | ||
MECHANISM OF ACTION | 671 | ||
PHARMACOKINETICS | 671 | ||
AVAILABILITY | 671 | ||
OFF-LABEL USES | 671 | ||
CONTRAINDICATIONS | 672 | ||
DIAGNOSTIC TEST EFFECTS | 672 | ||
SERIOUS REACTIONS | 672 | ||
MECHANISM OF ACTION | 673 | ||
PHARMACOKINETICS | 673 | ||
AVAILABILITY | 673 | ||
CONTRAINDICATIONS | 673 | ||
DIAGNOSTIC TEST EFFECTS | 674 | ||
SERIOUS REACTIONS | 674 | ||
AVAILABILITY | 674 | ||
CONTRAINDICATIONS | 675 | ||
DIAGNOSTIC TEST EFFECTS | 675 | ||
SERIOUS REACTIONS | 675 | ||
PHARMACOKINETICS | 676 | ||
AVAILABILITY | 676 | ||
OFF-LABEL USES | 676 | ||
CONTRAINDICATIONS | 676 | ||
INTERACTIONS | 676 | ||
DIAGNOSTIC TEST EFFECTS | 677 | ||
SERIOUS REACTIONS | 677 | ||
MECHANISM OF ACTION | 678 | ||
PHARMACOKINETICS | 678 | ||
AVAILABILITY | 678 | ||
DIAGNOSTIC TEST EFFECTS | 678 | ||
SERIOUS REACTIONS | 679 | ||
MECHANISM OF ACTION | 679 | ||
PHARMACOKINETICS | 679 | ||
AVAILABILITY | 679 | ||
CONTRAINDICATIONS | 680 | ||
DIAGNOSTIC TEST EFFECTS | 680 | ||
SERIOUS REACTIONS | 680 | ||
MECHANISM OF ACTION | 681 | ||
PHARMACOKINETICS | 681 | ||
AVAILABILITY | 681 | ||
CONTRAINDICATIONS | 681 | ||
DIAGNOSTIC TEST EFFECTS | 682 | ||
SERIOUS REACTIONS | 682 | ||
MECHANISM OF ACTION | 682 | ||
PHARMACOKINETICS | 682 | ||
AVAILABILITY | 682 | ||
CONTRAINDICATIONS | 683 | ||
DIAGNOSTIC TEST EFFECTS | 683 | ||
SERIOUS REACTIONS | 683 | ||
MECHANISM OF ACTION | 684 | ||
PHARMACOKINETICS | 684 | ||
AVAILABILITY | 684 | ||
CONTRAINDICATIONS | 684 | ||
INTERACTIONS | 684 | ||
SERIOUS REACTIONS | 685 | ||
MECHANISM OF ACTION | 686 | ||
PHARMACOKINETICS | 686 | ||
AVAILABILITY | 686 | ||
CONTRAINDICATIONS | 686 | ||
DIAGNOSTIC TEST EFFECTS | 686 | ||
SERIOUS REACTIONS | 686 | ||
MECHANISM OF ACTION | 687 | ||
PHARMACOKINETICS | 687 | ||
AVAILABILITY | 687 | ||
CONTRAINDICATIONS | 688 | ||
DIAGNOSTIC TEST EFFECTS | 688 | ||
SERIOUS REACTIONS | 688 | ||
MECHANISM OF ACTION | 689 | ||
PHARMACOKINETICS | 689 | ||
AVAILABILITY | 689 | ||
CONTRAINDICATIONS | 690 | ||
DIAGNOSTIC TEST EFFECTS | 690 | ||
SERIOUS REACTIONS | 690 | ||
MECHANISM OF ACTION | 691 | ||
AVAILABILITY | 691 | ||
OFF-LABEL USES | 691 | ||
CONTRAINDICATIONS | 691 | ||
DIAGNOSTIC TEST EFFECTS | 692 | ||
SERIOUS REACTIONS | 692 | ||
MECHANISM OF ACTION | 692 | ||
PHARMACOKINETICS | 693 | ||
AVAILABILITY | 693 | ||
CONTRAINDICATIONS | 693 | ||
DIAGNOSTIC TEST EFFECTS | 693 | ||
IV INCOMPATIBILITIES | 693 | ||
SIDE EFFECTS | 693 | ||
SERIOUS REACTIONS | 693 | ||
MECHANISM OF ACTION | 694 | ||
PHARMACOKINETICS | 694 | ||
AVAILABILITY | 694 | ||
CONTRAINDICATIONS | 694 | ||
DIAGNOSTIC TEST EFFECTS | 695 | ||
SERIOUS REACTIONS | 695 | ||
MECHANISM OF ACTION | 696 | ||
PHARMACOKINETICS | 696 | ||
AVAILABILITY | 696 | ||
CONTRAINDICATIONS | 696 | ||
DIAGNOSTIC TEST EFFECTS | 697 | ||
SERIOUS REACTIONS | 697 | ||
MECHANISM OF ACTION | 698 | ||
PHARMACOKINETICS | 698 | ||
AVAILABILITY | 698 | ||
CONTRAINDICATIONS | 698 | ||
DIAGNOSTIC TEST EFFECTS | 699 | ||
SERIOUS REACTIONS | 699 | ||
MECHANISM OF ACTION | 700 | ||
PHARMACOKINETICS | 700 | ||
AVAILABILITY | 700 | ||
INDICATIONS AND DOSAGES | 700 | ||
CONTRAINDICATIONS | 700 | ||
IV INCOMPATIBILITIES | 701 | ||
DIAGNOSTIC TEST EFFECTS | 701 | ||
SIDE EFFECTS | 701 | ||
SERIOUS REACTIONS | 701 | ||
MECHANISM OF ACTION | 702 | ||
PHARMACOKINETICS | 702 | ||
AVAILABILITY | 702 | ||
CONTRAINDICATIONS | 702 | ||
DIAGNOSTIC TEST EFFECTS | 702 | ||
IV INCOMPATIBILITIES | 702 | ||
IV COMPATIBILITIES | 703 | ||
SERIOUS REACTIONS | 703 | ||
MECHANISM OF ACTION | 704 | ||
AVAILABILITY | 704 | ||
CONTRAINDICATIONS | 704 | ||
DIAGNOSTIC TEST EFFECTS | 704 | ||
SERIOUS REACTIONS | 704 | ||
MECHANISM OF ACTION | 705 | ||
PHARMACOKINETICS | 705 | ||
AVAILABILITY | 705 | ||
OFF-LABEL USES | 705 | ||
CONTRAINDICATIONS | 705 | ||
DIAGNOSTIC TEST EFFECTS | 706 | ||
SERIOUS REACTIONS | 706 | ||
MECHANISM OF ACTION | 707 | ||
PHARMACOKINETICS | 707 | ||
AVAILABILITY | 707 | ||
CONTRAINDICATIONS | 707 | ||
DIAGNOSTIC TEST EFFECTS | 707 | ||
IV INCOMPATIBILITIES | 707 | ||
IV COMPATIBILITIES | 707 | ||
SERIOUS REACTIONS | 708 | ||
MECHANISM OF ACTION | 709 | ||
PHARMACOKINETICS | 709 | ||
AVAILABILITY | 709 | ||
INDICATIONS AND DOSAGES | 709 | ||
CONTRAINDICATIONS | 709 | ||
DIAGNOSTIC TEST EFFECTS | 709 | ||
IV INCOMPATIBILITIES | 709 | ||
SERIOUS REACTIONS | 710 | ||
MECHANISM OF ACTION | 711 | ||
PHARMACOKINETICS | 711 | ||
AVAILABILITY | 711 | ||
CONTRAINDICATIONS | 711 | ||
INTERACTIONS | 711 | ||
SIDE EFFECTS | 711 | ||
SERIOUS REACTIONS | 711 | ||
PHARMACOKINETICS | 712 | ||
AVAILABILITY | 712 | ||
OFF-LABEL USES | 712 | ||
CONTRAINDICATIONS | 712 | ||
G | 715 | ||
MECHANISM OF ACTION | 715 | ||
PHARMACOKINETICS | 715 | ||
AVAILABILITY | 715 | ||
HORIZANT | 716 | ||
GRALISE | 716 | ||
OFF-LABEL USES | 716 | ||
CONTRAINDICATIONS | 716 | ||
DIAGNOSTIC TEST EFFECTS | 716 | ||
SERIOUS REACTIONS | 716 | ||
MECHANISM OF ACTION | 717 | ||
PHARMACOKINETICS | 718 | ||
AVAILABILITY | 718 | ||
CONTRAINDICATIONS | 718 | ||
DIAGNOSTIC TEST EFFECTS | 718 | ||
SERIOUS REACTIONS | 718 | ||
MECHANISM OF ACTION | 719 | ||
PHARMACOKINETICS | 719 | ||
AVAILABILITY | 719 | ||
OFF-LABEL USES | 720 | ||
CONTRAINDICATIONS | 720 | ||
DIAGNOSTIC TEST EFFECTS | 720 | ||
IV INCOMPATIBILITIES | 720 | ||
DIAGNOSTIC TEST EFFECTS | 721 | ||
SERIOUS REACTIONS | 721 | ||
MECHANISM OF ACTION | 723 | ||
AVAILABILITY | 723 | ||
CONTRAINDICATIONS | 723 | ||
DIAGNOSTIC TEST EFFECTS | 723 | ||
SERIOUS REACTIONS | 723 | ||
MECHANISM OF ACTION | 724 | ||
PHARMACOKINETICS | 724 | ||
AVAILABILITY | 724 | ||
CONTRAINDICATIONS | 724 | ||
DIAGNOSTIC TEST EFFECTS | 724 | ||
SERIOUS REACTIONS | 724 | ||
PHARMACOKINETICS | 725 | ||
AVAILABILITY | 725 | ||
CONTRAINDICATIONS | 726 | ||
DIAGNOSTIC TEST EFFECTS | 726 | ||
SERIOUS REACTIONS | 726 | ||
MECHANISM OF ACTION | 727 | ||
PHARMACOKINETICS | 727 | ||
AVAILABILITY | 727 | ||
CONTRAINDICATIONS | 727 | ||
DIAGNOSTIC TEST EFFECTS | 728 | ||
SERIOUS REACTIONS | 728 | ||
MECHANISM OF ACTION | 729 | ||
PHARMACOKINETICS | 729 | ||
AVAILABILITY | 729 | ||
CONTRAINDICATIONS | 730 | ||
DIAGNOSTIC TEST EFFECTS | 730 | ||
IV INCOMPATIBILITIES | 730 | ||
IV COMPATIBILITIES | 730 | ||
SERIOUS REACTIONS | 731 | ||
MECHANISM OF ACTION | 732 | ||
PHARMACOKINETICS | 732 | ||
AVAILABILITY | 732 | ||
CONTRAINDICATIONS | 732 | ||
DIAGNOSTIC TEST EFFECTS | 733 | ||
SERIOUS REACTIONS | 733 | ||
MECHANISM OF ACTION | 733 | ||
PHARMACOKINETICS | 733 | ||
AVAILABILITY | 734 | ||
CONTRAINDICATIONS | 734 | ||
DIAGNOSTIC TEST EFFECTS | 734 | ||
SERIOUS REACTIONS | 734 | ||
MECHANISM OF ACTION | 735 | ||
PHARMACOKINETICS | 735 | ||
AVAILABILITY | 736 | ||
CONTRAINDICATIONS | 736 | ||
DIAGNOSTIC TEST EFFECTS | 736 | ||
SERIOUS REACTIONS | 736 | ||
MECHANISM OF ACTION | 737 | ||
AVAILABILITY | 737 | ||
OFF-LABEL USES | 738 | ||
CONTRAINDICATIONS | 738 | ||
DIAGNOSTIC TEST EFFECTS | 738 | ||
IV INCOMPATIBILITIES | 738 | ||
SERIOUS REACTIONS | 738 | ||
MECHANISM OF ACTION | 739 | ||
PHARMACOKINETICS | 739 | ||
AVAILABILITY | 739 | ||
CONTRAINDICATIONS | 739 | ||
DIAGNOSTIC TEST EFFECTS | 740 | ||
SERIOUS REACTIONS | 740 | ||
MECHANISM OF ACTION | 741 | ||
PHARMACOKINETICS | 741 | ||
AVAILABILITY | 741 | ||
CONTRAINDICATIONS | 741 | ||
DIAGNOSTIC TEST EFFECTS | 742 | ||
SERIOUS REACTIONS | 742 | ||
MECHANISM OF ACTION | 743 | ||
PHARMACOKINETICS | 743 | ||
AVAILABILITY | 743 | ||
CONTRAINDICATIONS | 743 | ||
DIAGNOSTIC TEST EFFECTS | 744 | ||
IV INCOMPATIBILITIES | 744 | ||
IV COMPATIBILITIES | 744 | ||
SERIOUS REACTIONS | 744 | ||
MECHANISM OF ACTION | 745 | ||
PHARMACOKINETICS | 745 | ||
AVAILABILITY | 745 | ||
INDICATIONS AND DOSAGES | 745 | ||
CONTRAINDICATIONS | 745 | ||
H | 758 | ||
PHARMACOKINETICS | 758 | ||
AVAILABILITY | 758 | ||
CONTRAINDICATIONS | 758 | ||
DIAGNOSTIC TEST EFFECTS | 758 | ||
SERIOUS REACTIONS | 758 | ||
MECHANISM OF ACTION | 759 | ||
PHARMACOKINETICS | 759 | ||
AVAILABILITY | 759 | ||
CONTRAINDICATIONS | 759 | ||
DIAGNOSTIC TEST EFFECTS | 759 | ||
SERIOUS REACTIONS | 759 | ||
MECHANISM OF ACTION | 760 | ||
PHARMACOKINETICS | 760 | ||
AVAILABILITY | 760 | ||
OFF-LABEL USES | 760 | ||
CONTRAINDICATIONS | 761 | ||
DIAGNOSTIC TEST EFFECTS | 761 | ||
IV INCOMPATIBILITIES | 761 | ||
IV COMPATIBILITIES | 761 | ||
SERIOUS REACTIONS | 762 | ||
MECHANISM OF ACTION | 763 | ||
PHARMACOKINETICS | 763 | ||
AVAILABILITY | 763 | ||
CONTRAINDICATIONS | 764 | ||
DIAGNOSTIC TEST EFFECTS | 764 | ||
IV INCOMPATIBILITIES | 764 | ||
IV COMPATIBILITIES | 764 | ||
SERIOUS REACTIONS | 765 | ||
MECHANISM OF ACTION | 767 | ||
AVAILABILITY | 767 | ||
CONTRAINDICATIONS | 767 | ||
DIAGNOSTIC TEST EFFECTS | 767 | ||
SERIOUS REACTIONS | 767 | ||
MECHANISM OF ACTION | 768 | ||
PHARMACOKINETICS | 768 | ||
AVAILABILITY | 768 | ||
CONTRAINDICATIONS | 768 | ||
DIAGNOSTIC TEST EFFECTS | 768 | ||
IV INCOMPATIBILITIES | 768 | ||
IV COMPATIBILITIES | 769 | ||
SERIOUS REACTIONS | 769 | ||
PHARMACOKINETICS | 770 | ||
AVAILABILITY | 770 | ||
OFF-LABEL USES | 771 | ||
CONTRAINDICATIONS | 771 | ||
DIAGNOSTIC TEST EFFECTS | 771 | ||
IV INCOMPATIBILITIES | 771 | ||
SERIOUS REACTIONS | 771 | ||
MECHANISM OF ACTION | 772 | ||
PHARMACOKINETICS | 772 | ||
AVAILABILITY | 772 | ||
OFF-LABEL USES | 773 | ||
CONTRAINDICATIONS | 773 | ||
DIAGNOSTIC TEST EFFECTS | 773 | ||
SERIOUS REACTIONS | 773 | ||
MECHANISM OF ACTION | 774 | ||
PHARMACOKINETICS | 775 | ||
AVAILABILITY | 775 | ||
INDICATIONS AND DOSAGES | 775 | ||
CONTRAINDICATIONS | 776 | ||
DIAGNOSTIC TEST EFFECTS | 776 | ||
SERIOUS REACTIONS | 777 | ||
MECHANISM OF ACTION | 778 | ||
PHARMACOKINETICS | 778 | ||
AVAILABILITY | 778 | ||
CONTRAINDICATIONS | 779 | ||
DIAGNOSTIC TEST EFFECTS | 779 | ||
IV INCOMPATIBILITIES | 779 | ||
IV COMPATIBILITIES | 779 | ||
SERIOUS REACTIONS | 780 | ||
MECHANISM OF ACTION | 782 | ||
PHARMACOKINETICS | 782 | ||
AVAILABILITY | 782 | ||
CONTRAINDICATIONS | 783 | ||
DIAGNOSTIC TEST EFFECTS | 783 | ||
IV INCOMPATIBILITIES | 783 | ||
IV COMPATIBILITIES | 783 | ||
SERIOUS REACTIONS | 784 | ||
MECHANISM OF ACTION | 785 | ||
PHARMACOKINETICS | 786 | ||
AVAILABILITY | 786 | ||
OFF-LABEL USES | 786 | ||
CONTRAINDICATIONS | 786 | ||
DIAGNOSTIC TEST EFFECTS | 786 | ||
SERIOUS REACTIONS | 786 | ||
MECHANISM OF ACTION | 787 | ||
PHARMACOKINETICS | 787 | ||
AVAILABILITY | 787 | ||
OFF-LABEL USES | 788 | ||
CONTRAINDICATIONS | 788 | ||
DIAGNOSTIC TEST EFFECTS | 788 | ||
SERIOUS REACTIONS | 788 | ||
MECHANISM OF ACTION | 789 | ||
PHARMACOKINETICS | 789 | ||
AVAILABILITY | 789 | ||
INDICATIONS AND DOSAGES | 789 | ||
CONTRAINDICATIONS | 789 | ||
INTERACTIONS | 789 | ||
DIAGNOSTIC TEST EFFECTS | 789 | ||
SIDE EFFECTS | 789 | ||
SERIOUS REACTIONS | 789 | ||
PHARMACOKINETICS | 791 | ||
AVAILABILITY | 791 | ||
CONTRAINDICATIONS | 791 | ||
DIAGNOSTIC TEST EFFECTS | 791 | ||
SIDE EFFECTS | 791 | ||
SERIOUS REACTIONS | 792 | ||
MECHANISM OF ACTION | 793 | ||
AVAILABILITY | 793 | ||
CONTRAINDICATIONS | 793 | ||
DIAGNOSTIC TEST EFFECTS | 793 | ||
SERIOUS REACTIONS | 794 | ||
Hyaluronan | 770.e2 | ||
PHARMACOKINETICS | 770.e2 | ||
AVAILABILITY | 770.e2 | ||
OFF-LABEL USES | 770.e2 | ||
CONTRAINDICATIONS | 770.e2 | ||
DIAGNOSTIC TEST EFFECTS | 770.e2 | ||
SERIOUS REACTIONS | 770.e2 | ||
I | 795 | ||
MECHANISM OF ACTION | 795 | ||
PHARMACOKINETICS | 795 | ||
AVAILABILITY | 795 | ||
CONTRAINDICATIONS | 795 | ||
DIAGNOSTIC TEST EFFECTS | 795 | ||
SERIOUS REACTIONS | 795 | ||
MECHANISM OF ACTION | 796 | ||
PHARMACOKINETICS | 797 | ||
AVAILABILITY | 797 | ||
OFF-LABEL USES | 797 | ||
CONTRAINDICATIONS | 797 | ||
DIAGNOSTIC TEST EFFECTS | 798 | ||
SERIOUS REACTIONS | 798 | ||
MECHANISM OF ACTION | 799 | ||
PHARMACOKINETICS | 799 | ||
AVAILABILITY | 799 | ||
INDICATIONS AND DOSAGES | 799 | ||
CONTRAINDICATIONS | 799 | ||
INTERACTIONS | 799 | ||
SERIOUS REACTIONS | 800 | ||
MECHANISM OF ACTION | 801 | ||
PHARMACOKINETICS | 802 | ||
AVAILABILITY | 802 | ||
CONTRAINDICATIONS | 802 | ||
DIAGNOSTIC TEST EFFECTS | 802 | ||
IV INCOMPATIBILITIES | 802 | ||
SIDE EFFECTS | 802 | ||
SERIOUS REACTIONS | 802 | ||
MECHANISM OF ACTION | 803 | ||
AVAILABILITY | 803 | ||
INDICATIONS AND DOSAGES | 803 | ||
CONTRAINDICATIONS | 803 | ||
INTERACTIONS | 803 | ||
DIAGNOSTIC TEST EFFECTS | 803 | ||
SIDE EFFECTS | 803 | ||
SERIOUS REACTIONS | 804 | ||
MECHANISM OF ACTION | 804 | ||
PHARMACOKINETICS | 804 | ||
AVAILABILITY | 804 | ||
INDICATIONS AND DOSAGES | 804 | ||
CONTRAINDICATIONS | 805 | ||
DIAGNOSTIC TEST EFFECTS | 805 | ||
SERIOUS REACTIONS | 806 | ||
MECHANISM OF ACTION | 807 | ||
AVAILABILITY | 807 | ||
CONTRAINDICATIONS | 807 | ||
DIAGNOSTIC TEST EFFECTS | 807 | ||
SERIOUS REACTIONS | 807 | ||
MECHANISM OF ACTION | 808 | ||
PHARMACOKINETICS | 808 | ||
AVAILABILITY | 808 | ||
CONTRAINDICATIONS | 809 | ||
DIAGNOSTIC TEST EFFECTS | 809 | ||
SERIOUS REACTIONS | 809 | ||
PHARMACOKINETICS | 810 | ||
AVAILABILITY | 810 | ||
CONTRAINDICATIONS | 811 | ||
DIAGNOSTIC TEST EFFECTS | 811 | ||
IV INCOMPATIBILITIES | 811 | ||
IV COMPATIBILITIES | 811 | ||
SERIOUS REACTIONS | 812 | ||
MECHANISM OF ACTION | 813 | ||
AVAILABILITY | 813 | ||
OFF-LABEL USES | 813 | ||
CONTRAINDICATIONS | 813 | ||
DIAGNOSTIC TEST EFFECTS | 814 | ||
SERIOUS REACTIONS | 814 | ||
MECHANISM OF ACTION | 815 | ||
PHARMACOKINETICS | 815 | ||
AVAILABILITY | 815 | ||
CONTRAINDICATIONS | 815 | ||
INTERACTIONS | 815 | ||
DIAGNOSTIC TEST EFFECTS | 815 | ||
SERIOUS REACTIONS | 815 | ||
MECHANISM OF ACTION | 816 | ||
PHARMACOKINETICS | 816 | ||
AVAILABILITY | 816 | ||
OFF-LABEL USES | 817 | ||
CONTRAINDICATIONS | 817 | ||
DIAGNOSTIC TEST EFFECTS | 817 | ||
IV INCOMPATIBILITIES | 817 | ||
SERIOUS REACTIONS | 817 | ||
MECHANISM OF ACTION | 818 | ||
PHARMACOKINETICS | 818 | ||
AVAILABILITY | 818 | ||
CONTRAINDICATIONS | 818 | ||
DIAGNOSTIC TEST EFFECTS | 819 | ||
IV INCOMPATIBILITIES | 819 | ||
IV COMPATIBILITIES | 819 | ||
SERIOUS REACTIONS | 819 | ||
MECHANISM OF ACTION | 819 | ||
AVAILABILITY | 820 | ||
INDICATIONS AND DOSAGES | 820 | ||
CONTRAINDICATIONS | 820 | ||
INTERACTIONS | 820 | ||
DIAGNOSTIC TEST EFFECTS | 820 | ||
MECHANISM OF ACTION | 821 | ||
PHARMACOKINETICS | 821 | ||
AVAILABILITY | 821 | ||
INDICATIONS AND DOSAGES | 822 | ||
CONTRAINDICATIONS | 822 | ||
INTERACTIONS | 822 | ||
DIAGNOSTIC TEST EFFECTS | 822 | ||
SIDE EFFECTS | 822 | ||
SERIOUS REACTIONS | 822 | ||
MECHANISM OF ACTION | 823 | ||
AVAILABILITY | 823 | ||
CONTRAINDICATIONS | 823 | ||
DIAGNOSTIC TEST EFFECTS | 823 | ||
SERIOUS REACTIONS | 824 | ||
MECHANISM OF ACTION | 824 | ||
PHARMACOKINETICS | 824 | ||
AVAILABILITY | 825 | ||
OFF-LABEL USES | 825 | ||
CONTRAINDICATIONS | 825 | ||
INTERACTIONS | 825 | ||
DIAGNOSTIC TEST EFFECTS | 826 | ||
SERIOUS REACTIONS | 826 | ||
MECHANISM OF ACTION | 827 | ||
PHARMACOKINETICS | 827 | ||
AVAILABILITY | 827 | ||
OFF-LABEL USES | 828 | ||
CONTRAINDICATIONS | 828 | ||
DIAGNOSTIC TEST EFFECTS | 829 | ||
IV INCOMPATIBILITIES | 829 | ||
IV COMPATIBILITIES | 829 | ||
SERIOUS REACTIONS | 829 | ||
MECHANISM OF ACTION | 830 | ||
PHARMACOKINETICS | 830 | ||
AVAILABILITY | 830 | ||
CONTRAINDICATIONS | 830 | ||
DIAGNOSTIC TEST EFFECTS | 831 | ||
IV INCOMPATIBILITIES | 831 | ||
SERIOUS REACTIONS | 831 | ||
MECHANISM OF ACTION | 832 | ||
PHARMACOKINETICS | 832 | ||
AVAILABILITY | 833 | ||
INDICATIONS AND DOSAGES | 833 | ||
OFF-LABEL USES | 833 | ||
CONTRAINDICATIONS | 834 | ||
DIAGNOSTIC TEST EFFECTS | 834 | ||
IV INCOMPATIBILITIES | 834 | ||
SERIOUS REACTIONS | 834 | ||
MECHANISM OF ACTION | 836 | ||
PHARMACOKINETICS | 836 | ||
AVAILABILITY | 836 | ||
OFF-LABEL USES | 837 | ||
CONTRAINDICATIONS | 837 | ||
DIAGNOSTIC TEST EFFECTS | 837 | ||
IV INCOMPATIBILITIES | 837 | ||
SERIOUS REACTIONS | 837 | ||
AVAILABILITY | 838 | ||
CONTRAINDICATIONS | 839 | ||
SERIOUS REACTIONS | 839 | ||
MECHANISM OF ACTION | 839 | ||
PHARMACOKINETICS | 839 | ||
AVAILABILITY | 839 | ||
OFF-LABEL USES | 840 | ||
CONTRAINDICATIONS | 840 | ||
DIAGNOSTIC TEST EFFECTS | 840 | ||
SERIOUS REACTIONS | 840 | ||
MECHANISM OF ACTION | 841 | ||
PHARMACOKINETICS | 841 | ||
AVAILABILITY | 841 | ||
CONTRAINDICATIONS | 841 | ||
DIAGNOSTIC TEST EFFECTS | 841 | ||
SERIOUS REACTIONS | 842 | ||
MECHANISM OF ACTION | 842 | ||
PHARMACOKINETICS | 842 | ||
AVAILABILITY | 843 | ||
OFF-LABEL USES | 843 | ||
CONTRAINDICATIONS | 843 | ||
DIAGNOSTIC TEST EFFECTS | 843 | ||
IV INCOMPATIBILITIES | 843 | ||
IV COMPATIBILITIES | 843 | ||
SIDE EFFECTS | 843 | ||
SERIOUS REACTIONS | 844 | ||
MECHANISM OF ACTION | 845 | ||
PHARMACOKINETICS | 845 | ||
AVAILABILITY | 845 | ||
OFF-LABEL USES | 845 | ||
CONTRAINDICATIONS | 845 | ||
DIAGNOSTIC TEST EFFECTS | 845 | ||
SERIOUS REACTIONS | 845 | ||
MECHANISM OF ACTION | 846 | ||
PHARMACOKINETICS | 846 | ||
AVAILABILITY | 846 | ||
CONTRAINDICATIONS | 846 | ||
DIAGNOSTIC TEST EFFECTS | 847 | ||
SERIOUS REACTIONS | 847 | ||
MECHANISM OF ACTION | 848 | ||
PHARMACOKINETICS | 848 | ||
AVAILABILITY | 848 | ||
OFF-LABEL USES | 848 | ||
CONTRAINDICATIONS | 848 | ||
DIAGNOSTIC TEST EFFECTS | 848 | ||
SERIOUS REACTIONS | 849 | ||
PHARMACOKINETICS | 849 | ||
AVAILABILITY | 850 | ||
CONTRAINDICATIONS | 850 | ||
DIAGNOSTIC TEST EFFECTS | 850 | ||
IV INCOMPATIBILITIES | 850 | ||
SERIOUS REACTIONS | 850 | ||
MECHANISM OF ACTION | 851 | ||
AVAILABILITY | 851 | ||
CONTRAINDICATIONS | 852 | ||
DIAGNOSTIC TEST EFFECTS | 852 | ||
IV INCOMPATIBILITIES | 852 | ||
SERIOUS REACTIONS | 852 | ||
MECHANISM OF ACTION | 853 | ||
PHARMACOKINETICS | 853 | ||
AVAILABILITY | 853 | ||
OFF-LABEL USES | 853 | ||
CONTRAINDICATIONS | 853 | ||
DIAGNOSTIC TEST EFFECTS | 854 | ||
SERIOUS REACTIONS | 854 | ||
MECHANISM OF ACTION | 854 | ||
PHARMACOKINETICS | 855 | ||
AVAILABILITY | 855 | ||
CONTRAINDICATIONS | 855 | ||
DIAGNOSTIC TEST EFFECTS | 855 | ||
SERIOUS REACTIONS | 856 | ||
MECHANISM OF ACTION | 857 | ||
PHARMACOKINETICS | 857 | ||
AVAILABILITY | 857 | ||
OFF-LABEL USES | 857 | ||
CONTRAINDICATIONS | 857 | ||
DIAGNOSTIC TEST EFFECTS | 857 | ||
IV INCOMPATIBILITIES | 857 | ||
IV COMPATIBILITIES | 857 | ||
SERIOUS REACTIONS | 858 | ||
MECHANISM OF ACTION | 858 | ||
PHARMACOKINETICS | 858 | ||
AVAILABILITY | 859 | ||
OFF-LABEL USES | 859 | ||
CONTRAINDICATIONS | 859 | ||
DIAGNOSTIC TEST EFFECTS | 859 | ||
SERIOUS REACTIONS | 859 | ||
MECHANISM OF ACTION | 860 | ||
PHARMACOKINETICS | 860 | ||
AVAILABILITY | 860 | ||
OFF-LABEL USES | 861 | ||
CONTRAINDICATIONS | 861 | ||
DIAGNOSTIC TEST EFFECTS | 861 | ||
SERIOUS REACTIONS | 861 | ||
MECHANISM OF ACTION | 862 | ||
PHARMACOKINETICS | 862 | ||
AVAILABILITY | 863 | ||
OFF-LABEL USES | 863 | ||
CONTRAINDICATIONS | 863 | ||
DIAGNOSTIC TEST EFFECTS | 863 | ||
SERIOUS REACTIONS | 863 | ||
MECHANISM OF ACTION | 864 | ||
PHARMACOKINETICS | 864 | ||
AVAILABILITY | 864 | ||
OFF-LABEL USES | 865 | ||
CONTRAINDICATIONS | 865 | ||
DIAGNOSTIC TEST EFFECTS | 865 | ||
IV INCOMPATIBILITIES | 865 | ||
SERIOUS REACTIONS | 866 | ||
MECHANISM OF ACTION | 867 | ||
PHARMACOKINETICS | 867 | ||
AVAILABILITY | 867 | ||
OFF-LABEL USES | 867 | ||
CONTRAINDICATIONS | 867 | ||
DIAGNOSTIC TEST EFFECTS | 867 | ||
SERIOUS REACTIONS | 868 | ||
AVAILABILITY | 810.e1 | ||
CONTRAINDICATIONS | 810.e1 | ||
INTERACTIONS | 810.e1 | ||
DIAGNOSTIC TEST EFFECTS | 810.e1 | ||
IV INCOMPATIBILITIES | 810.e1 | ||
SERIOUS REACTIONS | 810.e1 | ||
PHARMACOKINETICS | 838.e1 | ||
AVAILABILITY | 838.e1 | ||
CONTRAINDICATIONS | 838.e1 | ||
DIAGNOSTIC TEST EFFECTS | 838.e1 | ||
SERIOUS REACTIONS | 838.e1 | ||
MECHANISM OF ACTION | 842.e1 | ||
PHARMACOKINETICS | 842.e1 | ||
AVAILABILITY | 842.e1 | ||
CONTRAINDICATIONS | 842.e1 | ||
DIAGNOSTIC TEST EFFECTS | 842.e1 | ||
SERIOUS REACTIONS | 842.e1 | ||
PHARMACOKINETICS | 849.e1 | ||
AVAILABILITY | 849.e1 | ||
INDICATIONS AND DOSAGES | 849.e1 | ||
OFF-LABEL USES | 849.e1 | ||
CONTRAINDICATIONS | 849.e1 | ||
DIAGNOSTIC TEST EFFECTS | 849.e2 | ||
IV INCOMPATIBILITIES | 849.e2 | ||
SERIOUS REACTIONS | 849.e2 | ||
PHARMACOKINETICS | 868.e1 | ||
AVAILABILITY | 868.e1 | ||
INDICATIONS AND DOSAGES | 868.e1 | ||
CONTRAINDICATIONS | 868.e1 | ||
DIAGNOSTIC TEST EFFECTS | 868.e2 | ||
IV INCOMPATIBILITIES | 868.e2 | ||
SERIOUS REACTIONS | 868.e2 | ||
K | 869 | ||
PHARMACOKINETICS | 869 | ||
AVAILABILITY | 869 | ||
INDICATIONS AND DOSAGES | 869 | ||
OFF-LABEL USES | 869 | ||
CONTRAINDICATIONS | 869 | ||
INTERACTIONS | 869 | ||
DIAGNOSTIC TEST EFFECTS | 870 | ||
SERIOUS REACTIONS | 870 | ||
MECHANISM OF ACTION | 871 | ||
PHARMACOKINETICS | 871 | ||
AVAILABILITY | 871 | ||
OFF-LABEL USES | 871 | ||
CONTRAINDICATIONS | 871 | ||
DIAGNOSTIC TEST EFFECTS | 872 | ||
SERIOUS REACTIONS | 872 | ||
MECHANISM OF ACTION | 873 | ||
PHARMACOKINETICS | 873 | ||
AVAILABILITY | 873 | ||
CONTRAINDICATIONS | 874 | ||
DIAGNOSTIC TEST EFFECTS | 875 | ||
IV INCOMPATIBILITIES | 875 | ||
IV COMPATIBILITIES | 875 | ||
SERIOUS REACTIONS | 875 | ||
MECHANISM OF ACTION | 876 | ||
PHARMACOKINETICS | 876 | ||
AVAILABILITY | 876 | ||
INDICATIONS AND DOSAGES | 876 | ||
CONTRAINDICATIONS | 876 | ||
DIAGNOSTIC TEST EFFECTS | 877 | ||
SERIOUS REACTIONS | 877 | ||
MECHANISM OF ACTION | 869.e2 | ||
PHARMACOKINETICS | 869.e2 | ||
AVAILABILITY | 869.e2 | ||
CONTRAINDICATIONS | 869.e2 | ||
DIAGNOSTIC TEST EFFECTS | 869.e2 | ||
IV INCOMPATIBILITIES | 869.e2 | ||
IV COMPATIBILITIES | 869.e2 | ||
SERIOUS REACTIONS | 869.e3 | ||
L | 878 | ||
MECHANISM OF ACTION | 878 | ||
PHARMACOKINETICS | 878 | ||
AVAILABILITY | 878 | ||
OFF-LABEL USES | 878 | ||
CONTRAINDICATIONS | 878 | ||
DIAGNOSTIC TEST EFFECTS | 879 | ||
IV INCOMPATIBILITIES | 879 | ||
IV COMPATIBILITIES | 879 | ||
SERIOUS REACTIONS | 879 | ||
MECHANISM OF ACTION | 880 | ||
PHARMACOKINETICS | 880 | ||
AVAILABILITY | 880 | ||
INDICATIONS AND DOSAGES | 881 | ||
CONTRAINDICATIONS | 881 | ||
DIAGNOSTIC TEST EFFECTS | 881 | ||
IV INCOMPATIBILITIES | 881 | ||
SERIOUS REACTIONS | 881 | ||
MECHANISM OF ACTION | 882 | ||
PHARMACOKINETICS | 882 | ||
AVAILABILITY | 883 | ||
CONTRAINDICATIONS | 883 | ||
DIAGNOSTIC TEST EFFECTS | 883 | ||
SERIOUS REACTIONS | 883 | ||
MECHANISM OF ACTION | 884 | ||
PHARMACOKINETICS | 884 | ||
AVAILABILITY | 884 | ||
OFF-LABEL USES | 885 | ||
CONTRAINDICATIONS | 885 | ||
DIAGNOSTIC TEST EFFECTS | 885 | ||
SERIOUS REACTIONS | 885 | ||
MECHANISM OF ACTION | 886 | ||
PHARMACOKINETICS | 886 | ||
AVAILABILITY | 886 | ||
CONTRAINDICATIONS | 888 | ||
DIAGNOSTIC TEST EFFECTS | 888 | ||
SERIOUS REACTIONS | 888 | ||
MECHANISM OF ACTION | 889 | ||
PHARMACOKINETICS | 889 | ||
AVAILABILITY | 890 | ||
OFF-LABEL USES | 890 | ||
CONTRAINDICATIONS | 890 | ||
DIAGNOSTIC TEST EFFECTS | 891 | ||
IV INCOMPATIBILITIES | 891 | ||
SERIOUS REATIONS | 891 | ||
MECHANISM OF ACTION | 892 | ||
PHARMACOKINETICS | 892 | ||
AVAILABILITY | 892 | ||
CONTRAINDICATIONS | 892 | ||
DIAGNOSTIC TEST EFFECTS | 892 | ||
SERIOUS REACTIONS | 892 | ||
MECHANISM OF ACTION | 893 | ||
PHARMACOKINETICS | 893 | ||
AVAILABILITY | 893 | ||
INDICATIONS AND DOSAGES | 893 | ||
CONTRAINDICATIONS | 893 | ||
DIAGNOSTIC TEST EFFECTS | 893 | ||
SERIOUS REACTIONS | 893 | ||
MECHANISM OF ACTION | 894 | ||
PHARMACOKINETICS | 894 | ||
AVAILABILITY | 894 | ||
CONTRAINDICATIONS | 894 | ||
DIAGNOSTIC TEST EFFECTS | 894 | ||
SERIOUS REACTIONS | 895 | ||
MECHANISM OF ACTION | 895 | ||
PHARMACOKINETICS | 896 | ||
AVAILABILITY | 896 | ||
INDICATIONS AND DOSAGES | 896 | ||
CONTRAINDICATIONS | 896 | ||
DIAGNOSTIC TEST EFFECTS | 897 | ||
SERIOUS REACTIONS | 897 | ||
MECHANISM OF ACTION | 898 | ||
PHARMACOKINETICS | 898 | ||
AVAILABILITY | 898 | ||
CONTRAINDICATIONS | 898 | ||
DIAGNOSTIC TEST EFFECTS | 898 | ||
SERIOUS REACTIONS | 898 | ||
MECHANISM OF ACTION | 899 | ||
PHARMACOKINETICS | 899 | ||
AVAILABILITY | 899 | ||
OTHER USES | 900 | ||
CONTRAINDICATIONS | 900 | ||
DIAGNOSTIC TEST EFFECTS | 900 | ||
IV INCOMPATIBILITIES | 901 | ||
IV COMPATIBILITIES | 901 | ||
SERIOUS REACTIONS | 901 | ||
MECHANISM OF ACTION | 902 | ||
PHARMACOKINETICS | 902 | ||
AVAILABILITY | 902 | ||
CONTRAINDICATIONS | 903 | ||
DIAGNOSTIC TEST EFFECTS | 903 | ||
SERIOUS REACTIONS | 903 | ||
MECHANISM OF ACTION | 904 | ||
PHARMACOKINETICS | 904 | ||
AVAILABILITY | 904 | ||
CONTRAINDICATIONS | 904 | ||
DIAGNOSTIC TEST EFFECTS | 905 | ||
SERIOUS REACTIONS | 905 | ||
MECHANISM OF ACTION | 906 | ||
PHARMACOKINETICS | 906 | ||
AVAILABILITY | 906 | ||
CONTRAINDICATIONS | 906 | ||
DIAGNOSTIC TEST EFFECTS | 906 | ||
IV COMPATIBILITIES | 907 | ||
SERIOUS REACTIONS | 907 | ||
MECHANISM OF ACTION | 907 | ||
PHARMACOKINETICS | 908 | ||
AVAILABILITY | 908 | ||
INDICATIONS AND DOSAGES | 908 | ||
CONTRAINDICATIONS | 908 | ||
DIAGNOSTIC TEST EFFECTS | 908 | ||
SERIOUS REACTIONS | 908 | ||
MECHANISM OF ACTION | 909 | ||
PHARMACOKINETICS | 909 | ||
AVAILABILITY | 909 | ||
CONTRAINDICATIONS | 910 | ||
DIAGNOSTIC TEST EFFECTS | 910 | ||
IV INCOMPATIBILITIES | 910 | ||
IV COMPATIBILITIES | 910 | ||
SERIOUS REACTIONS | 911 | ||
MECHANISM OF ACTION | 912 | ||
PHARMACOKINETICS | 912 | ||
AVAILABILITY | 912 | ||
INDICATIONS AND DOSAGES | 913 | ||
OFF-LABEL USES | 913 | ||
CONTRAINDICATIONS | 913 | ||
DIAGNOSTIC TEST EFFECTS | 913 | ||
IV INCOMPATIBILITIES | 913 | ||
SERIOUS REACTIONS | 914 | ||
MECHANISM OF ACTION | 914 | ||
PHARMACOKINETICS | 914 | ||
AVAILABILITY | 914 | ||
CONTRAINDICATIONS | 915 | ||
DIAGNOSTIC TEST EFFECTS | 915 | ||
IV INCOMPATIBILITIES | 915 | ||
SIDE EFFECTS | 915 | ||
SERIOUS REACTIONS | 915 | ||
MECHANISM OF ACTION | 916 | ||
PHARMACOKINETICS | 917 | ||
AVAILABILITY | 917 | ||
CONTRAINDICATIONS | 917 | ||
DIAGNOSTIC TEST EFFECTS | 918 | ||
IV INCOMPATIBILITIES | 918 | ||
SERIOUS REACTIONS | 918 | ||
MECHANISM OF ACTION | 919 | ||
PHARMACOKINETICS | 919 | ||
AVAILABILITY | 919 | ||
CONTRAINDICATIONS | 920 | ||
DIAGNOSTIC TEST EFFECTS | 920 | ||
IV INCOMPATIBILITIES | 920 | ||
IV COMPATIBILITIES | 920 | ||
SIDE EFFECTS | 920 | ||
SERIOUS REACTIONS | 921 | ||
MECHANISM OF ACTION | 922 | ||
PHARMACOKINETICS | 922 | ||
AVAILABILITY | 922 | ||
INDICATIONS AND DOSAGES | 922 | ||
CONTRAINDICATIONS | 922 | ||
DIAGNOSTIC TEST EFFECTS | 923 | ||
SERIOUS REACTIONS | 923 | ||
MECHANISM OF ACTION | 923 | ||
PHARMACOKINETICS | 924 | ||
AVAILABILITY | 924 | ||
INDICATIONS AND DOSAGES | 924 | ||
CONTRAINDICATIONS | 924 | ||
DIAGNOSTIC TEST EFFECTS | 924 | ||
SERIOUS REACTIONS | 924 | ||
MECHANISM OF ACTION | 925 | ||
PHARMACOKINETICS | 925 | ||
AVAILABILITY | 925 | ||
CONTRAINDICATIONS | 925 | ||
DIAGNOSTIC TEST EFFECTS | 926 | ||
IV INCOMPATIBILITIES | 926 | ||
SERIOUS REACTIONS | 926 | ||
MECHANISM OF ACTION | 927 | ||
PHARMACOKINETICS | 927 | ||
AVAILABILITY | 927 | ||
CONTRAINDICATIONS | 928 | ||
DIAGNOSTIC TEST EFFECTS | 928 | ||
SERIOUS REACTIONS | 928 | ||
MECHANISM OF ACTION | 929 | ||
PHARMACOKINETICS | 929 | ||
AVAILABILITY | 929 | ||
INDICATIONS AND DOSAGES | 929 | ||
CONTRAINDICATIONS | 930 | ||
DIAGNOSTIC TEST EFFECTS | 930 | ||
SERIOUS REACTIONS | 930 | ||
MECHANISM OF ACTION | 931 | ||
PHARMACOKINETICS | 932 | ||
AVAILABILITY | 932 | ||
INDICATIONS AND DOSAGES | 932 | ||
CONTRAINDICATIONS | 932 | ||
DIAGNOSTIC TEST EFFECTS | 933 | ||
SERIOUS REACTIONS | 933 | ||
MECHANISM OF ACTION | 934 | ||
PHARMACOKINETICS | 934 | ||
AVAILABILITY | 934 | ||
OFF-LABEL USES | 935 | ||
CONTRAINDICATIONS | 935 | ||
DIAGNOSTIC TEST EFFECTS | 935 | ||
SERIOUS REACTIONS | 935 | ||
MECHANISM OF ACTION | 936 | ||
PHARMACOKINETICS | 936 | ||
AVAILABILITY | 937 | ||
OFF-LABEL USES | 937 | ||
CONTRAINDICATIONS | 937 | ||
DIAGNOSTIC TEST EFFECTS | 937 | ||
SIDE EFFECTS | 937 | ||
SERIOUS REACTIONS | 938 | ||
MECHANISM OF ACTION | 938 | ||
PHARMACOKINETICS | 939 | ||
AVAILABILITY | 939 | ||
CONTRAINDICATIONS | 939 | ||
DIAGNOSTIC TEST EFFECTS | 939 | ||
SERIOUS REACTIONS | 939 | ||
MECHANISM OF ACTION | 939 | ||
PHARMACOKINETICS | 940 | ||
AVAILABILITY | 940 | ||
CONTRAINDICATIONS | 940 | ||
DIAGNOSTIC TEST EFFECTS | 940 | ||
SERIOUS REACTIONS | 940 | ||
MECHANISM OF ACTION | 941 | ||
PHARMACOKINETICS | 941 | ||
AVAILABILITY | 941 | ||
CONTRAINDICATIONS | 942 | ||
INTERACTIONS | 942 | ||
DIAGNOSTIC TEST EFFECTS | 943 | ||
SERIOUS REACTIONS | 943 | ||
MECHANISM OF ACTION | 944 | ||
PHARMACOKINETICS | 944 | ||
AVAILABILITY | 944 | ||
CONTRAINDICATIONS | 945 | ||
DIAGNOSTIC TEST EFFECTS | 945 | ||
SERIOUS REACTIONS | 945 | ||
MECHANISM OF ACTION | 946 | ||
PHARMACOKINETICS | 946 | ||
AVAILABILITY | 946 | ||
OFF-LABEL USES | 946 | ||
CONTRAINDICATIONS | 947 | ||
DIAGNOSTIC TEST EFFECTS | 947 | ||
IV INCOMPATIBILITIES | 947 | ||
IV COMPATIBILITIES | 947 | ||
SERIOUS REACTIONS | 947 | ||
MECHANISM OF ACTION | 948 | ||
PHARMACOKINETICS | 948 | ||
AVAILABILITY | 948 | ||
INDICATIONS AND DOSAGES | 948 | ||
CONTRAINDICATIONS | 949 | ||
INTERACTIONS | 949 | ||
DIAGNOSTIC TEST EFFECTS | 949 | ||
MECHANISM OF ACTION | 950 | ||
PHARMACOKINETICS | 951 | ||
AVAILABILITY | 951 | ||
CONTRAINDICATIONS | 951 | ||
DIAGNOSTIC TEST EFFECTS | 951 | ||
SERIOUS REACTIONS | 951 | ||
MECHANISM OF ACTION | 952 | ||
PHARMACOKINETICS | 952 | ||
AVAILABILITY | 952 | ||
CONTRAINDICATIONS | 953 | ||
DIAGNOSTIC TEST EFFECTS | 953 | ||
SIDE EFFECTS | 953 | ||
SERIOUS REACTIONS | 953 | ||
MECHANISM OF ACTION | 954 | ||
PHARMACOKINETICS | 954 | ||
AVAILABILITY | 954 | ||
CONTRAINDICATIONS | 954 | ||
DIAGNOSTIC TEST EFFECTS | 954 | ||
SERIOUS REACTIONS | 955 | ||
MECHANISM OF ACTION | 955 | ||
PHARMACOKINETICS | 956 | ||
AVAILABILITY | 956 | ||
INDICATIONS AND DOSAGES | 956 | ||
CONTRAINDICATIONS | 956 | ||
DIAGNOSTIC TEST EFFECTS | 956 | ||
SERIOUS REACTIONS | 956 | ||
MECHANISM OF ACTION | 957 | ||
AVAILABILITY | 957 | ||
PHARMACOKINETICS | 957 | ||
INDICATIONS AND DOSAGES | 957 | ||
CONTRAINDICATIONS | 957 | ||
INTERACTIONS | 957 | ||
DIAGNOSTIC TEST EFFECTS | 958 | ||
SIDE EFFECTS | 958 | ||
SERIOUS REACTIONS | 958 | ||
M | 959 | ||
MECHANISM OF ACTION | 959 | ||
PHARMACOKINETICS | 959 | ||
AVAILABILITY | 959 | ||
CONTRAINDICATIONS | 959 | ||
DIAGNOSTIC TEST EFFECTS | 959 | ||
SIDE EFFECTS | 959 | ||
SERIOUS REACTIONS | 959 | ||
MECHANISM OF ACTION | 960 | ||
PHARMACOKINETICS | 960 | ||
AVAILABILITY | 960 | ||
INDICATIONS AND DOSAGES | 960 | ||
CONTRAINDICATIONS | 960 | ||
DIAGNOSTIC TEST EFFECTS | 961 | ||
SERIOUS REACTIONS | 961 | ||
MECHANISM OF ACTION | 961 | ||
PHARMACOKINETICS | 962 | ||
INDICATIONS AND DOSAGES | 962 | ||
CONTRAINDICATIONS | 963 | ||
DIAGNOSTIC TEST EFFECTS | 964 | ||
IV INCOMPATIBILITIES | 964 | ||
SERIOUS REACTIONS | 964 | ||
MECHANISM OF ACTION | 966 | ||
PHARMACOKINETICS | 966 | ||
AVAILABILITY | 966 | ||
INDICATIONS AND DOSAGES | 966 | ||
CONTRAINDICATIONS | 966 | ||
INTERACTIONS | 966 | ||
DIAGNOSTIC TEST EFFECTS | 966 | ||
SIDE EFFECTS | 966 | ||
SERIOUS REACTIONS | 966 | ||
MECHANISM OF ACTION | 967 | ||
PHARMACOKINETICS | 967 | ||
AVAILABILITY | 968 | ||
CONTRAINDICATIONS | 968 | ||
DIAGNOSTIC TEST EFFECTS | 968 | ||
IV INCOMPATIBILITIES | 968 | ||
IV COMPATIBILITIES | 968 | ||
SERIOUS REACTIONS | 968 | ||
MECHANISM OF ACTION | 970 | ||
PHARMACOKINETICS | 970 | ||
AVAILABILITY | 970 | ||
INDICATIONS AND DOSAGES | 970 | ||
CONTRAINDICATIONS | 971 | ||
DIAGNOSTIC TEST EFFECTS | 971 | ||
SERIOUS REACTIONS | 971 | ||
MECHANISM OF ACTION | 972 | ||
PHARMACOKINETICS | 972 | ||
AVAILABILITY | 972 | ||
OFF-LABEL USES | 972 | ||
CONTRAINDICATIONS | 972 | ||
DIAGNOSTIC TEST EFFECTS | 973 | ||
SERIOUS REACTIONS | 973 | ||
MECHANISM OF ACTION | 973 | ||
PHARMACOKINETICS | 973 | ||
AVAILABILITY | 974 | ||
CONTRAINDICATIONS | 974 | ||
DIAGNOSTIC TEST EFFECTS | 974 | ||
SERIOUS REACTIONS | 974 | ||
MECHANISM OF ACTION | 975 | ||
PHARMACOKINETICS | 975 | ||
AVAILABILITY | 975 | ||
CONTRAINDICATIONS | 975 | ||
DIAGNOSTIC TEST EFFECTS | 976 | ||
SERIOUS REACTIONS | 976 | ||
MECHANISM OF ACTION | 977 | ||
PHARMACOKINETICS | 977 | ||
AVAILABILITY | 977 | ||
CONTRAINDICATIONS | 977 | ||
DIAGNOSTIC TEST EFFECTS | 977 | ||
SERIOUS REACTIONS | 978 | ||
MECHANISM OF ACTION | 978 | ||
PHARMACOKINETICS | 978 | ||
AVAILABILITY | 978 | ||
OFF-LABEL USES | 979 | ||
CONTRAINDICATIONS | 979 | ||
DIAGNOSTIC TEST EFFECTS | 979 | ||
SERIOUS REACTIONS | 979 | ||
MECHANISM OF ACTION | 980 | ||
PHARMACOKINETICS | 980 | ||
AVAILABILITY | 980 | ||
CONTRAINDICATIONS | 980 | ||
DIAGNOSTIC TEST EFFECTS | 980 | ||
SERIOUS REACTIONS | 981 | ||
MECHANISM OF ACTION | 981 | ||
PHARMACOKINETICS | 981 | ||
AVAILABILITY | 981 | ||
CONTRAINDICATIONS | 982 | ||
DIAGNOSTIC TEST EFFECTS | 982 | ||
SERIOUS REACTIONS | 982 | ||
MECHANISM OF ACTION | 983 | ||
PHARMACOKINETICS | 983 | ||
AVAILABILITY | 983 | ||
CONTRAINDICATIONS | 984 | ||
DIAGNOSTIC TEST EFFECTS | 984 | ||
IV INCOMPATIBILITIES | 984 | ||
IV COMPATIBILITIES | 984 | ||
SERIOUS REACTIONS | 984 | ||
MECHANISM OF ACTION | 986 | ||
PHARMACOKINETICS | 986 | ||
AVAILABILITY | 986 | ||
DIAGNOSTIC TEST EFFECTS | 986 | ||
SERIOUS REACTIONS | 986 | ||
MECHANISM OF ACTION | 987 | ||
PHARMACOKINETICS | 987 | ||
AVAILABILITY | 987 | ||
OFF-LABEL USES | 988 | ||
CONTRAINDICATIONS | 988 | ||
DIAGNOSTIC TEST EFFECTS | 988 | ||
IV INCOMPATIBILITIES | 988 | ||
IV COMPATIBILITIES | 988 | ||
SERIOUS REACTIONS | 988 | ||
MECHANISM OF ACTION | 989 | ||
PHARMACOKINETICS | 989 | ||
AVAILABILITY | 989 | ||
CONTRAINDICATIONS | 990 | ||
DIAGNOSTIC TEST EFFECTS | 990 | ||
SIDE EFFECTS | 990 | ||
SERIOUS REACTIONS | 990 | ||
MECHANISM OF ACTION | 991 | ||
PHARMACOKINETICS | 991 | ||
AVAILABILITY | 991 | ||
CONTRAINDICATIONS | 991 | ||
DIAGNOSTIC TEST EFFECTS | 992 | ||
SERIOUS REACTIONS | 992 | ||
MECHANISM OF ACTION | 992 | ||
PHARMACOKINETICS | 992 | ||
AVAILABILITY | 992 | ||
OFF-LABEL USES | 993 | ||
CONTRAINDICATIONS | 993 | ||
DIAGNOSTIC TEST EFFECTS | 994 | ||
SERIOUS REACTIONS | 994 | ||
MECHANISM OF ACTION | 995 | ||
PHARMACOKINETICS | 995 | ||
AVAILABILITY | 995 | ||
CONTRAINDICATIONS | 996 | ||
DIAGNOSTIC TEST EFFECTS | 996 | ||
SERIOUS REACTIONS | 997 | ||
MECHANISM OF ACTION | 998 | ||
PHARMACOKINETICS | 998 | ||
AVAILABILITY | 998 | ||
OFF-LABEL USES | 998 | ||
CONTRAINDICATIONS | 998 | ||
DIAGNOSTIC TEST EFFECTS | 999 | ||
SERIOUS REACTIONS | 999 | ||
MECHANISM OF ACTION | 1000 | ||
PHARMACOKINETICS | 1000 | ||
AVAILABILITY | 1000 | ||
OFF-LABEL USES | 1000 | ||
CONTRAINDICATIONS | 1000 | ||
DIAGNOSTIC TEST EFFECTS | 1000 | ||
SERIOUS REACTIONS | 1000 | ||
MECHANISM OF ACTION | 1001 | ||
PHARMACOKINETICS | 1001 | ||
AVAILABILITY | 1001 | ||
CONTRAINDICATIONS | 1001 | ||
DIAGNOSTIC TEST EFFECTS | 1002 | ||
SERIOUS REACTIONS | 1002 | ||
MECHANISM OF ACTION | 1002 | ||
PHARMACOKINETICS | 1002 | ||
AVAILABILITY | 1003 | ||
CONTRAINDICATIONS | 1003 | ||
DIAGNOSTIC TEST EFFECTS | 1003 | ||
SERIOUS REACTIONS | 1003 | ||
MECHANISM OF ACTION | 1004 | ||
PHARMACOKINETICS | 1004 | ||
AVAILABILITY | 1005 | ||
CONTRAINDICATIONS | 1005 | ||
IV INCOMPATIBILITIES | 1006 | ||
SERIOUS REACTIONS | 1006 | ||
MECHANISM OF ACTION | 1007 | ||
PHARMACOKINETICS | 1007 | ||
AVAILABILITY | 1007 | ||
OFF-LABEL USES | 1007 | ||
CONTRAINDICATIONS | 1007 | ||
DIAGNOSTIC TEST EFFECTS | 1008 | ||
SERIOUS REACTIONS | 1008 | ||
MECHANISM OF ACTION | 1008 | ||
PHARMACOKINETICS | 1009 | ||
AVAILABILITY | 1009 | ||
OFF-LABEL USES | 1009 | ||
CONTRAINDICATIONS | 1009 | ||
DIAGNOSTIC TEST EFFECTS | 1009 | ||
SERIOUS REACTIONS | 1009 | ||
MECHANISM OF ACTION | 1010 | ||
PHARMACOKINETICS | 1010 | ||
AVAILABILITY | 1010 | ||
CONTRAINDICATIONS | 1010 | ||
DIAGNOSTIC TEST EFFECTS | 1011 | ||
SERIOUS REACTIONS | 1011 | ||
MECHANISM OF ACTION | 1011 | ||
PHARMACOKINETICS | 1011 | ||
AVAILABILITY | 1011 | ||
CONTRAINDICATIONS | 1012 | ||
IV INCOMPATIBILITIES | 1012 | ||
DIAGNOSTIC TEST EFFECTS | 1012 | ||
SERIOUS REACTIONS | 1012 | ||
MECHANISM OF ACTION | 1013 | ||
PHARMACOKINETICS | 1013 | ||
AVAILABILITY | 1013 | ||
OFF-LABEL USES | 1013 | ||
CONTRAINDICATIONS | 1013 | ||
DIAGNOSTIC TEST EFFECTS | 1014 | ||
IV INCOMPATIBILITIES | 1014 | ||
IV COMPATIBILITIES | 1014 | ||
SERIOUS REACTIONS | 1014 | ||
MECHANISM OF ACTION | 1015 | ||
PHARMACOKINETICS | 1015 | ||
AVAILABILITY | 1015 | ||
INDICATIONS AND DOSAGES | 1015 | ||
CONTRAINDICATIONS | 1015 | ||
DIAGNOSTIC TEST EFFECTS | 1016 | ||
SERIOUS REACTIONS | 1016 | ||
MECHANISM OF ACTION | 1016 | ||
PHARMACOKINETICS | 1016 | ||
AVAILABILITY | 1017 | ||
OFF-LABEL USES | 1017 | ||
CONTRAINDICATIONS | 1017 | ||
DIAGNOSTIC TEST EFFECTS | 1018 | ||
SERIOUS REACTIONS | 1018 | ||
MECHANISM OF ACTION | 1019 | ||
PHARMACOKINETICS | 1019 | ||
AVAILABILITY | 1019 | ||
CONTRAINDICATIONS | 1020 | ||
DIAGNOSTIC TEST EFFECTS | 1020 | ||
IV INCOMPATIBILITIES | 1020 | ||
IV COMPATIBILITIES | 1020 | ||
SERIOUS REACTIONS | 1020 | ||
MECHANISM OF ACTION | 1022 | ||
PHARMACOKINETICS | 1022 | ||
AVAILABILITY | 1022 | ||
OFF-LABEL USES | 1022 | ||
CONTRAINDICATIONS | 1022 | ||
DIAGNOSTIC TEST EFFECTS | 1022 | ||
SERIOUS REACTIONS | 1023 | ||
MECHANISM OF ACTION | 1023 | ||
PHARMACOKINETICS | 1023 | ||
AVAILABILITY | 1023 | ||
CONTRAINDICATIONS | 1023 | ||
DRUG INTERACTIONS | 1024 | ||
SERIOUS REACTIONS | 1024 | ||
MECHANISM OF ACTION | 1024 | ||
PHARMACOKINETICS | 1024 | ||
AVAILABILITY | 1024 | ||
OFF-LABEL USES | 1025 | ||
CONTRAINDICATIONS | 1025 | ||
DIAGNOSTIC TEST EFFECTS | 1025 | ||
IV INCOMPATIBILITIES | 1026 | ||
IV COMPATIBILITIES | 1026 | ||
SERIOUS REACTIONS | 1026 | ||
MECHANISM OF ACTION | 1027 | ||
PHARMACOKINETICS | 1027 | ||
AVAILABILITY | 1027 | ||
CONTRAINDICATIONS | 1027 | ||
DIAGNOSTIC TEST EFFECTS | 1028 | ||
SERIOUS REACTIONS | 1028 | ||
MECHANISM OF ACTION | 1029 | ||
PHARMACOKINETICS | 1029 | ||
AVAILABILITY | 1029 | ||
OFF-LABEL USES | 1030 | ||
CONTRAINDICATIONS | 1030 | ||
DIAGNOSTIC TEST EFFECTS | 1030 | ||
IV INCOMPATIBILITIES | 1030 | ||
IV COMPATIBILITIES | 1030 | ||
SIDE EFFECTS | 1030 | ||
SERIOUS REACTIONS | 1031 | ||
MECHANISM OF ACTION | 1032 | ||
PHARMACOKINETICS | 1032 | ||
AVAILABILITY | 1032 | ||
OFF-LABEL USES | 1033 | ||
CONTRAINDICATIONS | 1033 | ||
DIAGNOSTIC TEST EFFECTS | 1033 | ||
IV INCOMPATIBILITIES | 1033 | ||
IV COMPATIBILITIES | 1034 | ||
SERIOUS REACTIONS | 1034 | ||
MECHANISM OF ACTION | 1035 | ||
PHARMACOKINETICS | 1035 | ||
AVAILABILITY | 1035 | ||
CONTRAINDICATIONS | 1035 | ||
DIAGNOSTIC TEST EFFECTS | 1035 | ||
SERIOUS REACTIONS | 1036 | ||
MECHANISM OF ACTION | 1036 | ||
PHARMACOKINETICS | 1036 | ||
AVAILABILITY | 1036 | ||
INDICATIONS AND DOSAGES | 1036 | ||
CONTRAINDICATIONS | 1037 | ||
DIAGNOSTIC TEST EFFECTS | 1037 | ||
IV INCOMPATIBILITIES | 1037 | ||
SERIOUS REACTIONS | 1037 | ||
MECHANISM OF ACTION | 1038 | ||
PHARMACOKINETICS | 1038 | ||
AVAILABILITY | 1038 | ||
CONTRAINDICATIONS | 1038 | ||
DIAGNOSTIC TEST EFFECTS | 1039 | ||
SERIOUS REACTIONS | 1039 | ||
MECHANISM OF ACTION | 1040 | ||
PHARMACOKINETICS | 1040 | ||
AVAILABILITY | 1040 | ||
CONTRAINDICATIONS | 1040 | ||
DIAGNOSTIC TEST EFFECTS | 1041 | ||
IV INCOMPATIBILITIES | 1041 | ||
IV COMPATIBILITIES | 1041 | ||
SERIOUS REACTIONS | 1041 | ||
MECHANISM OF ACTION | 1042 | ||
PHARMACOKINETICS | 1042 | ||
AVAILABILITY | 1042 | ||
CONTRAINDICATIONS | 1042 | ||
DIAGNOSTIC TEST EFFECTS | 1043 | ||
SERIOUS REACTIONS | 1043 | ||
MECHANISM OF ACTION | 1043 | ||
PHARMACOKINETICS | 1043 | ||
AVAILABILITY | 1044 | ||
OFF-LABEL USES | 1044 | ||
CONTRAINDICATIONS | 1044 | ||
DIAGNOSTIC TEST EFFECTS | 1044 | ||
SERIOUS REACTIONS | 1044 | ||
MECHANISM OF ACTION | 1045 | ||
PHARMACOKINETICS | 1045 | ||
AVAILABILITY | 1045 | ||
CONTRAINDICATIONS | 1045 | ||
DIAGNOSTIC TEST EFFECTS | 1045 | ||
SERIOUS REACTIONS | 1046 | ||
MECHANISM OF ACTION | 1046 | ||
PHARMACOKINETICS | 1046 | ||
AVAILABILITY | 1046 | ||
CONTRAINDICATIONS | 1047 | ||
DIAGNOSTIC TEST EFFECTS | 1047 | ||
SERIOUS REACTIONS | 1047 | ||
MECHANISM OF ACTION | 1047 | ||
PHARMACOKINETICS | 1048 | ||
AVAILABILITY | 1048 | ||
INDICATIONS AND DOSAGES | 1048 | ||
CONTRAINDICATIONS | 1048 | ||
DIAGNOSTIC TEST EFFECTS | 1048 | ||
SERIOUS REACTIONS | 1048 | ||
MECHANISM OF ACTION | 1049 | ||
PHARMACOKINETICS | 1049 | ||
AVAILABILITY | 1049 | ||
CONTRAINDICATIONS | 1050 | ||
DIAGNOSTIC TEST EFFECTS | 1050 | ||
IV INCOMPATIBILITIES | 1050 | ||
IV COMPATIBILITIES | 1050 | ||
SERIOUS REACTIONS | 1050 | ||
MECHANISM OF ACTION | 1051 | ||
PHARMACOKINETICS | 1051 | ||
AVAILABILITY | 1051 | ||
CONTRAINDICATIONS | 1051 | ||
IV INCOMPATIBILITIES | 1052 | ||
DIAGNOSTIC TEST EFFECTS | 1052 | ||
SERIOUS REACTIONS | 1052 | ||
MECHANISM OF ACTION | 1053 | ||
PHARMACOKINETICS | 1053 | ||
AVAILABILITY | 1053 | ||
CONTRAINDICATIONS | 1054 | ||
DIAGNOSTIC TEST EFFECTS | 1054 | ||
SERIOUS REACTIONS | 1054 | ||
MECHANISM OF ACTION | 1055 | ||
PHARMACOKINETICS | 1056 | ||
AVAILABILITY | 1056 | ||
OFF-LABEL USES | 1056 | ||
CONTRAINDICATIONS | 1056 | ||
DIAGNOSTIC TEST EFFECTS | 1056 | ||
SERIOUS REACTIONS | 1056 | ||
MECHANISM OF ACTION | 1057 | ||
PHARMACOKINETICS | 1057 | ||
AVAILABILITY | 1057 | ||
OFF-LABEL USES | 1058 | ||
CONTRAINDICATIONS | 1058 | ||
DIAGNOSTIC TEST EFFECTS | 1058 | ||
SERIOUS REACTIONS | 1058 | ||
MECHANISM OF ACTION | 1059 | ||
PHARMACOKINETICS | 1059 | ||
AVAILABILITY | 1059 | ||
OFF-LABEL USES | 1059 | ||
CONTRAINDICATIONS | 1059 | ||
DIAGNOSTIC TEST EFFECTS | 1059 | ||
SERIOUS REACTIONS | 1059 | ||
MECHANISM OF ACTION | 1060 | ||
PHARMACOKINETICS | 1060 | ||
AVAILABILITY | 1060 | ||
CONTRAINDICATIONS | 1060 | ||
DIAGNOSTIC TEST EFFECTS | 1060 | ||
N | 1078 | ||
MECHANISM OF ACTION | 1078 | ||
PHARMACOKINETICS | 1078 | ||
AVAILABILITY | 1078 | ||
CONTRAINDICATIONS | 1078 | ||
DIAGNOSTIC TEST EFFECTS | 1078 | ||
SERIOUS REACTIONS | 1079 | ||
MECHANISM OF ACTION | 1079 | ||
PHARMACOKINETICS | 1080 | ||
AVAILABILITY | 1080 | ||
OFF-LABEL USES | 1080 | ||
CONTRAINDICATIONS | 1080 | ||
DIAGNOSTIC TEST EFFECTS | 1080 | ||
SIDE EFFECTS | 1080 | ||
SERIOUS REACTIONS | 1081 | ||
MECHANISM OF ACTION | 1081 | ||
PHARMACOKINETICS | 1081 | ||
AVAILABILITY | 1082 | ||
INDICATIONS AND DOSAGES | 1082 | ||
CONTRAINDICATIONS | 1082 | ||
INTERACTIONS | 1082 | ||
DIAGNOSTIC TEST EFFECTS | 1082 | ||
SIDE EFFECTS | 1082 | ||
MECHANISM OF ACTION | 1083 | ||
PHARMACOKINETICS | 1083 | ||
AVAILABILITY | 1084 | ||
OFF-LABEL USES | 1084 | ||
CONTRAINDICATIONS | 1084 | ||
DIAGNOSTIC TEST EFFECTS | 1084 | ||
IV INCOMPATIBILITIES | 1084 | ||
SERIOUS REACTIONS | 1084 | ||
MECHANISM OF ACTION | 1085 | ||
PHARMACOKINETICS | 1085 | ||
AVAILABILITY | 1085 | ||
OFF-LABEL USES | 1085 | ||
CONTRAINDICATIONS | 1085 | ||
DIAGNOSTIC TEST EFFECTS | 1085 | ||
SERIOUS REACTIONS | 1086 | ||
MECHANISM OF ACTION | 1086 | ||
PHARMACOKINETICS | 1086 | ||
AVAILABILITY | 1086 | ||
CONTRAINDICATIONS | 1087 | ||
DIAGNOSTIC TEST EFFECTS | 1087 | ||
IV INCOMPATIBILITIES | 1087 | ||
IV COMPATIBILITIES | 1087 | ||
SERIOUS REACTIONS | 1087 | ||
MECHANISM OF ACTION | 1088 | ||
PHARMACOKINETICS | 1088 | ||
AVAILABILITY | 1088 | ||
CONTRAINDICATIONS | 1089 | ||
DIAGNOSTIC TEST EFFECTS | 1089 | ||
IV INCOMPATIBILITIES | 1089 | ||
IV COMPATIBILITIES | 1089 | ||
SIDE EFFECTS | 1089 | ||
SERIOUS REACTIONS | 1089 | ||
MECHANISM OF ACTION | 1090 | ||
PHARMACOKINETICS | 1090 | ||
AVAILABILITY | 1090 | ||
CONTRAINDICATIONS | 1090 | ||
DIAGNOSTIC TEST EFFECTS | 1091 | ||
MECHANISM OF ACTION | 1092 | ||
PHARMACOKINETICS | 1092 | ||
AVAILABILITY | 1092 | ||
CONTRAINDICATIONS | 1092 | ||
DIAGNOSTIC TEST EFFECTS | 1092 | ||
SERIOUS REACTIONS | 1092 | ||
MECHANISM OF ACTION | 1093 | ||
PHARMACOKINETICS | 1093 | ||
AVAILABILITY | 1093 | ||
OFF-LABEL USES | 1094 | ||
CONTRAINDICATIONS | 1094 | ||
DIAGNOSTIC TEST EFFECTS | 1094 | ||
SERIOUS REACTIONS | 1094 | ||
MECHANISM OF ACTION | 1095 | ||
PHARMACOKINETICS | 1096 | ||
AVAILABILITY | 1096 | ||
CONTRAINDICATIONS | 1096 | ||
DIAGNOSTIC TEST EFFECTS | 1096 | ||
SERIOUS REACTIONS | 1096 | ||
MECHANISM OF ACTION | 1097 | ||
PHARMACOKINETICS | 1097 | ||
AVAILABILITY | 1097 | ||
CONTRAINDICATIONS | 1097 | ||
DIAGNOSTIC TEST EFFECTS | 1097 | ||
IV INCOMPATIBILITIES | 1097 | ||
SERIOUS REACTIONS | 1098 | ||
MECHANISM OF ACTION | 1098 | ||
PHARMACOKINETICS | 1098 | ||
AVAILABILITY | 1098 | ||
CONTRAINDICATIONS | 1099 | ||
DIAGNOSTIC TEST EFFECTS | 1099 | ||
SERIOUS REACTIONS | 1099 | ||
MECHANISM OF ACTION | 1099 | ||
PHARMACOKINETICS | 1099 | ||
AVAILABILITY | 1099 | ||
CONTRAINDICATIONS | 1100 | ||
DIAGNOSTIC TEST EFFECTS | 1100 | ||
SERIOUS REACTIONS | 1100 | ||
MECHANISM OF ACTION | 1101 | ||
PHARMACOKINETICS | 1101 | ||
AVAILABILITY | 1101 | ||
INDICATIONS AND DOSAGES | 1101 | ||
CONTRAINDICATIONS | 1101 | ||
DIAGNOSTIC TEST EFFECTS | 1102 | ||
SIDE EFFECTS | 1102 | ||
SERIOUS REACTIONS | 1102 | ||
O | 1152 | ||
MECHANISM OF ACTION | 1152 | ||
PHARMACOKINETICS | 1152 | ||
AVAILABILITY | 1152 | ||
OFF-LABEL USES | 1152 | ||
CONTRAINDICATIONS | 1152 | ||
IV INCOMPATIBILITIES | 1152 | ||
DIAGNOSTIC TEST EFFECTS | 1153 | ||
SERIOUS REACTIONS | 1153 | ||
MECHANISM OF ACTION | 1154 | ||
PHARMACOKINETICS | 1154 | ||
AVAILABILITY | 1154 | ||
INDICATIONS AND DOSAGES | 1154 | ||
CONTRAINDICATIONS | 1154 | ||
DIAGNOSTIC TEST EFFECTS | 1154 | ||
IV INCOMPATIBILITIES | 1154 | ||
SERIOUS REACTIONS | 1154 | ||
MECHANISM OF ACTION | 1155 | ||
PHARMACOKINETICS | 1156 | ||
AVAILABILITY | 1156 | ||
CONTRAINDICATIONS | 1156 | ||
DIAGNOSTIC TEST EFFECTS | 1157 | ||
SERIOUS REACTIONS | 1157 | ||
MECHANISM OF ACTION | 1158 | ||
PHARMACOKINETICS | 1158 | ||
AVAILABILITY | 1158 | ||
OFF-LABEL USES | 1159 | ||
CONTRAINDICATIONS | 1159 | ||
DIAGNOSTIC TEST EFFECTS | 1159 | ||
SERIOUS REACTIONS | 1160 | ||
MECHANISM OF ACTION | 1161 | ||
PHARMACOKINETICS | 1161 | ||
AVAILABILITY | 1161 | ||
CONTRAINDICATIONS | 1161 | ||
DIAGNOSTIC TEST EFFECTS | 1161 | ||
SERIOUS REACTIONS | 1162 | ||
MECHANISM OF ACTION | 1162 | ||
PHARMACOKINETICS | 1162 | ||
AVAILABILITY | 1163 | ||
CONTRAINDICATIONS | 1163 | ||
SERIOUS REACTIONS | 1163 | ||
MECHANISM OF ACTION | 1163 | ||
PHARMACOKINETICS | 1164 | ||
AVAILABILITY | 1164 | ||
OFF-LABEL USES | 1164 | ||
CONTRAINDICATIONS | 1164 | ||
DIAGNOSTIC TEST EFFECTS | 1164 | ||
SERIOUS REACTIONS | 1164 | ||
MECHANISM OF ACTION | 1165 | ||
PHARMACOKINETICS | 1165 | ||
AVAILABILITY | 1165 | ||
OFF-LABEL USES | 1166 | ||
CONTRAINDICATIONS | 1166 | ||
DIAGNOSTIC TEST EFFECTS | 1166 | ||
SERIOUS REACTIONS | 1166 | ||
MECHANISM OF ACTION | 1167 | ||
PHARMACOKINETICS | 1167 | ||
AVAILABILITY | 1167 | ||
OFF-LABEL USES | 1168 | ||
CONTRAINDICATIONS | 1168 | ||
DIAGNOSTIC TEST EFFECTS | 1168 | ||
SERIOUS REACTIONS | 1168 | ||
MECHANISM OF ACTION | 1169 | ||
AVAILABILITY | 1169 | ||
INDICATIONS AND DOSAGES | 1169 | ||
OFF-LABEL USES | 1170 | ||
CONTRAINDICATIONS | 1170 | ||
DIAGNOSTIC TEST EFFECTS | 1170 | ||
SERIOUS REACTIONS | 1170 | ||
PRECAUTIONS & CONSIDERATIONS | 1170 | ||
MECHANISM OF ACTION | 1171 | ||
PHARMACOKINETICS | 1171 | ||
AVAILABILITY | 1171 | ||
OFF-LABEL USES | 1172 | ||
CONTRAINDICATIONS | 1172 | ||
DIAGNOSTIC TEST EFFECTS | 1172 | ||
IV INCOMPATIBILITIES | 1172 | ||
IV COMPATIBILITIES | 1172 | ||
SERIOUS REACTIONS | 1173 | ||
MECHANISM OF ACTION | 1174 | ||
PHARMACOKINETICS | 1174 | ||
AVAILABILITY | 1174 | ||
CONTRAINDICATIONS | 1174 | ||
DIAGNOSTIC TEST EFFECTS | 1174 | ||
SERIOUS REACTIONS | 1174 | ||
MECHANISM OF ACTION | 1175 | ||
PHARMACOKINETICS | 1175 | ||
AVAILABILITY | 1175 | ||
CONTRAINDICATIONS | 1175 | ||
DIAGNOSTIC TEST EFFECTS | 1176 | ||
SERIOUS REACTIONS | 1176 | ||
MECHANISM OF ACTION | 1176 | ||
PHARMACOKINETICS | 1177 | ||
AVAILABILITY | 1177 | ||
OFF-LABEL USES | 1177 | ||
CONTRAINDICATIONS | 1177 | ||
DIAGNOSTIC TEST EFFECTS | 1177 | ||
IV INCOMPATIBILITIES | 1177 | ||
IV COMPATIBILITIES | 1177 | ||
SERIOUS REACTIONS | 1177 | ||
MECHANISM OF ACTION | 1178 | ||
PHARMACOKINETICS | 1178 | ||
AVAILABILITY | 1178 | ||
INDICATIONS AND DOSAGES | 1178 | ||
OFF-LABEL USES | 1179 | ||
CONTRAINDICATIONS | 1179 | ||
DIAGNOSTIC TEST EFFECTS | 1179 | ||
SERIOUS REACTIONS | 1179 | ||
MECHANISM OF ACTION | 1180 | ||
PHARMACOKINETICS | 1180 | ||
AVAILABILITY | 1180 | ||
CONTRAINDICATIONS | 1180 | ||
DIAGNOSTIC TEST EFFECTS | 1180 | ||
IV INCOMPATIBILITIES | 1180 | ||
SERIOUS REACTIONS | 1180 | ||
P | 1203 | ||
PHARMACOKINETICS | 1203 | ||
AVAILABILITY | 1203 | ||
CONTRAINDICATIONS | 1204 | ||
DIAGNOSTIC TEST EFFECTS | 1204 | ||
SERIOUS REACTIONS | 1204 | ||
MECHANISM OF ACTION | 1205 | ||
PHARMACOKINETICS | 1205 | ||
AVAILABILITY | 1205 | ||
CONTRAINDICATIONS | 1205 | ||
INTERACTIONS | 1206 | ||
DIAGNOSTIC TEST EFFECTS | 1206 | ||
IV INCOMPATIBILITIES | 1206 | ||
SERIOUS REACTIONS | 1206 | ||
MECHANISM OF ACTION | 1206 | ||
PHARMACOKINETICS | 1206 | ||
AVAILABILITY | 1207 | ||
CONTRAINDICATIONS | 1207 | ||
Q\r | 1365 | ||
MECHANISM OF ACTION | 1365 | ||
PHARMACOKINETICS | 1365 | ||
AVAILABILITY | 1365 | ||
CONTRAINDICATIONS | 1365 | ||
DIAGNOSTIC TEST EFFECTS | 1365 | ||
SERIOUS REACTIONS | 1365 | ||
MECHANISM OF ACTION | 1366 | ||
PHARMACOKINETICS | 1366 | ||
AVAILABILITY | 1366 | ||
CONTRAINDICATIONS | 1367 | ||
DIAGNOSTIC TEST EFFECTS | 1367 | ||
SERIOUS REACTIONS | 1367 | ||
MECHANISM OF ACTION | 1368 | ||
PHARMACOKINETICS | 1369 | ||
AVAILABILITY | 1369 | ||
CONTRAINDICATIONS | 1369 | ||
DIAGNOSTIC TEST EFFECTS | 1369 | ||
SERIOUS REACTIONS | 1370 | ||
MECHANISM OF ACTION | 1370 | ||
AVAILABILITY | 1370 | ||
CONTRAINDICATIONS | 1371 | ||
DIAGNOSTIC TEST EFFECTS | 1371 | ||
IV INCOMPATIBILITIES | 1371 | ||
IV COMPATIBILITIES | 1371 | ||
SERIOUS REACTIONS | 1372 | ||
MECHANISM OF ACTION | 1372 | ||
PHARMACOKINETICS | 1373 | ||
AVAILABILITY | 1373 | ||
CONTRAINDICATIONS | 1373 | ||
DIAGNOSTIC TEST EFFECTS | 1373 | ||
SERIOUS REACTIONS | 1374 | ||
MECHANISM OF ACTION | 1374 | ||
PHARMACOKINETICS | 1374 | ||
AVAILABILITY | 1375 | ||
CONTRAINDICATIONS | 1375 | ||
DIAGNOSTIC TEST EFFECTS | 1375 | ||
IV INCOMPATIBILITIES | 1375 | ||
IV COMPATIBILITIES | 1375 | ||
SERIOUS REACTIONS | 1375 | ||
R\r | 1377 | ||
MECHANISM OF ACTION | 1377 | ||
PHARMACOKINETICS | 1377 | ||
AVAILABILITY | 1377 | ||
CONTRAINDICATIONS | 1377 | ||
DIAGNOSTIC TEST EFFECTS | 1378 | ||
SERIOUS REACTIONS | 1378 | ||
MECHANISM OF ACTION | 1378 | ||
PHARMACOKINETICS | 1378 | ||
AVAILABILITY | 1379 | ||
CONTRAINDICATIONS | 1379 | ||
DIAGNOSTIC TEST EFFECTS | 1379 | ||
SERIOUS REACTIONS | 1379 | ||
MECHANISM OF ACTION | 1380 | ||
PHARMACOKINETICS | 1380 | ||
AVAILABILITY | 1380 | ||
INDICATIONS AND DOSAGES | 1380 | ||
CONTRAINDICATIONS | 1380 | ||
DIAGNOSTIC TEST EFFECTS | 1381 | ||
SERIOUS REACTIONS | 1381 | ||
MECHANISM OF ACTION | 1382 | ||
PHARMACOKINETICS | 1382 | ||
AVAILABILITY | 1382 | ||
INDICATIONS AND DOSAGES | 1383 | ||
CONTRAINDICATIONS | 1383 | ||
DIAGNOSTIC TEST EFFECTS | 1383 | ||
SERIOUS REACTIONS | 1383 | ||
MECHANISM OF ACTION | 1384 | ||
PHARMACOKINETICS | 1384 | ||
AVAILABILITY | 1384 | ||
OFF-LABEL USES | 1384 | ||
CONTRAINDICATIONS | 1385 | ||
DIAGNOSTIC TEST EFFECTS | 1385 | ||
SERIOUS REACTIONS | 1385 | ||
MECHANISM OF ACTION | 1386 | ||
PHARMACOKINETICS | 1386 | ||
AVAILABILITY | 1386 | ||
OFF-LABEL USES | 1387 | ||
CONTRAINDICATIONS | 1387 | ||
DIAGNOSTIC TEST EFFECTS | 1387 | ||
IV INCOMPATIBILITIES | 1387 | ||
IV COMPATIBILITIES | 1387 | ||
SERIOUS REACTIONS | 1388 | ||
MECHANISM OF ACTION | 1388 | ||
PHARMACOKINETICS | 1389 | ||
AVAILABILITY | 1389 | ||
INDICATIONS AND DOSAGES | 1389 | ||
CONTRAINDICATIONS | 1389 | ||
DIAGNOSTIC TEST EFFECTS | 1389 | ||
SERIOUS REACTIONS | 1390 | ||
MECHANISM OF ACTION | 1390 | ||
PHARMACOKINETICS | 1390 | ||
AVAILABILITY | 1391 | ||
INDICATIONS AND DOSAGES | 1391 | ||
CONTRAINDICATIONS | 1391 | ||
DIAGNOSTIC TEST EFFECTS | 1391 | ||
SERIOUS REACTIONS | 1392 | ||
MECHANISM OF ACTION | 1392 | ||
PHARMACOKINETICS | 1393 | ||
AVAILABILITY | 1393 | ||
INDICATIONS AND DOSAGES | 1393 | ||
CONTRAINDICATIONS | 1393 | ||
DIAGNOSTIC TEST EFFECTS | 1393 | ||
IV INCOMPATIBILITIES | 1393 | ||
SERIOUS REACTIONS | 1393 | ||
MECHANISM OF ACTION | 1394 | ||
PHARMACOKINETICS | 1394 | ||
AVAILABILITY | 1395 | ||
CONTRAINDICATIONS | 1395 | ||
DIAGNOSTIC TEST EFFECTS | 1395 | ||
SERIOUS REACTIONS | 1395 | ||
MECHANISM OF ACTION | 1396 | ||
PHARMACOKINETICS | 1396 | ||
AVAILABILITY | 1396 | ||
CONTRAINDICATIONS | 1397 | ||
DIAGNOSTIC TEST EFFECTS | 1397 | ||
SERIOUS REACTIONS | 1397 | ||
MECHANISM OF ACTION | 1398 | ||
PHARMACOKINETICS | 1398 | ||
AVAILABILITY | 1398 | ||
INDICATIONS AND DOSAGES | 1398 | ||
OFF-LABEL USES | 1398 | ||
CONTRAINDICATIONS | 1398 | ||
DIAGNOSTIC TEST EFFECTS | 1398 | ||
SERIOUS REACTIONS | 1399 | ||
MECHANISM OF ACTION | 1399 | ||
PHARMACOKINETICS | 1399 | ||
AVAILABILITY | 1399 | ||
CONTRAINDICATIONS | 1399 | ||
DIAGNOSTIC TEST EFFECTS | 1400 | ||
IV INCOMPATIBILITIES | 1400 | ||
SERIOUS REACTIONS | 1400 | ||
MECHANISM OF ACTION | 1401 | ||
PHARMACOKINETICS | 1401 | ||
AVAILABILITY | 1401 | ||
OFF-LABEL USES | 1402 | ||
CONTRAINDICATIONS | 1402 | ||
DIAGNOSTIC TEST EFFECTS | 1402 | ||
SERIOUS REACTIONS | 1402 | ||
MECHANISM OF ACTION | 1403 | ||
PHARMACOKINETICS | 1403 | ||
AVAILABILITY | 1403 | ||
OFF LABEL USES | 1404 | ||
CONTRAINDICATIONS | 1404 | ||
INTERACTIONS | 1404 | ||
DIAGNOSTIC TEST EFFECTS | 1404 | ||
SERIOUS REACTIONS | 1404 | ||
MECHANISM OF ACTION | 1405 | ||
PHARMACOKINETICS | 1405 | ||
AVAILABILITY | 1405 | ||
OFF-LABEL USES | 1406 | ||
CONTRAINDICATIONS | 1406 | ||
INTERACTIONS | 1406 | ||
DIAGNOSTIC TEST EFFECTS | 1406 | ||
IV INCOMPATIBILITIES | 1406 | ||
SERIOUS REACTIONS | 1407 | ||
MECHANISM OF ACTION | 1408 | ||
AVAILABILITY | 1408 | ||
CONTRAINDICATIONS | 1408 | ||
INTERACTIONS | 1408 | ||
DIAGNOSTIC TEST EFFECTS | 1408 | ||
SERIOUS REACTIONS | 1408 | ||
MECHANISM OF ACTION | 1409 | ||
PHARMACOKINETICS | 1409 | ||
AVAILABILITY | 1409 | ||
INDICATIONS AND DOSAGES | 1409 | ||
OFF-LABEL USES | 1409 | ||
CONTRAINDICATIONS | 1409 | ||
DIAGNOSTIC TEST EFFECTS | 1409 | ||
SERIOUS REACTIONS | 1409 | ||
MECHANISM OF ACTION | 1410 | ||
PHARMACOKINETICS | 1410 | ||
AVAILABILITY | 1410 | ||
INDICATIONS AND DOSAGES | 1410 | ||
CONTRAINDICATIONS | 1410 | ||
INTERACTIONS | 1410 | ||
DIAGNOSTIC TEST EFFECTS | 1411 | ||
SIDE EFFECTS | 1411 | ||
SERIOUS REACTIONS | 1411 | ||
Riluzole | 1412 | ||
PHARMACOKINETICS | 1412 | ||
AVAILABILITY | 1412 | ||
CONTRAINDICATIONS | 1412 | ||
DIAGNOSTIC TEST EFFECTS | 1412 | ||
SERIOUS REACTIONS | 1412 | ||
MECHANISM OF ACTION | 1413 | ||
AVAILABILITY | 1413 | ||
CONTRAINDICATIONS | 1413 | ||
DIAGNOSTIC TEST EFFECTS | 1413 | ||
SERIOUS REACTIONS | 1413 | ||
MECHANISM OF ACTION | 1414 | ||
AVAILABILITY | 1414 | ||
CONTRAINDICATIONS | 1415 | ||
DIAGNOSTIC TEST EFFECTS | 1415 | ||
SERIOUS REACTIONS | 1415 | ||
MECHANISM OF ACTION | 1416 | ||
PHARMACOKINETICS | 1416 | ||
AVAILABILITY | 1416 | ||
OFF-LABEL USES | 1417 | ||
CONTRAINDICATIONS | 1417 | ||
DIAGNOSTIC TEST EFFECTS | 1417 | ||
SERIOUS REACTIONS | 1417 | ||
MECHANISM OF ACTION | 1418 | ||
PHARMACOKINETICS | 1419 | ||
AVAILABILITY | 1419 | ||
CONTRAINDICATIONS | 1419 | ||
INTERACTIONS | 1419 | ||
DIAGNOSTIC TEST EFFECTS | 1420 | ||
SERIOUS REACTIONS | 1420 | ||
MECHANISM OF ACTION | 1421 | ||
PHARMACOKINETICS | 1421 | ||
AVAILABILITY | 1421 | ||
CONTRAINDICATIONS | 1422 | ||
DIAGNOSTIC TEST EFFECTS | 1422 | ||
IV INCOMPATIBILITIES | 1422 | ||
SERIOUS REACTIONS | 1422 | ||
MECHANISM OF ACTION | 1423 | ||
PHARMACOKINETICS | 1423 | ||
AVAILABILITY | 1423 | ||
INDICATIONS AND DOSAGES | 1423 | ||
CONTRAINDICATIONS | 1424 | ||
INTERACTIONS | 1424 | ||
DIAGNOSTIC TEST EFFECTS | 1425 | ||
SIDE EFFECTS | 1425 | ||
SERIOUS REACTIONS | 1425 | ||
MECHANISM OF ACTION | 1426 | ||
PHARMACOKINETICS | 1426 | ||
AVAILABILITY | 1426 | ||
INDICATIONS AND DOSAGES | 1426 | ||
CONTRAINDICATIONS | 1426 | ||
DIAGNOSTIC TEST EFFECTS | 1427 | ||
SERIOUS REACTIONS | 1427 | ||
MECHANISM OF ACTION | 1428 | ||
PHARMACOKINETICS | 1428 | ||
AVAILABILITY | 1428 | ||
CONTRAINDICATIONS | 1428 | ||
DIAGNOSTIC TEST EFFECTS | 1429 | ||
SERIOUS REACTIONS | 1429 | ||
MECHANISM OF ACTION | 1429 | ||
PHARMACOKINETICS | 1430 | ||
AVAILABILITY | 1430 | ||
INDICATIONS AND DOSAGES | 1430 | ||
CONTRAINDICATIONS | 1430 | ||
INTERACTIONS | 1430 | ||
DIAGNOSTIC TEST EFFECTS | 1430 | ||
SIDE EFFECTS | 1430 | ||
SERIOUS REACTIONS | 1430 | ||
Ropinirole | 1431 | ||
PHARMACOKINETICS | 1431 | ||
AVAILABILITY | 1431 | ||
CONTRAINDICATIONS | 1431 | ||
DIAGNOSTIC TEST EFFECTS | 1432 | ||
SERIOUS REACTIONS | 1432 | ||
MECHANISM OF ACTION | 1433 | ||
PHARMACOKINETICS | 1433 | ||
AVAILABILITY | 1433 | ||
INDICATIONS AND DOSAGES | 1433 | ||
CONTRAINDICATIONS | 1433 | ||
DIAGNOSTIC TEST EFFECTS | 1434 | ||
SERIOUS REACTIONS | 1434 | ||
MECHANISM OF ACTION | 1435 | ||
PHARMACOKINETICS | 1435 | ||
AVAILABILITY | 1435 | ||
CONTRAINDICATIONS | 1435 | ||
INTERACTIONS | 1435 | ||
DIAGNOSTIC TEST EFFECTS | 1436 | ||
SIDE EFFECTS | 1436 | ||
SERIOUS REACTIONS | 1436 | ||
MECHANISM OF ACTION | 1437 | ||
PHARMACOKINETICS | 1437 | ||
AVAILABILITY | 1437 | ||
INDICATIONS AND DOSAGES | 1437 | ||
CONTRAINDICATIONS | 1437 | ||
DIAGNOSTIC TEST EFFECTS | 1437 | ||
SERIOUS REACTIONS | 1438 | ||
S\r | 1439 | ||
MECHANISM OF ACTION | 1439 | ||
PHARMACOKINETICS | 1439 | ||
AVAILABILITY | 1439 | ||
CONTRAINDICATIONS | 1439 | ||
DIAGNOSTIC TEST EFFECTS | 1440 | ||
SERIOUS REACTIONS | 1440 | ||
MECHANISM OF ACTION | 1441 | ||
PHARMACOKINETICS | 1441 | ||
AVAILABILITY | 1441 | ||
CONTRAINDICATIONS | 1441 | ||
DIAGNOSTIC TEST EFFECTS | 1442 | ||
SERIOUS REACTIONS | 1442 | ||
MECHANISM OF ACTION | 1443 | ||
PHARMACOKINETICS | 1443 | ||
AVAILABILITY | 1443 | ||
INDICATIONS AND DOSAGES | 1443 | ||
CONTRAINDICATIONS | 1443 | ||
INTERACTIONS | 1444 | ||
DIAGNOSTIC TEST EFFECTS | 1444 | ||
SIDE EFFECTS | 1444 | ||
SERIOUS REACTIONS | 1444 | ||
MECHANISM OF ACTION | 1445 | ||
PHARMACOKINETICS | 1446 | ||
AVAILABILITY | 1446 | ||
INDICATIONS AND DOSAGES | 1446 | ||
CONTRAINDICATIONS | 1446 | ||
DIAGNOSTIC TEST EFFECTS | 1446 | ||
SERIOUS REACTIONS | 1446 | ||
MECHANISM OF ACTION | 1447 | ||
PHARMACOKINETICS | 1447 | ||
AVAILABILITY | 1447 | ||
CONTRAINDICATIONS | 1447 | ||
DIAGNOSTIC TEST EFFECTS | 1448 | ||
SERIOUS REACTIONS | 1448 | ||
MECHANISM OF ACTION | 1449 | ||
PHARMACOKINETICS | 1449 | ||
AVAILABILITY | 1450 | ||
OFF-LABEL USES | 1450 | ||
CONTRAINDICATIONS | 1450 | ||
DIAGNOSTIC TEST EFFECTS | 1450 | ||
IV INCOMPATIBILITIES | 1450 | ||
IV COMPATIBILITIES | 1451 | ||
SERIOUS REACTIONS | 1451 | ||
MECHANISM OF ACTION | 1452 | ||
PHARMACOKINETICS | 1452 | ||
AVAILABILITY | 1452 | ||
INDICATIONS AND DOSAGES | 1452 | ||
CONTRAINDICATIONS | 1452 | ||
DIAGNOSTIC TEST EFFECTS | 1453 | ||
SERIOUS REACTIONS | 1453 | ||
MECHANISM OF ACTION | 1454 | ||
AVAILABILITY | 1454 | ||
CONTRAINDICATIONS | 1454 | ||
DIAGNOSTIC TEST EFFECTS | 1454 | ||
SERIOUS REACTIONS | 1454 | ||
MECHANISM OF ACTION | 1455 | ||
PHARMACOKINETICS | 1455 | ||
AVAILABILITY | 1455 | ||
CONTRAINDICATIONS | 1456 | ||
DIAGNOSTIC TEST EFFECTS | 1456 | ||
SERIOUS REACTIONS | 1456 | ||
MECHANISM OF ACTION | 1457 | ||
PHARMACOKINETICS | 1457 | ||
AVAILABILITY | 1457 | ||
CONTRAINDICATIONS | 1457 | ||
DIAGNOSTIC TEST EFFECTS | 1458 | ||
SERIOUS REACTIONS | 1458 | ||
MECHANISM OF ACTION | 1459 | ||
PHARMACOKINETICS | 1459 | ||
AVAILABILITY | 1459 | ||
CONTRAINDICATIONS | 1459 | ||
DIAGNOSTIC TEST EFFECTS | 1460 | ||
SERIOUS REACTIONS | 1460 | ||
MECHANISM OF ACTION | 1460 | ||
T\r | 1512 | ||
MECHANISM OF ACTION | 1512 | ||
PHARMACOKINETICS | 1512 | ||
AVAILABILITY | 1512 | ||
OFF-LABEL USES | 1512 | ||
CONTRAINDICATIONS | 1512 | ||
DIAGNOSTIC TEST EFFECTS | 1513 | ||
IV INCOMPATIBILITIES | 1513 | ||
IV COMPATIBILITIES | 1513 | ||
SERIOUS REACTIONS | 1513 | ||
MECHANISM OF ACTION | 1514 | ||
PHARMACOKINETICS | 1515 | ||
AVAILABILITY | 1515 | ||
CONTRAINDICATIONS | 1515 | ||
DIAGNOSTIC TEST EFFECTS | 1516 | ||
SERIOUS REACTIONS | 1516 | ||
MECHANISM OF ACTION | 1516 | ||
PHARMACOKINETICS | 1516 | ||
AVAILABILITY | 1516 | ||
CONTRAINDICATIONS | 1517 | ||
DIAGNOSTIC TEST EFFECTS | 1517 | ||
SERIOUS REACTIONS | 1517 | ||
MECHANISM OF ACTION | 1517 | ||
PHARMACOKINETICS | 1518 | ||
AVAILABILITY | 1518 | ||
OFF-LABEL USES | 1518 | ||
CONTRAINDICATIONS | 1518 | ||
DIAGNOSTIC TEST EFFECTS | 1518 | ||
SERIOUS REACTIONS | 1519 | ||
MECHANISM OF ACTION | 1519 | ||
PHARMACOKINETICS | 1519 | ||
AVAILABILITY | 1520 | ||
CONTRAINDICATIONS | 1520 | ||
DIAGNOSTIC TEST EFFECTS | 1520 | ||
SERIOUS REACTIONS | 1520 | ||
MECHANISM OF ACTION | 1521 | ||
PHARMACOKINETICS | 1521 | ||
AVAILABILITY | 1521 | ||
INDICATIONS AND DOSAGES | 1521 | ||
CONTRAINDICATIONS | 1522 | ||
DIAGNOSTIC TEST EFFECTS | 1522 | ||
SERIOUS REACTIONS | 1522 | ||
MECHANISM OF ACTION | 1523 | ||
PHARMACOKINETICS | 1523 | ||
AVAILABILITY | 1523 | ||
CONTRAINDICATIONS | 1523 | ||
DIAGNOSTIC TEST EFFECTS | 1523 | ||
Telaprevir | 1524 | ||
MECHANISM OF ACTION | 1524 | ||
PHARMACOKINETICS | 1524 | ||
AVAILABILITY | 1524 | ||
INDICATIONS AND DOSAGES | 1525 | ||
CONTRAINDICATIONS | 1525 | ||
INTERACTIONS | 1525 | ||
DIAGNOSTIC TEST EFFECTS | 1526 | ||
SIDE EFFECTS | 1526 | ||
SERIOUS REACTIONS | 1526 | ||
MECHANISM OF ACTION | 1527 | ||
PHARMACOKINETICS | 1527 | ||
AVAILABILITY | 1527 | ||
INDICATIONS AND DOSAGES | 1527 | ||
OFF-LABEL USES | 1527 | ||
CONTRAINDICATIONS | 1527 | ||
DIAGNOSTIC TEST EFFECTS | 1528 | ||
IV INCOMPATIBILITIES | 1528 | ||
SERIOUS REACTIONS | 1528 | ||
MECHANISM OF ACTION | 1529 | ||
PHARMACOKINETICS | 1529 | ||
AVAILABILITY | 1529 | ||
INDICATIONS AND DOSAGES | 1529 | ||
CrCl | 1529 | ||
CONTRAINDICATIONS | 1529 | ||
DIAGNOSTIC TEST EFFECTS | 1530 | ||
SERIOUS REACTIONS | 1530 | ||
MECHANISM OF ACTION | 1531 | ||
PHARMACOKINETICS | 1531 | ||
AVAILABILITY | 1531 | ||
CONTRAINDICATIONS | 1531 | ||
DIAGNOSTIC TEST EFFECTS | 1532 | ||
SERIOUS REACTIONS | 1532 | ||
MECHANISM OF ACTION | 1532 | ||
PHARMACOKINETICS | 1533 | ||
AVAILABILITY | 1533 | ||
OFF-LABEL USES | 1533 | ||
CONTRAINDICATIONS | 1533 | ||
DIAGNOSTIC TEST EFFECTS | 1533 | ||
SERIOUS REACTIONS | 1533 | ||
MECHANISM OF ACTION | 1534 | ||
PHARMACOKINETICS | 1534 | ||
AVAILABILITY | 1534 | ||
CONTRAINDICATIONS | 1534 | ||
DIAGNOSTIC TEST EFFECTS | 1534 | ||
SERIOUS REACTIONS | 1535 | ||
MECHANISM OF ACTION | 1535 | ||
PHARMACOKINETICS | 1535 | ||
AVAILABILITY | 1535 | ||
INDICATIONS AND DOSAGES | 1535 | ||
CONTRAINDICATIONS | 1536 | ||
DIAGNOSTIC TEST EFFECTS | 1536 | ||
IV INCOMPATIBILITIES | 1536 | ||
SERIOUS REACTIONS | 1536 | ||
MECHANISM OF ACTION | 1537 | ||
PHARMACOKINETICS | 1537 | ||
AVAILABILITY | 1537 | ||
CONTRAINDICATIONS | 1538 | ||
DIAGNOSTIC TEST EFFECTS | 1538 | ||
SERIOUS REACTIONS | 1538 | ||
MECHANISM OF ACTION | 1539 | ||
PHARMACOKINETICS | 1539 | ||
AVAILABILITY | 1539 | ||
CONTRAINDICATIONS | 1539 | ||
DIAGNOSTIC TEST EFFECTS | 1539 | ||
SERIOUS REACTIONS | 1540 | ||
MECHANISM OF ACTION | 1540 | ||
AVAILABILITY | 1540 | ||
CONTRAINDICATIONS | 1541 | ||
DIAGNOSTIC TEST EFFECTS | 1541 | ||
SERIOUS REACTIONS | 1541 | ||
MECHANISM OF ACTION | 1542 | ||
PHARMACOKINETICS | 1542 | ||
AVAILABILITY | 1542 | ||
CONTRAINDICATIONS | 1542 | ||
DIAGNOSTIC TEST EFFECTS | 1542 | ||
SERIOUS REACTIONS | 1543 | ||
MECHANISM OF ACTION | 1543 | ||
PHARMACOKINETICS | 1543 | ||
AVAILABILITY | 1543 | ||
CONTRAINDICATIONS | 1544 | ||
DIAGNOSTIC TEST EFFECTS | 1544 | ||
SERIOUS REACTIONS | 1544 | ||
MECHANISM OF ACTION | 1544 | ||
PHARMACOKINETICS | 1544 | ||
AVAILABILITY | 1544 | ||
CONTRAINDICATIONS | 1545 | ||
DIAGNOSTIC TEST EFFECTS | 1545 | ||
SERIOUS REACTIONS | 1545 | ||
Tesamorelin | 1545 | ||
MECHANISM OF ACTION | 1545 | ||
PHARMACOKINETICS | 1546 | ||
AVAILABILITY | 1546 | ||
INDICATIONS AND DOSAGES | 1546 | ||
CONTRAINDICATIONS | 1546 | ||
INTERACTIONS | 1546 | ||
DIAGNOSTIC TEST EFFECTS | 1546 | ||
SIDE EFFECTS | 1546 | ||
SERIOUS REACTIONS | 1546 | ||
MECHANISM OF ACTION | 1547 | ||
PHARMACOKINETICS | 1548 | ||
AVAILABILITY | 1548 | ||
CONTRAINDICATIONS | 1549 | ||
DIAGNOSTIC TEST EFFECTS | 1549 | ||
SERIOUS REACTIONS | 1549 | ||
MECHANISM OF ACTION | 1550 | ||
PHARMACOKINETICS | 1551 | ||
AVAILABILITY | 1551 | ||
INDICATIONS AND DOSAGES | 1551 | ||
CONTRAINDICATIONS | 1551 | ||
DIAGNOSTIC TEST EFFECTS | 1552 | ||
SERIOUS REACTIONS | 1552 | ||
MECHANISM OF ACTION | 1553 | ||
PHARMACOKINETICS | 1553 | ||
AVAILABILITY | 1553 | ||
Creatinine Clearance (mL/min) | 1553 | ||
CONTRAINDICATIONS | 1553 | ||
DIAGNOSTIC TEST EFFECTS | 1553 | ||
SERIOUS REACTIONS | 1554 | ||
MECHANISM OF ACTION | 1554 | ||
AVAILABILITY | 1554 | ||
OFF-LABEL USES | 1555 | ||
CONTRAINDICATIONS | 1555 | ||
DIAGNOSTIC TEST EFFECTS | 1555 | ||
SERIOUS REACTIONS | 1555 | ||
MECHANISM OF ACTION | 1556 | ||
PHARMACOKINETICS | 1556 | ||
AVAILABILITY | 1556 | ||
OFF-LABEL USES | 1557 | ||
CONTRAINDICATIONS | 1557 | ||
DIAGNOSTIC TEST EFFECTS | 1557 | ||
IV INCOMPATIBILITIES | 1557 | ||
SIDE EFFECTS | 1557 | ||
SERIOUS REACTIONS | 1557 | ||
MECHANISM OF ACTION | 1558 | ||
PHARMACOKINETICS | 1558 | ||
AVAILABILITY | 1558 | ||
CONTRAINDICATIONS | 1559 | ||
DIAGNOSTIC TEST EFFECTS | 1559 | ||
IV INCOMPATIBILITIES | 1559 | ||
IV COMPATIBILITIES | 1559 | ||
SERIOUS REACTIONS | 1559 | ||
MECHANISM OF ACTION | 1560 | ||
AVAILABILITY | 1560 | ||
OFF-LABEL USES | 1560 | ||
CONTRAINDICATIONS | 1560 | ||
DIAGNOSTIC TEST EFFECTS | 1560 | ||
SERIOUS REACTIONS | 1561 | ||
MECHANISM OF ACTION | 1561 | ||
PHARMACOKINETICS | 1561 | ||
AVAILABILITY | 1561 | ||
CONTRAINDICATIONS | 1561 | ||
DIAGNOSTIC TEST EFFECTS | 1562 | ||
SERIOUS REACTIONS | 1562 | ||
MECHANISM OF ACTION | 1563 | ||
PHARMACOKINETICS | 1563 | ||
AVAILABILITY | 1563 | ||
CONTRAINDICATIONS | 1563 | ||
DIAGNOSTIC TEST EFFECTS | 1564 | ||
SERIOUS REACTIONS | 1564 | ||
MECHANISM OF ACTION | 1564 | ||
PHARMACOKINETICS | 1565 | ||
AVAILABILITY | 1565 | ||
CONTRAINDICATIONS | 1565 | ||
DIAGNOSTIC TEST EFFECTS | 1565 | ||
SERIOUS REACTIONS | 1565 | ||
Ticagrelor | 1566 | ||
MECHANISM OF ACTION | 1566 | ||
PHARMACOKINETICS | 1566 | ||
AVAILABILITY | 1566 | ||
INDICATIONS AND DOSAGES | 1566 | ||
CONTRAINDICATIONS | 1566 | ||
INTERACTIONS | 1566 | ||
DIAGNOSTIC TEST EFFECTS | 1567 | ||
SIDE EFFECTS | 1567 | ||
MECHANISM OF ACTION | 1568 | ||
PHARMACOKINETICS | 1568 | ||
AVAILABILITY | 1568 | ||
CONTRAINDICATIONS | 1568 | ||
DIAGNOSTIC TEST EFFECTS | 1568 | ||
IV INCOMPATIBILITIES | 1569 | ||
IV COMPATIBILITIES | 1569 | ||
SERIOUS REACTIONS | 1569 | ||
MECHANISM OF ACTION | 1570 | ||
AVAILABILITY | 1570 | ||
OFF-LABEL USES | 1570 | ||
CONTRAINDICATIONS | 1570 | ||
DIAGNOSTIC TEST EFFECTS | 1570 | ||
SERIOUS REACTIONS | 1570 | ||
MECHANISM OF ACTION | 1571 | ||
PHARMACOKINETICS | 1571 | ||
AVAILABILITY | 1571 | ||
INDICATIONS AND DOSAGES | 1571 | ||
CONTRAINDICATIONS | 1571 | ||
DIAGNOSTIC TEST EFFECTS | 1571 | ||
IV INCOMPATIBILITIES | 1572 | ||
IV COMPATIBILITIES | 1572 | ||
SERIOUS REACTIONS | 1572 | ||
MECHANISM OF ACTION | 1573 | ||
PHARMACOKINETICS | 1573 | ||
AVAILABILITY | 1573 | ||
CONTRAINDICATIONS | 1573 | ||
DIAGNOSTIC TEST EFFECTS | 1573 | ||
SERIOUS REACTIONS | 1574 | ||
MECHANISM OF ACTION | 1574 | ||
PHARMACOKINETICS | 1575 | ||
AVAILABILITY | 1575 | ||
OFF-LABEL USES | 1575 | ||
CONTRAINDICATIONS | 1575 | ||
DIAGNOSTIC TEST EFFECTS | 1576 | ||
SERIOUS REACTIONS | 1576 | ||
MECHANISM OF ACTION | 1577 | ||
PHARMACOKINETICS | 1577 | ||
AVAILABILITY | 1577 | ||
CONTRAINDICATIONS | 1577 | ||
DIAGNOSTIC TEST EFFECTS | 1578 | ||
SERIOUS REACTIONS | 1578 | ||
MECHANISM OF ACTION | 1579 | ||
PHARMACOKINETICS | 1579 | ||
AVAILABILITY | 1579 | ||
CONTRAINDICATIONS | 1579 | ||
DIAGNOSTIC TEST EFFECTS | 1579 | ||
SERIOUS REACTIONS | 1579 | ||
MECHANISM OF ACTION | 1580 | ||
PHARMOCOKINETICS | 1580 | ||
AVAILABILITY | 1580 | ||
CONTRAINDICATIONS | 1580 | ||
DIAGNOSTIC TEST EFFECTS | 1580 | ||
SERIOUS REACTIONS | 1580 | ||
MECHANISM OF ACTION | 1581 | ||
PHARMACOKINETICS | 1581 | ||
AVAILABILITY | 1581 | ||
CONTRAINDICATIONS | 1581 | ||
DIAGNOSTIC TEST EFFECTS | 1581 | ||
SERIOUS REACTIONS | 1581 | ||
MECHANISM OF ACTION | 1582 | ||
PHARMACOKINETICS | 1582 | ||
AVAILABILITY | 1583 | ||
INDICATIONS AND DOSAGES | 1583 | ||
CONTRAINDICATIONS | 1583 | ||
INTERACTIONS | 1583 | ||
DIAGNOSTIC TEST EFFECTS | 1584 | ||
SERIOUS REACTIONS | 1584 | ||
MECHANISM OF ACTION | 1584 | ||
PHARMACOKINETICS | 1585 | ||
AVAILABILITY | 1585 | ||
CONTRAINDICATIONS | 1585 | ||
DIAGNOSTIC TEST EFFECTS | 1585 | ||
IV INCOMPATIBILITIES | 1585 | ||
SERIOUS REACTIONS | 1585 | ||
MECHANISM OF ACTION | 1586 | ||
PHARMACOKINETICS | 1586 | ||
AVAILABILITY | 1586 | ||
OFF-LABEL USES | 1586 | ||
CONTRAINDICATIONS | 1586 | ||
DIAGNOSTIC TEST EFFECTS | 1587 | ||
SERIOUS REACTIONS | 1587 | ||
MECHANISM OF ACTION | 1587 | ||
PHARMACOKINETICS | 1588 | ||
AVAILABILITY | 1588 | ||
CONTRAINDICATIONS | 1588 | ||
DIAGNOSTIC TEST EFFECTS | 1589 | ||
IV INCOMPATIBILITIES | 1589 | ||
IV COMPATIBILITIES | 1589 | ||
SERIOUS REACTIONS | 1589 | ||
Tocilizumab | 1590 | ||
MECHANISM OF ACTION | 1590 | ||
PHARMACOKINETICS | 1590 | ||
AVAILABILITY | 1590 | ||
INDICATIONS AND DOSAGES | 1590 | ||
CONTRAINDICATIONS | 1591 | ||
INTERACTIONS | 1591 | ||
DIAGNOSTIC TEST EFFECTS | 1591 | ||
IV INCOMPATIBILITIES | 1591 | ||
SIDE EFFECTS | 1591 | ||
SERIOUS REACTIONS | 1591 | ||
MECHANISM OF ACTION | 1592 | ||
PHARMACOKINETICS | 1592 | ||
AVAILABILITY | 1593 | ||
CONTRAINDICATIONS | 1593 | ||
DIAGNOSTIC TEST EFFECTS | 1593 | ||
SIDE EFFECTS | 1593 | ||
SERIOUS REACTIONS | 1593 | ||
MECHANISM OF ACTION | 1594 | ||
PHARMACOKINETICS | 1594 | ||
AVAILABILITY | 1594 | ||
OFF-LABEL USES | 1594 | ||
CONTRAINDICATIONS | 1594 | ||
DIAGNOSTIC TEST EFFECTS | 1595 | ||
SERIOUS REACTIONS | 1595 | ||
MECHANISM OF ACTION | 1596 | ||
AVAILABILITY | 1596 | ||
CONTRAINDICATIONS | 1596 | ||
DIAGNOSTIC TEST EFFECTS | 1596 | ||
SERIOUS REACTIONS | 1596 | ||
MECHANISM OF ACTION | 1597 | ||
PHARMACOKINETICS | 1597 | ||
AVAILABILITY | 1597 | ||
CONTRAINDICATIONS | 1597 | ||
DIAGNOSTIC TEST EFFECTS | 1597 | ||
SERIOUS REACTIONS | 1597 | ||
MECHANISM OF ACTION | 1598 | ||
PHARMACOKINETICS | 1598 | ||
AVAILABILITY | 1598 | ||
INDICATIONS AND DOSAGES | 1598 | ||
CONTRAINDICATIONS | 1598 | ||
DIAGNOSTIC TEST EFFECTS | 1599 | ||
SERIOUS REACTIONS | 1599 | ||
MECHANISM OF ACTION | 1600 | ||
PHARMACOKINETICS | 1600 | ||
AVAILABILITY | 1600 | ||
OFF-LABEL USES | 1601 | ||
CONTRAINDICATIONS | 1601 | ||
DIAGNOSTIC TEST EFFECTS | 1601 | ||
SERIOUS REACTIONS | 1601 | ||
Toremifene | 1602 | ||
PHARMACOKINETICS | 1602 | ||
AVAILABILITY | 1602 | ||
OFF-LABEL USES | 1602 | ||
CONTRAINDICATIONS | 1602 | ||
DIAGNOSTIC TEST EFFECTS | 1602 | ||
SERIOUS REACTIONS | 1603 | ||
MECHANISM OF ACTION | 1603 | ||
PHARMACOKINETICS | 1604 | ||
AVAILABILITY | 1604 | ||
CONTRAINDICATIONS | 1604 | ||
DIAGNOSTIC TEST EFFECTS | 1604 | ||
IV INCOMPATIBILITIES | 1604 | ||
IV COMPATIBILITIES | 1604 | ||
SERIOUS REACTIONS | 1605 | ||
MECHANISM OF ACTION | 1605 | ||
PHARMACOKINETICS | 1606 | ||
AVAILABILITY | 1606 | ||
CONTRAINDICATIONS | 1606 | ||
DIAGNOSTIC TEST EFFECTS | 1606 | ||
SERIOUS REACTIONS | 1607 | ||
MECHANISM OF ACTION | 1607 | ||
PHARMACOKINETICS | 1607 | ||
AVAILABILITY | 1608 | ||
CONTRAINDICATIONS | 1608 | ||
DIAGNOSTIC TEST EFFECTS | 1608 | ||
SERIOUS REACTIONS | 1608 | ||
Tranexamic acid | 1609 | ||
MECHANISM OF ACTION | 1609 | ||
PHARMACOKINETICS | 1609 | ||
AVAILABILITY | 1609 | ||
INDICATIONS AND DOSAGES | 1609 | ||
CONTRAINDICATIONS | 1609 | ||
INTERACTIONS | 1610 | ||
SIDE EFFECTS | 1610 | ||
SERIOUS REACTIONS | 1610 | ||
MECHANISM OF ACTION | 1611 | ||
AVAILABILITY | 1611 | ||
CONTRAINDICATIONS | 1611 | ||
DIAGNOSTIC TEST EFFECTS | 1611 | ||
SERIOUS REACTIONS | 1612 | ||
Travoprost | 1612 | ||
U\r | 1635 | ||
MECHANISM OF ACTION | 1635 | ||
AVAILABILITY | 1635 | ||
PHARMACOKINETICS | 1635 | ||
OFF-LABEL USES | 1635 | ||
CONTRAINDICATIONS | 1635 | ||
DIAGNOSTIC TEST EFFECTS | 1636 | ||
SIDE EFFECTS | 1636 | ||
SERIOUS REACTIONS | 1636 | ||
MECHANISM OF ACTION | 1636 | ||
PHARMACOKINETICS | 1636 | ||
AVAILABILITY | 1636 | ||
INDICATIONS AND DOSAGES | 1636 | ||
CONTRAINDICATIONS | 1636 | ||
DIAGNOSTIC TEST EFFECTS | 1637 | ||
SERIOUS REACTIONS | 1637 | ||
V\r | 1639 | ||
MECHANISM OF ACTION | 1639 | ||
PHARMACOKINETICS | 1639 | ||
AVAILABILITY | 1639 | ||
CONTRAINDICATIONS | 1639 | ||
DIAGNOSTIC TEST EFFECTS | 1640 | ||
SERIOUS REACTIONS | 1640 | ||
MECHANISM OF ACTION | 1641 | ||
PHARMACOKINETICS | 1641 | ||
AVAILABILITY | 1641 | ||
CONTRAINDICATIONS | 1641 | ||
DIAGNOSTIC TEST EFFECTS | 1642 | ||
SERIOUS REACTIONS | 1642 | ||
MECHANISM OF ACTION | 1643 | ||
PHARMACOKINETICS | 1643 | ||
AVAILABILITY | 1643 | ||
OFF-LABEL USES | 1644 | ||
CONTRAINDICATIONS | 1644 | ||
DIAGNOSTIC TEST EFFECTS | 1644 | ||
IV INCOMPATIBILITIES | 1644 | ||
SERIOUS REACTIONS | 1644 | ||
Valsartan | 1646 | ||
PHARMACOKINETICS | 1646 | ||
AVAILABILITY | 1646 | ||
CONTRAINDICATIONS | 1646 | ||
DIAGNOSTIC TEST EFFECTS | 1646 | ||
SERIOUS REACTIONS | 1647 | ||
MECHANISM OF ACTION | 1647 | ||
PHARMACOKINETICS | 1647 | ||
AVAILABILITY | 1648 | ||
OFF-LABEL USES | 1648 | ||
CONTRAINDICATIONS | 1648 | ||
DIAGNOSTIC TEST EFFECTS | 1648 | ||
IV INCOMPATIBILITIES | 1648 | ||
IV COMPATIBILITIES | 1649 | ||
SERIOUS REACTIONS | 1649 | ||
MECHANISM OF ACTION | 1650 | ||
PHARMACOKINETICS | 1650 | ||
AVAILABILITY | 1650 | ||
INDICATIONS AND DOSAGES | 1650 | ||
CONTRAINDICATIONS | 1650 | ||
INTERACTIONS | 1650 | ||
DIAGNOSTIC TEST EFFECTS | 1651 | ||
SIDE EFFECTS | 1651 | ||
SERIOUS REACTIONS | 1651 | ||
MECHANISM OF ACTION | 1652 | ||
PHARMACOKINETICS | 1652 | ||
AVAILABILITY | 1652 | ||
OFF-LABEL USES | 1653 | ||
CONTRAINDICATIONS | 1653 | ||
DIAGNOSTIC TEST EFFECTS | 1653 | ||
SERIOUS REACTIONS | 1653 | ||
MECHANISM OF ACTION | 1654 | ||
PHARMACOKINETICS | 1654 | ||
AVAILABILITY | 1654 | ||
CONTRAINDICATIONS | 1654 | ||
DIAGNOSTIC TEST EFFECTS | 1654 | ||
SERIOUS REACTIONS | 1654 | ||
MECHANISM OF ACTION | 1655 | ||
PHARMACOKINETICS | 1655 | ||
AVAILABILITY | 1656 | ||
OFF-LABEL USES | 1656 | ||
CONTRAINDICATIONS | 1656 | ||
DIAGNOSTIC TEST EFFECTS | 1656 | ||
IV INCOMPATIBILITIES | 1656 | ||
IV COMPATIBILITIES | 1656 | ||
SERIOUS REACTIONS | 1657 | ||
MECHANISM OF ACTION | 1657 | ||
PHARMACOKINETICS | 1657 | ||
AVAILABILITY | 1658 | ||
INDICATIONS AND DOSAGES | 1658 | ||
CONTRAINDICATIONS | 1658 | ||
INTERACTIONS | 1658 | ||
DIAGNOSTIC TEST EFFECTS | 1658 | ||
SIDE EFFECTS | 1658 | ||
SERIOUS REACTIONS | 1659 | ||
MECHANISM OF ACTION | 1660 | ||
PHARMACOKINETICS | 1660 | ||
AVAILABILITY | 1660 | ||
OFF-LABEL USES | 1660 | ||
CONTRAINDICATIONS | 1660 | ||
DIAGNOSTIC TEST EFFECTS | 1660 | ||
SERIOUS REACTIONS | 1661 | ||
MECHANISM OF ACTION | 1661 | ||
PHARMACOKINETICS | 1662 | ||
AVAILABILITY | 1662 | ||
OFF-LABEL USES | 1663 | ||
CONTRAINDICATIONS | 1663 | ||
DIAGNOSTIC TEST EFFECTS | 1663 | ||
IV INCOMPATIBILITIES | 1663 | ||
IV COMPATIBILITIES | 1663 | ||
SERIOUS REACTIONS | 1664 | ||
MECHANISM OF ACTION | 1665 | ||
PHARMACOKINETICS | 1665 | ||
AVAILABILITY | 1665 | ||
INDICATIONS AND DOSAGES | 1665 | ||
CONTRAINDICATIONS | 1665 | ||
DIAGNOSTIC TEST EFFECTS | 1665 | ||
SERIOUS REACTIONS | 1666 | ||
MECHANISM OF ACTION | 1667 | ||
PHARMACOKINETICS | 1667 | ||
AVAILABILITY | 1667 | ||
INDICATIONS AND DOSAGES | 1667 | ||
CONTRAINDICATIONS | 1667 | ||
INTERACTIONS | 1667 | ||
DIAGNOSTIC TEST EFFECTS | 1667 | ||
SIDE EFFECTS | 1667 | ||
SERIOUS REACTIONS | 1668 | ||
Vitamin A | 1668 | ||
W\r | 1679 | ||
MECHANISM OF ACTION | 1679 | ||
PHARMACOKINETICS | 1679 | ||
Well absorbed from the GI tract. | 1679 | ||
AVAILABILITY | 1679 | ||
CONTRAINDICATIONS | 1679 | ||
DIAGNOSTIC TEST EFFECTS | 1680 | ||
SERIOUS REACTIONS | 1680 | ||
Y\r | 1682 | ||
MECHANISM OF ACTION | 1682 | ||
PHARMACOKINETICS | 1682 | ||
AVAILABILITY | 1682 | ||
INDICATIONS AND DOSAGES | 1682 | ||
OFF-LABEL USES | 1682 | ||
CONTRAINDICATIONS | 1682 | ||
DIAGNOSTIC TEST EFFECTS | 1682 | ||
SIDE EFFECTS | 1682 | ||
SERIOUS REACTIONS | 1683 | ||
Z\r | 1684 | ||
MECHANISM OF ACTION | 1684 | ||
PHARMACOKINETICS | 1684 | ||
AVAILABILITY | 1684 | ||
CONTRAINDICATIONS | 1684 | ||
DIAGNOSTIC TEST EFFECTS | 1684 | ||
SERIOUS REACTIONS | 1684 | ||
MECHANISM OF ACTION | 1685 | ||
AVAILABILITY | 1685 | ||
PHARMACOKINETICS | 1685 | ||
CONTRAINDICATIONS | 1686 | ||
SERIOUS REACTIONS | 1686 | ||
MECHANISM OF ACTION | 1687 | ||
AVAILABILITY | 1687 | ||
PHARMACOKINETICS | 1687 | ||
CONTRAINDICATIONS | 1687 | ||
DIAGNOSTIC TEST EFFECTS | 1687 | ||
SERIOUS REACTIONS | 1688 | ||
MECHANISM OF ACTION | 1688 | ||
PHARMACOKINETICS | 1689 | ||
AVAILABILITY | 1689 | ||
CONTRAINDICATIONS | 1689 | ||
DIAGNOSTIC TEST EFFECTS | 1690 | ||
IV INCOMPATIBILITIES | 1690 | ||
SERIOUS REACTIONS | 1690 | ||
APPENDIX A FDA PREGNANCY CATEGORIES | 1700 | ||
APPENDIX B NORMAL LABORATORY VALUES | 1701 | ||
NORMAL LABORATORY VALUES | 1701 | ||
HEMATOLOGY/COAGULATION | 1701 | ||
CLINICAL CHEMISTRY (SERUM PLASMA/URINE) | 1701 | ||
INDEX | 1703 | ||
IBC | IBC |